EurekaMag PDF full texts Chapter 51,591

Ferreira, I.C.F.R.; Barros, L.; Abreu, R.M.V. 2009: Antioxidants in wild mushrooms. Current Medicinal Chemistry 16(12): 1543-1560

Fiorito, C.; Rienzo, M.; Crimi, E.; Rossiello, R.; Balestrieri, M.Luisa.; Casamassimi, A.; Muto, F.; Grimaldi, V.; Giovane, A.; Farzati, B.; Mancini, F.P.; Napoli, C. 2008: Antioxidants increase number of progenitor endothelial cells through multiple gene expression pathways. Free Radical Research 42(8): 754-762

Rzepczynska, I.J.; Foyouzi, N.; Piotrowski, P.C.; Celik-Ozenci, C.; Cress, A.; Duleba, A.J. 2011: Antioxidants induce apoptosis of rat ovarian theca-interstitial cells. Biology of Reproduction 84(1): 162-166

Da Rosa, D.P.; Forgiarini, L.F.; e Silva, M.B.; Fiori, C.ín.Z.; Andrade, C.F.ó; Martinez, D.ên.; Marroni, N.P. 2015: Antioxidants inhibit the inflammatory and apoptotic processes in an intermittent hypoxia model of sleep apnea. Inflammation Research: Official Journal of the European Histamine Research Society . 64(1): 21-29

Li, X.-y.; Xu, F.; Xing, R.-q.; Li, J.-h.; Liu, B.-w.; Fu, M.-d.; Fu, Q. 2010: Antioxidants inhibit the oxidative modification of high density lipoproteins. Sichuan da Xue Xue Bao. Yi Xue Ban 41(2): 226-230

Naghii, M.R.; Mofid, M.; Hedayati, M.; Khalagi, K. 2014: Antioxidants inhibition of high plasma androgenic markers in the pathogenesis of ethylene glycol (EG)-induced nephrolithiasis in Wistar rats. Urolithiasis 42(2): 97-103

Drouault-Holowacz, S.; Bieuvelet, S.év.; Burckel, A.é; Rigal, D.èl.; Dubray, C.; Lichon, J.-L.; Bringer, P.; Pilon, F.; Chiambaretta, F.éd.ér. 2009: Antioxidants intake and dry eye syndrome: a crossover, placebo-controlled, randomized trial. European Journal of Ophthalmology 19(3): 337-342

Khan, M.T.; van Dijl, J.M.; Harmsen, H.J.M. 2014: Antioxidants keep the potentially probiotic but highly oxygen-sensitive human gut bacterium Faecalibacterium prausnitzii alive at ambient air. Plos one 9(5): E96097

Gao, H.; Wu, X.; Simon, L.; Fossett, N. 2014: Antioxidants maintain E-cadherin levels to limit Drosophila prohemocyte differentiation. Plos one 9(9): E107768

Liu, Z-Qun. 2014: Antioxidants may not always be beneficial to health. Nutrition 30(2): 131-133

Akan, Z.; Garip, A.Inhan. 2013: Antioxidants may protect cancer cells from apoptosis signals and enhance cell viability. Asian Pacific Journal of Cancer Prevention: Apjcp 14(8): 4611-4614

Ahmad, N.; Mukhtar, H. 2013: Antioxidants meet molecular targets for cancer prevention and therapeutics. Antioxidants and Redox Signaling 19(2): 85-88

Skalska, A.; Gasowski, J.; Grodzicki, T. 2009: Antioxidants modify the relationship between endothelin-1 level and glucose metabolism-associated parameters. Metabolism, Clinical and Experimental 58(9): 1229-1233

Liang, J.; Ludescher, R.D. 2011: Antioxidants modulate molecular mobility, oxygen permeability, and microstructure in zein films. Journal of Agricultural and Food Chemistry 59(24): 13173-13180

Zółtowska, K.; Farjan, M.; Lopieńska-Biernat, E.; Rokicki, J. 2008: Antioxidants of Contracaecum rudolphii (Nematoda). Wiadomosci Parazytologiczne 54(3): 237-241

Flores, G.; Dastmalchi, K.; Dabo, A.J.; Whalen, K.; Pedraza-Peñalosa, P.; Foronjy, R.F.; D'Armiento, J.M.; Kennelly, E.J. 2012: Antioxidants of therapeutic relevance in COPD from the neotropical blueberry Anthopterus wardii. Food Chemistry 131(1): 119-125

Sala, G.; Trombin, F.; Beretta, S.; Tremolizzo, L.; Presutto, P.; Montopoli, M.; Fantin, M.; Martinuzzi, A.; Carelli, V.; Ferrarese, C. 2008: Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids. Journal of Neuroscience Research 86(15): 3331-3337

Nguyen-Khac, E.; Thevenot, T.; Piquet, M-Astrid.; Benferhat, S.; Hezam, A.; Goria, O.; Tramier, B.; Chatelain, D.; Dupas, J.Louis. 2008: Antioxidants plus corticosteroids in the treatment of severe acute alcoholic hepatitis: the question is still open. Journal of hepatology 49(1): 147-8; author reply 148

Stehli, J.; Fuchs, T.A.; Ghadri, J.R.; Gaemperli, O.; Fiechter, M.; Kaufmann, P.A. 2014: Antioxidants prevent DNA double-strand breaks from X-ray-based cardiac examinations: a randomized, double-blinded, placebo-controlled trial. Journal of the American College of Cardiology 64(1): 117-118

Talanov, S.A.; Sahach, V.F. 2008: Antioxidants prevent experimental hemiparkinsonism in rats. Fiziolohichnyi Zhurnal 54(4): 23-29

Ristow, M.; Zarse, K.; Oberbach, A.; Klöting, N.; Birringer, M.; Kiehntopf, M.; Stumvoll, M.; Kahn, C.Ronald.; Blüher, M. 2009: Antioxidants prevent health-promoting effects of physical exercise in humans. Proceedings of the National Academy of Sciences of the United States of America 106(21): 8665-8670

Marreilha dos Santos, A.P.; Santos, D.; Au, C.; Milatovic, D.; Aschner, M.; Batoréu, M.Camila.C. 2008: Antioxidants prevent the cytotoxicity of manganese in RBE4 cells. Brain Research 1236: 200-205

Miyake, Y.; Ito, C.; Itoigawa, M.; Osawa, T. 2009: Antioxidants produced by Eurotium herbariorum of filamentous fungi used for the manufacture of karebushi, dried bonito (Katsuobushi). Bioscience Biotechnology and Biochemistry 73(6): 1323-1327

Grönberg, A.; Zettergren, L.; Bergh, K.; Ståhle, M.; Heilborn, J.; Angeby, K.; Small, P.L.; Akuffo, H.; Britton, S. 2010: Antioxidants protect keratinocytes against M. ulcerans mycolactone cytotoxicity. Plos one 5(11): E13839

Lu, J.; Li, W.; Du, X.; Ewert, D.L.; West, M.B.; Stewart, C.; Floyd, R.A.; Kopke, R.D. 2014: Antioxidants reduce cellular and functional changes induced by intense noise in the inner ear and cochlear nucleus. Journal of the Association for Research in Otolaryngology: Jaro 15(3): 353-372

Okunieff, P.; Swarts, S.; Keng, P.; Sun, W.; Wang, W.; Kim, J.; Yang, S.; Zhang, H.; Liu, C.; Williams, J.P.; Huser, A.K.; Zhang, L. 2008: Antioxidants reduce consequences of radiation exposure. Advances in Experimental Medicine and Biology 614: 165-178

Malhotra, J.D.; Miao, H.; Zhang, K.; Wolfson, A.; Pennathur, S.; Pipe, S.W.; Kaufman, R.J. 2008: Antioxidants reduce endoplasmic reticulum stress and improve protein secretion. Proceedings of the National Academy of Sciences of the United States of America 105(47): 18525-18530

Moshkdanian, G.; Nematollahi-Mahani, S.N.; Pouya, F.; Nematollahi-Mahani, A. 2011: Antioxidants rescue stressed embryos at a rate comparable with co-culturing of embryos with human umbilical cord mesenchymal cells. Journal of Assisted Reproduction and Genetics 28(4): 343-349

Ferrer, M.D.; Tauler, P.; Sureda, A.; Palacín, C.; Tur, J.A.; Pons, A. 2013: Antioxidants restore protoporphyrinogen oxidase in variegate porphyria patients. European Journal of Clinical Investigation 43(7): 668-678

Miller, S.J.; Coppinger, B.J.; Zhou, X.; Unthank, J.L. 2010: Antioxidants reverse age-related collateral growth impairment. Journal of Vascular Research 47(2): 108-114

Enescu, O. 2010: Antioxidants rich foods may influence chronic obstructive pulmonary disease evolution. Maedica 5(4): 308

Gallego-Villar, L.; Pérez, B.én.; Ugarte, M.; Desviat, L.R.; Richard, E. 2014: Antioxidants successfully reduce ROS production in propionic acidemia fibroblasts. Biochemical and Biophysical Research Communications 452(3): 457-461

Otero-Losada, M.; Vila, S.; Azzato, F.; Milei, Jé. 2013: Antioxidants supplementation in elderly cardiovascular patients. Oxidative Medicine and Cellular Longevity 2013: 408260

Yang, J.; Su, Y.; Richmond, A. 2007: Antioxidants tiron and N-acetyl-L-cysteine differentially mediate apoptosis in melanoma cells via a reactive oxygen species-independent NF-kappaB pathway. Free Radical Biology and Medicine 42(9): 1369-1380

Ménézo, Y.J.R.; Hazout, A.é; Panteix, G.; Robert, F.ço.; Rollet, J.; Cohen-Bacrie, P.; Chapuis, F.ço.; Clément, P.; Benkhalifa, M. 2007: Antioxidants to reduce sperm DNA fragmentation: an unexpected adverse effect. Reproductive Biomedicine Online 14(4): 418-421

Bendala-Tufanisco, E.; Grisolía, S. 2007: Antioxidants treatment of ocular diseases. Archivos de la Sociedad Espanola de Oftalmologia 82(11): 673; Author Reply 673-4

Chissov, V.I.; Iakubovskaia, R.I.; Nemtsova, E.R.; Osipova, N.A.; Edeleva, N.V.; Utkin, M.M.; Zviagin, A.A. 2008: Antioxidants treatment of severe post-operative pyoinflammatory and septic complications. Khirurgiia 11: 14-19

Bogdan Allemann, I.; Baumann, L. 2008: Antioxidants used in skin care formulations. Skin Therapy Letter 13(7): 5-9

Nan, Y-Min.; Wu, W-Juan.; Fu, N.; Liang, B-Li.; Wang, R-Qi.; Li, L-Xiao.; Zhao, S-Xian.; Zhao, J-Min.; Yu, J. 2009: Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice. Scandinavian Journal of Gastroenterology 44(9): 1121-1131

Aminova, L.R.; Siddiq, A.; Ratan, R.R. 2008: Antioxidants, HIF prolyl hydroxylase inhibitors or short interfering RNAs to BNIP3 or PUMA, can prevent prodeath effects of the transcriptional activator, HIF-1alpha, in a mouse hippocampal neuronal line. Antioxidants and Redox Signaling 10(12): 1989-1998

Dong, Q.; Tollner, T.L.; Rodenburg, S.E.; Hill, D.L.; VandeVoort, C.A. 2010: Antioxidants, Oxyrase, and mitochondrial uncoupler 2,4-dinitrophenol improved postthaw survival of rhesus monkey sperm from ejaculates with low cryosurvival. Fertility and Sterility 94(6): 2359-2361

Obianime, A.W.; Roberts, I.I. 2009: Antioxidants, cadmium-induced toxicity, serum biochemical and the histological abnormalities of the kidney and testes of the male Wistar rats. Nigerian Journal of Physiological Sciences: Official Publication of the Physiological Society of Nigeria 24(2): 177-185

Koleckár, V.; Brojerová, E.; Opletal, L.; Jun, D.; Kuca, K. 2007: Antioxidants, free radicals, mechanism of action and application in the therapy of the sulfur mustard caused injury. Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 56(2): 73-76

Mangge, H.; Becker, K.; Fuchs, D.; Gostner, J.M. 2014: Antioxidants, inflammation and cardiovascular disease. World Journal of Cardiology 6(6): 462-477

Moon, H-Jin.; Ko, W-Kyu.; Han, S.Wook.; Kim, D-Su.; Hwang, Y-Shik.; Park, H-Kuk.; Kwon, I.Keun. 2012: Antioxidants, like coenzyme Q10, selenite, and curcumin, inhibited osteoclast differentiation by suppressing reactive oxygen species generation. Biochemical and Biophysical Research Communications 418(2): 247-253

Enrico, P.; Sirca, D.; Mereu, M. 2007: Antioxidants, minerals, vitamins, and herbal remedies in tinnitus therapy. Progress in Brain Research 166: 323-330

Lay, M.M.; Karsani, S.A.; Banisalam, B.; Mohajer, S.; Abd Malek, S.N. 2014: Antioxidants, phytochemicals, and cytotoxicity studies on Phaleria macrocarpa (Scheff.) Boerl seeds. Biomed Research International 2014: 410184

Yao, J.K.; Keshavan, M.S. 2011: Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxidants and Redox Signaling 15(7): 2011-2035

Pizent, A.; Pavlovic, M.; Jurasovic, J.; Dodig, S.; Pasalic, D.; Mujagic, R. 2010: Antioxidants, trace elements and metabolic syndrome in elderly subjects. Journal of Nutrition Health and Aging 14(10): 866-871

Meffert, H. 2008: Antioxidants--friend or foe?. German Medical Science: Gms E-Journal 6: Doc09

Anonymous 2007: Antioxidants. Preventing disease, naturally. Mayo Clinic Health Letter 25(9): 7

Anonymous 2013: Antioxidants. Reap the benefits from food sources. Mayo Clinic Health Letter 31(11): 1-3

Venkatesh, P.; Satpal, G.; Verma, L.; Kumar, T.H.; Garg, S. 2001: Antioxidants: Basis concepts in relation to the eye. Indian Journal of Clinical Biochemistry: Ijcb 16(1): 9-14

Forman, H.J.; Traber, M.; Ursini, F. 2014: Antioxidants: GRABbing new headlines. Free Radical Biology and Medicine 66: 1-2

Gutteridge, J.M.C.; Halliwell, B. 2010: Antioxidants: Molecules, medicines, and myths. Biochemical and Biophysical Research Communications 393(4): 561-564

Block, K.I. 2009: Antioxidants: SELECTed out?. Integrative Cancer Therapies 8(1): 5-8

Fliesler, S.J. 2013: Antioxidants: the Missing Key to Improved Therapeutic Intervention in Smith-Lemli-Opitz Syndrome?. Hereditary Genetics: Current Research 2(2): 119

Tewari, A.; Mahendru, V.; Sinha, A.; Bilotta, F. 2014: Antioxidants: The new frontier for translational research in cerebroprotection. Journal of Anaesthesiology Clinical Pharmacology 30(2): 160-171

Pauwels, E.K.J.; Erba, P.A.; Kostkiewicz, M. 2007: Antioxidants: a tale of two stories. Drug News and Perspectives 20(9): 579-585

Niki, E. 2014: Antioxidants: basic principles, emerging concepts, and problems. Biomedical Journal 37(3): 106-111

Yoshihara, D.; Fujiwara, N.; Suzuki, K. 2010: Antioxidants: benefits and risks for long-term health. Maturitas 67(2): 103-107

Coleman, M.D. 2001: Antioxidants: unlocking their potential. Environmental Toxicology and Pharmacology 10(4): 139-140

Tregubova, I.A.; Kosolapov, V.A.; Spasov, A.A. 2012: Antioxidants: current situation and perspectives. Uspekhi Fiziologicheskikh Nauk 43(1): 75-94

Anonymous 2009: Antioxidants: not for prevention. Prescrire International 18(99): 34

Zhang, Y.; Wang, Z.; Chen, H.; Chen, Z.; Tian, Y. 2014: Antioxidants: potential antiviral agents for Japanese encephalitis virus infection. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 24: 30-36

Coleman, M.D. 2001: Antioxidants: unlocking their potential. Environmental Toxicology and Pharmacology 10(4): 139-140

Liu, Y.-C.; Yang, Z.-Y. 2010: Antioxidation and DNA-binding properties of binuclear Er(III) complexes with Schiff-base ligands derived from 8-hydroxyquinoline-2-carboxaldehyde and four aroylhydrazines. Journal of Biochemistry 147(3): 381-391

Liu, Y.; Zhang, K.; Wu, Y.; Zhao, J.; Liu, J. 2012: Antioxidation and DNA-binding properties of binuclear lanthanide(III) complexes with a Schiff base ligand derived from 8-hydroxyquinoline-7-carboxaldehyde and benzoylhydrazine. Chemistry and Biodiversity 9(8): 1533-1544

Sue, Y-Mou.; Cheng, C-Feng.; Chang, C-Cheng.; Chou, Y.; Chen, C-Hsien.; Juan, S-Hui. 2009: Antioxidation and anti-inflammation by haem oxygenase-1 contribute to protection by tetramethylpyrazine against gentamicin-induced apoptosis in murine renal tubular cells. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 24(3): 769-777

Zhao, J.; Song, T.; Ying, S.; Feng, M. 2013: Antioxidation and multidrug resistance of structure-similar ATP-binding cassette transporter proteins in two fungal entomopathogens. Wei Sheng Wu Xue Bao 53(1): 24-30

Pokorski, M.; Rekawek, A.; Zasada, I.; Antosiewicz, J.; Delgado, R. 2012: Antioxidation and the hypoxic ventilatory response. Advances in Experimental Medicine and Biology 758: 373-380

Du, Z.-Y.; Jiang, Y.-F.; Tang, Z.-K.; Mo, R.-Q.; Xue, G.-H.; Lu, Y.-J.; Zheng, X.; Dong, C.-Z.; Zhang, K. 2011: Antioxidation and tyrosinase inhibition of polyphenolic curcumin analogs. Bioscience Biotechnology and Biochemistry 75(12): 2351-2358

Pei, M.; Zhang, Y.; Li, J.; Chen, D. 2013: Antioxidation of decellularized stem cell matrix promotes human synovium-derived stem cell-based chondrogenesis. Stem Cells and Development 22(6): 889-900

Lee, I-Chul.; Kim, D.Yong.; Choi, B.Young. 2014: Antioxidative Activity of Blueberry Leaf Extract Prevents High-fat Diet-induced Obesity in C57BL/6 Mice. Journal of Cancer Prevention 19(3): 209-215

Zhang, L.-J.; Yeh, S.-F.; Yu, Y.-T.; Kuo, L.-M.Y.; Kuo, Y.-H. 2011: Antioxidative Flavonol Glucuronides and Anti-HBsAg Flavonol from Rotala rotundifolia. Journal of Traditional and Complementary Medicine 1(1): 57-63

Nishimura, K.; Murakoshi, M.; Katayama, S.; Saeki, H. 2011: Antioxidative ability of chicken myofibrillar protein developed by glycosylation and changes in the solubility and thermal stability. Bioscience Biotechnology and Biochemistry 75(2): 247-254

Liu, Y.-M.; Lin, K.-W. 2009: Antioxidative ability, dioscorin stability, and the quality of yam chips from various yam species as affected by processing method. Journal of Food Science 74(2): C118-C125

Tauseef, M.; Shahid, M.; Sharma, K.K.; Fahim, M. 2008: Antioxidative action of aspirin on endothelial function in hypercholesterolaemic rats. Basic and Clinical Pharmacology and Toxicology 103(4): 314-321

Kim, H.-J.; Kim, B.-H.; Kim, Y.-C. 2011: Antioxidative action of corni fructus aqueous extract on kidneys of diabetic mice. Toxicological Research 27(1): 37-41

Gomes, R.de.Camargo.; Bonamin, Fávia.; Darin, D.Delabio.; Seito, L.Noboru.; Di Stasi, L.Claudio.; Dokkedal, A.Ligia.; Vilegas, W.; Souza Brito, A.Regina.Monteiro.; Hiruma-Lima, Célia.Akiko. 2009: Antioxidative action of methanolic extract and buthanolic fraction of Vochysia tucanorum Mart. in the gastroprotection. Journal of Ethnopharmacology 121(3): 466-471

Guo, D.-J.; Cheng, H.-L.; Chan, S.-W.; Yu, P.H.-F. 2008: Antioxidative activities and the total phenolic contents of tonic Chinese medicinal herbs. Inflammopharmacology 16(5): 201-207

Midoh, N.; Tanaka, A.; Nagayasu, M.; Furuta, C.; Suzuki, K.; Ichikawa, T.; Isomura, T.; Nomura, K. 2010: Antioxidative activities of Oxindole-3-acetic acid derivatives from supersweet corn powder. Bioscience Biotechnology and Biochemistry 74(9): 1794-1801

Dambeck, M.; Sandmann, G. 2014: Antioxidative activities of algal keto carotenoids acting as antioxidative protectants in the chloroplast. Photochemistry and Photobiology 90(4): 814-819

Seo, H.-S.; Kwak, S.-Y.; Lee, Y.-S. 2010: Antioxidative activities of histidine containing caffeic acid-dipeptides. Bioorganic and Medicinal Chemistry Letters 20(14): 4266-4272

Bao, H.N.D.; Ochiai, Y.; Ohshima, T. 2010: Antioxidative activities of hydrophilic extracts prepared from the fruiting body and spent culture medium of Flammulina velutipes. Bioresource Technology 101(15): 6248-6255

Liu, Q.-M.; Jiang, J.-G. 2012: Antioxidative activities of medicinal plants from TCM. Mini Reviews in Medicinal Chemistry 12(11): 1154-1172

Bao, H.N.D.; Ushio, H.; Ohshima, T. 2009: Antioxidative activities of mushroom (Flammulina velutipes) extract added to bigeye tuna meat: dose-dependent efficacy and comparison with other biological antioxidants. Journal of Food Science 74(2): C162-C169

Park, D.; Jeon, J.H.; Kwon, S.-C.; Shin, S.; Jang, J.Y.; Jeong, H.S.; Lee, D.I.; Kim, Y.-B.; Joo, S.S. 2009: Antioxidative activities of white rose flower extract and pharmaceutical advantages of its hexane fraction via free radical scavenging effects. Biochemistry and Cell Biology 87(6): 943-952

Hsieh, M.-C.; Shen, Y.-J.; Kuo, Y.-H.; Hwang, L.S. 2008: Antioxidative activity and active components of longan (Dimocarpus longan Lour.) flower extracts. Journal of Agricultural and Food Chemistry 56(16): 7010-7016

Bao, H.N.D.; Ushio, H.; Ohshima, T. 2008: Antioxidative activity and antidiscoloration efficacy of ergothioneine in mushroom (Flammulina velutipes) extract added to beef and fish meats. Journal of Agricultural and Food Chemistry 56(21): 10032-10040

Ninomiya, M.; Satoh, H.; Yamaguchi, Y.; Takenaka, H.; Koketsu, M. 2011: Antioxidative activity and chemical constituents of edible terrestrial alga Nostoc commune Vauch. Bioscience Biotechnology and Biochemistry 75(11): 2175-2177

Ibrahim, M.Auwal.; Koorbanally, N.Anthony.; Islam, M.Shahidul. 2014: Antioxidative activity and inhibition of key enzymes linked to type-2 diabetes (α-glucosidase and α-amylase) by Khaya senegalensis. Acta Pharmaceutica 64(3): 311-324

Masteikova, R.ūt.; Muselik, J.; Bernatoniene, J.; Bernatoniene, R.ūt. 2007: Antioxidative activity of Ginkgo, Echinacea, and Ginseng tinctures. Medicina 43(4): 306-309

Milaeva, E.R.; Filimonova, S.I.; Meleshonkova, N.N.; Dubova, L.G.; Shevtsova, E.F.; Bachurin, S.O.; Zefirov, N.S. 2010: Antioxidative activity of ferrocenes bearing 2,6-di-tert-butylphenol moieties. Bioinorganic Chemistry and Applications 2010: 165482

Shim, J.U.; Lim, K.T. 2009: Antioxidative activity of glycoprotein isolated from Geranium sibiricum Linne. Natural Product Research 23(4): 375-387

Xu, M.; Shangguan, X.; Wang, W.; Chen, J. 2007: Antioxidative activity of hen egg ovalbumin hydrolysates. Asia Pacific Journal of Clinical Nutrition 16(Suppl 1): 178-182

Takagaki, A.; Otani, S.; Nanjo, F. 2011: Antioxidative activity of microbial metabolites of (-)-epigallocatechin gallate produced in rat intestines. Bioscience Biotechnology and Biochemistry 75(3): 582-585

Lin, C.L.; Wang, C.C.; Chang, S.C.; Inbaraj, B.S.; Chen, B.H. 2009: Antioxidative activity of polysaccharide fractions isolated from Lycium barbarum Linnaeus. International Journal of Biological Macromolecules 45(2): 146-151

Cigut, T.; Polak, T.ž; Gašperlin, L.; Raspor, P.; Jamnik, P. 2011: Antioxidative activity of propolis extract in yeast cells. Journal of Agricultural and Food Chemistry 59(21): 11449-11455

Bilinska, M.; Wolszakiewicz, J.; Duda, M.; Janas, J.; Beresewicz, A.; Piotrowicz, R. 2009: Antioxidative activity of sulodexide, a glycosaminoglycan, in patients with stable coronary artery disease: a pilot study. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 15(12): Cr618-Cr623

Awatsuhara, R.; Harada, K.; Maeda, T.; Nomura, T.; Nagao, K. 2010: Antioxidative activity of the buckwheat polyphenol rutin in combination with ovalbumin. Molecular Medicine Reports 3(1): 121-125

Schönfeld, P.; Kruska, N.; Reiser, G. 2009: Antioxidative activity of the olive oil constituent hydroxy-1-aryl-isochromans in cells and cell-free systems. Biochimica et Biophysica Acta 1790(12): 1698-1704

Ovchinnikova, L.P.; Rotskaia, U.N.; Vasiunina, E.A.; Sinitsina, O.I.; Kandalintseva, N.V.; Prosenko, A.E.; Nevinskiĭ, G.A. 2009: Antioxidative activity of thiophane [bis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propyl)sulfide. Bioorganicheskaia Khimiia 35(3): 417-423

Liao, W.C.; Lai, Y.-C.; Yuan, M.-C.; Hsu, Y.-L.; Chan, C.-F. 2011: Antioxidative activity of water extract of sweet potato leaves in Taiwan. Food Chemistry 127(3): 1224-1228

Nara, K.; Yamaguchi, A.; Maeda, N.; Koga, H. 2009: Antioxidative activity of water soluble polysaccharide in pumpkin fruits (Cucurbita maxima Duchesne). Bioscience Biotechnology and Biochemistry 73(6): 1416-1418

Whang, K.; Aberle, E.D.; Judge, M.D.; Peng, I.C. 1986: Antioxidative activity of α-tocopherol in cooked and uncooked ground pork. Meat Science 17(4): 235-249

Liao, W.C.; Hsueh, C-Yen.; Chan, C-Feng. 2014: Antioxidative activity, moisture retention, film formation, and viscosity stability of Auricularia fuscosuccinea, white strain water extract. Bioscience Biotechnology and Biochemistry 78(6): 1029-1036

Kusirisin, W.; Srichairatanakool, S.; Lerttrakarnnon, P.; Lailerd, N.; Suttajit, M.; Jaikang, C.; Chaiyasut, C. 2009: Antioxidative activity, polyphenolic content and anti-glycation effect of some Thai medicinal plants traditionally used in diabetic patients. Medicinal Chemistry 5(2): 139-147

Kwon, S.-C.; Kim, Y.-B. 2011: Antioxidative and aldose reductase-inhibitory effects of a fermentation filtrate of Rubus coreanus. Laboratory Animal Research 27(4): 365-368

Samaranayaka, A.G.P.; Kitts, D.D.; Li-Chan, E.C.Y. 2010: Antioxidative and angiotensin-I-converting enzyme inhibitory potential of a Pacific Hake ( Merluccius productus ) fish protein hydrolysate subjected to simulated gastrointestinal digestion and Caco-2 cell permeation. Journal of Agricultural and Food Chemistry 58(3): 1535-1542

Yang, C.S.; Lambert, J.D.; Sang, S. 2009: Antioxidative and anti-carcinogenic activities of tea polyphenols. Archives of Toxicology 83(1): 11-21

Rifaioglu, M.M.; Nacar, A.; Yuksel, R.; Yonden, Z.; Karcioglu, M.; Zorba, O.U.; Davarci, I.; Sefil, N.K. 2013: Antioxidative and anti-inflammatory effect of thymoquinone in an acute Pseudomonas prostatitis rat model. Urologia Internationalis 91(4): 474-481

Chan, K.-c.; Mong, M.-c.; Yin, M.-c. 2009: Antioxidative and anti-inflammatory neuroprotective effects of astaxanthin and canthaxanthin in nerve growth factor differentiated PC12 cells. Journal of Food Science 74(7): H225-H231

Tsai, S.-J.; Kuo, W.-W.; Liu, W.-H.; Yin, M.-C. 2010: Antioxidative and anti-inflammatory protection from carnosine in the striatum of MPTP-treated mice. Journal of Agricultural and Food Chemistry 58(21): 11510-11516

Li, J.; Wang, Q.; Cheng, D.; Xiong, C.-L. 2014: Antioxidative and antiapoptotic effects of the Attractin gene on Sertoli cells in mice. Zhonghua Nan Ke Xue 20(9): 787-791

Chanda, S.; Dudhatra, S.; Kaneria, M. 2010: Antioxidative and antibacterial effects of seeds and fruit rind of nutraceutical plants belonging to the Fabaceae family. Food and Function 1(3): 308-315

Lee, C.-C.; Hsieh, H.J.; Hsieh, C.-H.; Hwang, D.-F. 2014: Antioxidative and anticancer activities of various ethanolic extract fractions from crown-of-thorns starfish (Acanthaster planci). Environmental Toxicology and Pharmacology 38(3): 761-773

Ali Hassan, S.H.; Abu Bakar, M.F. 2013: Antioxidative and anticholinesterase activity of Cyphomandra betacea fruit. Thescientificworldjournal 2013: 278071

Jang, I.-C.; Park, J.-H.; Park, E.; Park, H.-R.; Lee, S.-C. 2008: Antioxidative and antigenotoxic activity of extracts from cosmos (Cosmos bipinnatus) flowers. Plant Foods for Human Nutrition 63(4): 205-210

Park, J.-H.; Park, Y.K.; Park, E. 2009: Antioxidative and antigenotoxic effects of garlic (Allium sativum L.) prepared by different processing methods. Plant Foods for Human Nutrition 64(4): 244-249

Dartsch, P.C.; Kler, A.; Kriesl, E. 2009: Antioxidative and antiinflammatory potential of different functional drink concepts in vitro. PhytoTherapy Research: Ptr 23(2): 165-171

Oh, H.-T.; Kim, S.-H.; Choi, H.-J.; Chung, M.J.; Ham, S.-S. 2008: Antioxidative and antimutagenic activities of 70% ethanol extract from masou salmon (Oncorhynchus masou). Toxicology in Vitro: An International Journal Published in Association with Bibra 22(6): 1484-1488

Cetojević-Simin, D.D.; Canadanović-Brunet, J.M.; Bogdanović, G.M.; Djilas, S.M.; Cetković, G.S.; Tumbas, V.T.; Stojiljković, B.T. 2010: Antioxidative and antiproliferative activities of different horsetail (Equisetum arvense L.) extracts. Journal of Medicinal Food 13(2): 452-459

Cetojević-Simin, D.D.; Canadanović-Brunet, J.M.; Bogdanović, G.M.; Cetković, G.S.; Tumbas, V.T.; Djilas, S.M. 2004: Antioxidative and antiproliferative effects of Satureja montana L. extracts. Journal of BUON: Official Journal of the Balkan Union of Oncology 9(4): 443-449

Prabhu, P.N.; Ashokkumar, P.; Sudhandiran, G. 2009: Antioxidative and antiproliferative effects of astaxanthin during the initiation stages of 1,2-dimethyl hydrazine-induced experimental colon carcinogenesis. Fundamental and Clinical Pharmacology 23(2): 225-234

Kosaric, J.V.; Cvetkovic, D.M.; Zivanovic, M.N.; Curcic, M.G.; Seklic, D.S.; Bugarcic, Z.M.; Markovic, S.D. 2014: Antioxidative and antiproliferative evaluation of 2-(phenylselenomethyl)tetrahydrofuran and 2-(phenylselenomethyl)tetrahydropyran. Journal of BUON: Official Journal of the Balkan Union of Oncology 19(1): 283-290

Zhang, X.-Y.; Li, W.-G.; Wu, Y.-J.; Tian, X. 2007: Antioxidative and antitumor activity of derivatives of 4-beta-amino-4'-demethylepipodophyllotoxin and their structure-activity relationship. Die Pharmazie 62(6): 432-438

Cakar, J.; Parić, A.; Maksimović, M.; Bajrović, K. 2012: Antioxidative and antitumor properties of in vitro-cultivated broccoli (Brassica oleracea var. italica). Pharmaceutical Biology 50(2): 175-181

Yook, H.-S.; Kim, K.-H.; Park, J.-E.; Shin, H.-J. 2010: Antioxidative and antiviral properties of flowering cherry fruits (Prunus serrulata L. var. spontanea). American Journal of Chinese Medicine 38(5): 937-948

Jiang, J.; Yuan, X.; Wang, T.; Chen, H.; Zhao, H.; Yan, X.; Wang, Z.; Sun, X.; Zheng, Q. 2014: Antioxidative and cardioprotective effects of total flavonoids extracted from Dracocephalum moldavica L. against acute ischemia/reperfusion-induced myocardial injury in isolated rat heart. Cardiovascular Toxicology 14(1): 74-82

Khoo, H.Eng.; Azlan, A.; Nurulhuda, M.Halid.; Ismail, A.; Abas, F.; Hamid, M.; Roowi, S. 2013: Antioxidative and cardioprotective properties of anthocyanins from defatted dabai extracts. Evidence-Based Complementary and Alternative Medicine: Ecam 2013: 434057

Behera, B.C.; Mahadik, N.; Morey, M. 2012: Antioxidative and cardiovascular-protective activities of metabolite usnic acid and psoromic acid produced by lichen species Usnea complanata under submerged fermentation. Pharmaceutical Biology 50(8): 968-979

Zhang, K.; Yang, L.; Lu, F.; Wu, X.; Zhu, J.-J. 2018: A Universal Upconversion Sensing Platform for the Sensitive Detection of Tumour-Related ncRNA through an Exo III-Assisted Cycling Amplification Strategy. Small 14(10)

Farombi, E.O.; Owoeye, O. 2011: Antioxidative and chemopreventive properties of Vernonia amygdalina and Garcinia biflavonoid. International Journal of Environmental Research and Public Health 8(6): 2533-2555

Hong, J.-H.; Lee, J.-W.; Park, J.-H.; Lee, I.-S. 2007: Antioxidative and cytoprotective effects of Artemisia capillaris fractions. Biofactors 31(1): 43-53

Yang, L.; Zhou, C.; Huang, K.; Song, L.; Zheng, Q.; Yu, R.; Zhang, R.; Wu, Y.; Zeng, S.; Cheng, C.H.K.; Zhao, Y.; Li, X.; Qu, J. 2009: Antioxidative and cytotoxic properties of diarylheptanoids isolated from Zingiber officinale. Zhongguo Zhong Yao Za Zhi 34(3): 319-323

Intarasirisawat, R.; Benjakul, S.; Visessanguan, W.; Wu, J. 2012: Antioxidative and functional properties of protein hydrolysate from defatted skipjack (Katsuwonous pelamis) roe. Food Chemistry 135(4): 3039-3048

Chen, H.-L.; Wang, C.-H.; Kuo, Y.-W.; Tsai, C.-H. 2011: Antioxidative and hepatoprotective effects of fructo-oligosaccharide in d-galactose-treated Balb/cJ mice. British Journal of Nutrition 105(6): 805-809

Chen, Y.-H.; Lin, F.-Y.; Liu, P.-L.; Huang, Y.-T.; Chiu, J.-H.; Chang, Y.-C.; Man, K.-M.; Hong, C.-Y.; Ho, Y.-Y.; Lai, M.-T. 2009: Antioxidative and hepatoprotective effects of magnolol on acetaminophen-induced liver damage in rats. Archives of Pharmacal Research 32(2): 221-228

Chung, M.J.; Sung, N.-J.; Park, C.-S.; Kweon, D.-K.; Mantovani, A.; Moon, T.-W.; Lee, S.-J.; Park, K.-H. 2008: Antioxidative and hypocholesterolemic activities of water-soluble puerarin glycosides in HepG2 cells and in C57 BL/6J mice. European Journal of Pharmacology 578(2-3): 159-170

Kalpana, K.; Pugalendi, K.V. 2011: Antioxidative and hypolipidemic efficacy of alcoholic seed extract of Swietenia macrophylla in streptozotocin diabetic rats. Journal of Basic and Clinical Physiology and Pharmacology 22(1-2): 11-21

Pongpom, M.; Sawatdeechaikul, P.; Kummasook, A.; Khanthawong, S.; Vanittanakom, N. 2013: Antioxidative and immunogenic properties of catalase-peroxidase protein in Penicillium marneffei. Medical Mycology 51(8): 835-842

Yuan, C.; Wang, C.; Bu, Y.; Xiang, T.; Huang, X.; Wang, Z.; Yi, F.; Ren, G.; Liu, G.; Song, F. 2010: Antioxidative and immunoprotective effects of Pyracantha fortuneana (Maxim.) Li polysaccharides in mice. Immunology Letters 133(1): 14-18

Predes, F.S.; Ruiz, A.L.T.G.; Carvalho, J.ão.E.; Foglio, M.A.; Dolder, H. 2011: Antioxidative and in vitro antiproliferative activity of Arctium lappa root extracts. Bmc Complementary and Alternative Medicine 11: 25

Akihisa, T.; Kawashima, K.; Orido, M.; Akazawa, H.; Matsumoto, M.; Yamamoto, A.; Ogihara, E.; Fukatsu, M.; Tokuda, H.; Fuji, J. 2013: Antioxidative and melanogenesis-inhibitory activities of caffeoylquinic acids and other compounds from moxa. Chemistry and Biodiversity 10(3): 313-327

Popov, A.M.; Krivoshapko, O.N.; Osipov, A.N.; Korepanova, E.A. 2014: Antioxidative and membranotropic activities of rosmarinic acid. Voprosy Pitaniia 83(3): 25-31

Asadullina, N.R.; Usacheva, A.M.; Smirnova, V.S.; Gudkov, S.V. 2010: Antioxidative and radiation modulating properties of guanosine-5'-monophosphate. Nucleosides Nucleotides and Nucleic Acids 29(10): 786-799

Kumar, R.; Bansal, D.D.; Patel, D.D.; Mishra, S.; Karamalakova, Y.; Zheleva, A.; Gadjeva, V.; Sharma, R.K. 2011: Antioxidative and radioprotective activities of semiquinone glucoside derivative (SQGD) isolated from Bacillus sp. INM-1. Molecular and Cellular Biochemistry 349(1-2): 57-67

Patil, S.L.; Mallaiah, S.H.; Patil, R.K. 2013: Antioxidative and radioprotective potential of rutin and quercetin in Swiss albino mice exposed to gamma radiation. Journal of Medical Physics 38(2): 87-92

Sung, J.-H.; Park, S.-H.; Seo, D.-H.; Lee, J.-H.; Hong, S.-W.; Hong, S.-S. 2009: Antioxidative and skin-whitening effect of an aqueous extract of Salicornia herbacea. Bioscience Biotechnology and Biochemistry 73(3): 552-556

Gurbuz, N.; Coskun, Z.K.; Omeroglu, S.; Bayraktar, A.C.; Ciraci, Z. 2013: Antioxidative and therapeutic effects of spirulina on trichloroethylene induced cutaneous irritation balb/c mice. Bratislavske Lekarske Listy 114(4): 192-198

Sun, Y.; Jiang, J.; Zhang, Z.; Yu, P.; Wang, L.; Xu, C.; Liu, W.; Wang, Y. 2008: Antioxidative and thrombolytic TMP nitrone for treatment of ischemic stroke. Bioorganic and Medicinal Chemistry 16(19): 8868-8874

Okokon, J.E.; Nwafor, P.A.; Charles, U.; Dar, A.; Choudhary, M.I. 2013: Antioxidative burst and hepatoprotective effects of ethanol root extract of Hippocratea africana against paracetamol-induced liver injury. Pharmaceutical Biology 51(7): 872-880

Lin, Y.-L.; Lu, C.-K.; Huang, Y.-J.; Chen, H.-J. 2011: Antioxidative caffeoylquinic acids and flavonoids from Hemerocallis fulva flowers. Journal of Agricultural and Food Chemistry 59(16): 8789-8795

Iwamoto, N.; Kobayashi, T.; Adachi, S. 2009: Antioxidative capacities of durum wheat flour and its components on linoleic acid. Journal of Oleo Science 58(10): 537-541

Fang, Y.; Wang, H.; Zhu, W.; Wang, L.; Liu, H.; He, Y.; Xu, X.; Yin, W.; Sima, Y.; Xu, S. 2014: Antioxidative capacity in the fat body of Bombyx mori is increased following oral administration of 4-methylumbelliferone. Comparative Biochemistry and Physiology. Toxicology and Pharmacology: Cbp 159: 31-37

Lens, M.; Medenica, L.; Citernesi, U. 2008: Antioxidative capacity of C(60) (buckminsterfullerene) and newly synthesized fulleropyrrolidine derivatives encapsulated in liposomes. Biotechnology and Applied Biochemistry 51(Part 3): 135-140

Persichetti, E.; De Michele, A.; Codini, M.; Traina, G. 2014: Antioxidative capacity of Lactobacillus fermentum LF31 evaluated in vitro by oxygen radical absorbance capacity assay. Nutrition 30(7-8): 936-938

Chou, T.-H.; Ding, H.-Y.; Hung, W.J.; Liang, C.-H. 2010: Antioxidative characteristics and inhibition of alpha-melanocyte-stimulating hormone-stimulated melanogenesis of vanillin and vanillic acid from Origanum vulgare. Experimental Dermatology 19(8): 742-750

Huang, H.-C.; Lien, H.-M.; Ke, H.-J.; Chang, L.-L.; Chen, C.-C.; Chang, T.-M. 2012: Antioxidative characteristics of Anisomeles indica extract and inhibitory effect of ovatodiolide on melanogenesis. International Journal of Molecular Sciences 13(5): 6220-6235

Kim, J.-I.; Kim, H.-H.; Kim, S.; Lee, K.-T.; Ham, I.-H.; Whang, W.-K. 2008: Antioxidative compounds from Quercus salicina Blume stem. Archives of Pharmacal Research 31(3): 274-278

Ostrowska-Nawarycz, L.; Rutkowski, M.; Fijałkowski, P.ł; Błaszczyk, J.; Majczyk, M.łg.; Nawarycz, T. 2007: Antioxidative defense and level of microelements in youth with hypertension. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 23(136): 255-258

Petrović, V.; Buzadžić, B.; Korać, A.; Korać, B. 2010: Antioxidative defense and mitochondrial thermogenic response in brown adipose tissue. Genes and Nutrition 5(3): 225-235

Pristov, J.B.; Spasojevic, I.; Mikovic, Z.; Mandic, V.; Cerovic, N.; Spasic, M. 2009: Antioxidative defense enzymes in placenta protect placenta and fetus in inherited thrombophilia from hydrogen peroxide. Oxidative Medicine and Cellular Longevity 2(1): 14-18

Lim, J.L.; Wilhelmus, M.M.M.; de Vries, H.E.; Drukarch, B.; Hoozemans, J.J.M.; van Horssen, J. 2014: Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases. Archives of Toxicology 88(10): 1773-1786

Abogadallah, G.M. 2010: Antioxidative defense under salt stress. Plant Signaling and Behavior 5(4): 369-374

Wang, L.; Gao, S.; Jiang, W.; Luo, C.; Xu, M.; Bohlin, L.; Rosendahl, M.; Huang, W. 2014: Antioxidative dietary compounds modulate gene expression associated with apoptosis, DNA repair, inhibition of cell proliferation and migration. International Journal of Molecular Sciences 15(9): 16226-16245

Lin, H.-Y.; Kuo, Y.-H.; Lin, Y.-L.; Chiang, W. 2009: Antioxidative effect and active components from leaves of Lotus ( Nelumbo nucifera ). Journal of Agricultural and Food Chemistry 57(15): 6623-6629

Guo, J.; Jono, H.; Kugimiya, T.; Saito, S.; Maruyama, T.; Misumi, Y.; Hoshii, Y.; Su, Y.; Shono, M.; Ueda, M.; Obayashi, K.; Otagiri, M.; Ando, Y. 2011: Antioxidative effect of albumin on amyloid fibril formation in transthyretin-related amyloidosis. Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis 18(Suppl 1): 17-18

Demirci, B.; Demir, O.; Dost, T.; Birincioglu, M. 2014: Antioxidative effect of aspirin on vascular function of aged ovariectomized rats. Age 36(1): 223-229

Dhar, P.; Chattopadhyay, K.; Bhattacharyya, D.; Roychoudhury, A.; Biswas, A.; Ghosh, S. 2006: Antioxidative effect of conjugated linolenic acid in diabetic and non-diabetic blood: an in vitro study. Journal of Oleo Science 56(1): 19-24

Aziza, A.E.; Quezada, N.; Cherian, G. 2010: Antioxidative effect of dietary Camelina meal in fresh, stored, or cooked broiler chicken meat. Poultry Science 89(12): 2711-2718

Sáyago-Ayerdi, S.G.; Brenes, A.; Viveros, A.; Goñi, I. 2009: Antioxidative effect of dietary grape pomace concentrate on lipid oxidation of chilled and long-term frozen stored chicken patties. Meat Science 83(3): 528-533

Moravcova, A.; Cervinkova, Z.; Kucera, O.; Mezera, V.; Lotkova, H. 2014: Antioxidative effect of epigallocatechin gallate against D-galactosamine-induced injury in primary culture of rat hepatocytes. Acta Medica 57(1): 3-8

Chakraborty, S.Prasad.; Mahapatra, S.Kar.; Sahu, S.Kumar.; Pramanik, P.; Roy, S. 2011: Antioxidative effect of folate-modified chitosan nanoparticles. Asian Pacific Journal of Tropical Biomedicine 1(1): 29-38

Alemán, M.; Bou, R.; Guardiola, F.; Durand, E.; Villeneuve, P.; Jacobsen, C.; Sørensen, A-Dorit.Moltke. 2015: Antioxidative effect of lipophilized caffeic acid in fish oil enriched mayonnaise and milk. Food Chemistry 167: 236-244

Li, C-Ying.; Kim, H-Woong.; Li, H.; Lee, D-Chan.; Rhee, H-Ik. 2014: Antioxidative effect of purple corn extracts during storage of mayonnaise. Food Chemistry 152: 592-596

Asnani, V.; Verma, R.J. 2007: Antioxidative effect of rhizome of Zinziber officinale on paraben induced lipid peroxidation: an in vitro study. Acta Poloniae Pharmaceutica 64(1): 35-37

Sengupta, A.; Ghosh, M.; Bhattacharyya, D.K. 2014: Antioxidative effect of rice bran oil and medium chain fatty acid rich rice bran oil in arsenite induced oxidative stress in rats. Journal of Oleo Science 63(11): 1117-1124

Silici, S.; Ekmekcioglu, O.; Eraslan, G.; Demirtas, A. 2009: Antioxidative effect of royal jelly in cisplatin-induced testes damage. Urology 74(3): 545-551

Sersen, F.; Walko, M.; Loos, D. 2009: Antioxidative effect of some hydroxy substituted aromatic bisimines. General Physiology and Biophysics 28(2): 210-214

Hudz', I.A.; Hula, N.M.; Khmel', T.O.; Horid'ko, T.M.; Berdyshev, A.H. 2011: Antioxidative effect of the N-stearoylethanolamine in the heart tissue and blood plasma of rats under doxorubicin treatment. Ukrains'kyi Biokhimichnyi Zhurnal 83(6): 86-91

Kang, Y.; Hu, M.; Zhu, Y.; Gao, X.; Wang, M.-W. 2009: Antioxidative effect of the herbal remedy Qin Huo Yi Hao and its active component tetramethylpyrazine on high glucose-treated endothelial cells. Life Sciences 84(13-14): 428-436

Zaborowska, Z.; Przygoński, K.; Bilska, A. 2012: Antioxidative effect of thyme (Thymus vulgaris) in sunflower oil. Acta Scientiarum Polonorum. Technologia Alimentaria 11(3): 283-291

Alonso, C.; Rubio, L.; Touriño, S.; Martí, M.; Barba, C.; Fernández-Campos, F.; Coderch, L.; Parra, J.é L.ís. 2014: Antioxidative effects and percutaneous absorption of five polyphenols. Free Radical Biology and Medicine 75: 149-155

Han, C.W.; Kang, E.S.; Ham, S.A.; Woo, H.J.; Lee, J.H.; Seo, H.G. 2012: Antioxidative effects of Alisma orientale extract in palmitate-induced cellular injury. Pharmaceutical Biology 50(10): 1281-1288

Seo, S.Kyo.; Hong, Y.; Yun, B.Hyon.; Chon, S.Joo.; Jung, Y.Soo.; Park, J.Hyun.; Cho, S.; Choi, Y.Sik.; Lee, B.Seok. 2014: Antioxidative effects of Korean red ginseng in postmenopausal women: a double-blind randomized controlled trial. Journal of Ethnopharmacology 154(3): 753-757

Sevgiler, Y.; Karaytug, S.; Karayakar, F. 2011: Antioxidative effects of N-acetylcysteine, lipoic acid, taurine, and curcumin in the muscle of Cyprinus carpio L. exposed to cadmium. Arhiv Za Higijenu Rada i Toksikologiju 62(1): 1-9

Zhou, N.; Tang, Y.; Keep, R.F.; Ma, X.; Xiang, J. 2014: Antioxidative effects of Panax notoginseng saponins in brain cells. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 21(10): 1189-1195

Oktar, G.L.; Kirisci, M.; Dursun, A.D.; Zor, M.H.; Iriz, E.; Erer, D.; Comu, F.M.; Arslan, M. 2013: Antioxidative effects of adrenomedullin and vascular endothelial growth factor on lung injury induced by skeletal muscle ischemia-reperfusion. Bratislavske Lekarske Listy 114(11): 625-628

Jang, H.Y.; Ji, S.J.; Kim, Y.H.; Lee, H.Y.; Shin, J.S.; Cheong, H.T.; Kim, J.T.; Park, I.C.; Kong, H.S.; Park, C.K.; Yang, B.K. 2010: Antioxidative effects of astaxanthin against nitric oxide-induced oxidative stress on cell viability and gene expression in bovine oviduct epithelial cell and the developmental competence of bovine IVM/IVF embryos. Reproduction in Domestic Animals 45(6): 967-974

Taguchi, N.; Uemura, N.; Goto, Y.; Sakura, M.; Hara, K.; Niwa, M.; Iida, M.; Yanagishita, T.; Watanabe, D.; Kato, M. 2011: Antioxidative effects of cherry leaves extract on tert-butyl hydroperoxide-mediated cytotoxicity through regulation of thioredoxin-2 protein expression levels. Journal of Toxicology and Environmental Health. Part a 74(18): 1240-1247

Chung, J.-W.; Kim, J.-J.; Kim, S.-J. 2011: Antioxidative effects of cinnamomi cortex: a potential role of iNOS and COX-Ii. Pharmacognosy Magazine 7(28): 314-319

Dai, F.; Chen, W.-F.; Zhou, B.; Yang, L.; Liu, Z.-L. 2009: Antioxidative effects of curcumin and its analogues against the free-radical-induced peroxidation of linoleic acid in micelles. PhytoTherapy Research: Ptr 23(9): 1220-1228

Ciftci, O.; Ozdemir, I.; Tanyildizi, S.; Yildiz, S.; Oguzturk, H. 2011: Antioxidative effects of curcumin, β-myrcene and 1,8-cineole against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced oxidative stress in rats liver. Toxicology and Industrial Health 27(5): 447-453

Sarıözkan, S.; Tuncer, P.B.; Büyükleblebici, S.; Bucak, M.N.; Cantürk, F.; Eken, A. 2015: Antioxidative effects of cysteamine, hyaluronan and fetuin on post-thaw semen quality, DNA integrity and oxidative stress parameters in the Brown Swiss bull. Andrologia 47(2): 138-147

Xu, D.-m.; Zhang, X.-y.; Wang, X.-r.; Chen, L.; Zhang, L.-h.; Shi, Q.-j.; Fang, S.-h.; Lu, Y.-b.; Zhang, W.-p.; Wei, E.-q. 2014: Antioxidative effects of cysteinyl leukotriene receptor antagonists montelukast and HAMi 3379 on ischemic injury in rat cortical neurons in vitro. Zhejiang da Xue Xue Bao. Yi Xue Ban 43(3): 257-264

Kolodziejczyk-Czepas, J.; Wachowicz, B.; Moniuszko-Szajwaj, B.; Kowalska, I.; Oleszek, W.; Stochmal, A. 2013: Antioxidative effects of extracts from Trifolium species on blood platelets exposed to oxidative stress. Journal of Physiology and Biochemistry 69(4): 879-887

Song, J.-L.; Choi, J.-H.; Seo, J.-H.; Kil, J.-H.; Park, K.-Y. 2014: Antioxidative effects of fermented sesame sauce against hydrogen peroxide-induced oxidative damage in LLC-PK1 porcine renal tubule cells. Nutrition Research and Practice 8(2): 138-145

Wang, J.; Zhu, H.; Yang, Z.; Liu, Z. 2013: Antioxidative effects of hesperetin against lead acetate-induced oxidative stress in rats. Indian Journal of Pharmacology 45(4): 395-398

Kedziora-Kornatowska, K.; Szewczyk-Golec, K.; Czuczejko, J.; Pawluk, H.; van Marke de Lumen, K.; Kozakiewicz, M.; Bartosz, G.; Kedziora, J.óz. 2008: Antioxidative effects of melatonin administration in elderly primary essential hypertension patients. Journal of Pineal Research 45(3): 312-317

Talas, Z.S.; Ozdemir, I.; Yilmaz, I.; Gok, Y. 2009: Antioxidative effects of novel synthetic organoselenium compound in rat lung and kidney. Ecotoxicology and Environmental Safety 72(3): 916-921

Khoshraftar, E.; Ranjbar, A.; Kharkhane, B.; Tavakol Heidary, S.; Gharebaghi, Z.; Zadkhosh, N. 2014: Antioxidative effects of propofol vs. ketamin in individuals undergoing surgery. Archives of Iranian Medicine 17(7): 486-489

Deng, Y.; Xu, Z.; Xu, B.; Liu, W.; Feng, S.; Yang, T. 2014: Antioxidative effects of schidandrin B and green tea polyphenols against mercuric chloride-induced hepatotoxicity in rats. Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 33(4): 349-361

Adam, O.; Laufs, U. 2008: Antioxidative effects of statins. Archives of Toxicology 82(12): 885-892

Sato, K.; Dohi, Y.; Kojima, M.; Takase, H.; Suzuki, S.; Ito, S. 2010: Antioxidative effects of thiazide diuretics in refractory hypertensive patients. a randomized crossover trial of chlortalidone and trichlormethiazide. Arzneimittel-Forschung 60(10): 612-616

Dey, S.K.; Jena, P.P.; Kundu, S. 2009: Antioxidative efficiency of Triticum aestivum L. exposed to chromium stress. Journal of Environmental Biology 30(4): 539-544

Dama, C.Lal.; Kumar, S.; Mishra, B.K.; Shukla, K.Bihari.; Mathur, S.; Doshi, A. 2010: Antioxidative enzymatic profile of mushrooms stored at low temperature. Journal of Food Science and Technology 47(6): 650-655

Adamczyk-Sowa, M.; Sowa, P.; Pierzchala, K.; Polaniak, R.; Labuz-Roszak, B. 2012: Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 63(6): 683-690

Kodydková, J.; Vávrová, L.; Zeman, M.; Jirák, R.; Macásek, J.; Stanková, B.; Tvrzická, E.; Zák, A. 2009: Antioxidative enzymes and increased oxidative stress in depressive women. Clinical Biochemistry 42(13-14): 1368-1374

Zhang, Y-Xiu.; Zhang, H-Mei.; Huang, Z-Bo.; Li, L-Feng.; Liu, J-Guang.; Li, X. 2011: Antioxidative enzymes play key roles in cadmium tolerance of Phytolacca americana. Huan Jing Ke Xue= Huanjing Kexue 32(3): 896-900

Gałecka, E.; Jacewicz, R.; Mrowicka, M.łg.; Florkowski, A.; Gałecki, P. 2008: Antioxidative enzymes--structure, properties, functions. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 25(147): 266-268

Yang, X.; Li, C.-J.; Wan, Y.; Smith, P.; Shang, G.; Cui, Q. 2014: Antioxidative fullerol promotes osteogenesis of human adipose-derived stem cells. International Journal of Nanomedicine 9: 4023-4031

Yoshida, S.; Kumakura, F.; Komatsu, I.; Arai, K.; Onuma, Y.; Hojo, H.; Singh, B.G.; Priyadarsini, K.I.; Iwaoka, M. 2011: Antioxidative glutathione peroxidase activity of selenoglutathione. Angewandte Chemie 50(9): 2125-2128

Kwak, J.H.; Kim, H.J.; Lee, K.H.; Kang, S.C.; Zee, O.P. 2009: Antioxidative iridoid glycosides and phenolic compounds from Veronica peregrina. Archives of Pharmacal Research 32(2): 207-213

Ijaz, F.; Ul Haq, A.; Ahmad, I.; Ahmad, N.; Hussain, J.; Chen, S. 2011: Antioxidative iridoid glycosides from the sky flower (Duranta repens Linn). Journal of Enzyme Inhibition and Medicinal Chemistry 26(1): 88-92

Saha, S.; Shrivastav, P.S.; Verma, R.J. 2014: Antioxidative mechanism involved in the preventive efficacy of Bergenia ciliata rhizomes against experimental nephrolithiasis in rats. Pharmaceutical Biology 52(6): 712-722

Bouayed, J.; Hoffmann, L.; Bohn, T. 2011: Antioxidative mechanisms of whole-apple antioxidants employing different varieties from Luxembourg. Journal of Medicinal Food 14(12): 1631-1637

Páez, P.L.; Becerra, M.ía.C.; Albesa, I.és. 2010: Antioxidative mechanisms protect resistant strains of Staphylococcus aureus against ciprofloxacin oxidative damage. Fundamental and Clinical Pharmacology 24(6): 771-776

Yang, X.; Jin, L.; Yao, L.; Shen, F.H.; Shimer, A.L.; Li, X. 2014: Antioxidative nanofullerol prevents intervertebral disk degeneration. International Journal of Nanomedicine 9: 2419-2430

Zou, W.; Wen, F. 2007: Antioxidative nutrients and age-related macular degeneration. Yan Ke Xue Bao 23(4): 193-198

Jin, Q.; Han, X.H.; Hong, S.S.; Lee, C.; Choe, S.; Lee, D.; Kim, Y.; Hong, J.T.; Lee, M.K.; Hwang, B.Y. 2012: Antioxidative oligostilbenes from Caragana sinica. Bioorganic and Medicinal Chemistry Letters 22(2): 973-976

Lin, Y.-J.; Le, G.-W.; Wang, J.-Y.; Li, Y.-X.; Shi, Y.-H.; Sun, J. 2010: Antioxidative peptides derived from enzyme hydrolysis of bone collagen after microwave assisted acid pre-treatment and nitrogen protection. International Journal of Molecular Sciences 11(11): 4297-4308

Sarmadi, B.H.; Ismail, A. 2010: Antioxidative peptides from food proteins: a review. Peptides 31(10): 1949-1956

Freitas, A.C.; Andrade, J.C.; Silva, F.M.; Rocha-Santos, T.A.P.; Duarte, A.C.; Gomes, A.M. 2013: Antioxidative peptides: trends and perspectives for future research. Current Medicinal Chemistry 20(36): 4575-4594

Hammad, S. 2013: Antioxidative plant extracts for chemoprevention. Archives of Toxicology 87(12): 2243-2245

Khan, M.A.; Rahman, M.M.; Tania, M.; Shoshee, N.F.; Xu, A.-h.; Chen, H.-c. 2013: Antioxidative potential of Duranta repens (Linn.) fruits against H2O2 induced cell death in vitro. African Journal of Traditional Complementary and Alternative Medicines: Ajtcam 10(3): 436-441

Ben Abdallah, F.; Zribi, N.; Ammar-Keskes, L. 2011: Antioxidative potential of Quercetin against hydrogen peroxide induced oxidative stress in spermatozoa in vitro. Andrologia 43(4): 261-265

Barollo, M.; Medici, V.; D'Incà, R.; Banerjee, A.; Ingravallo, G.; Scarpa, M.; Patak, S.; Ruffolo, C.; Cardin, R.; Sturniolo, G.C. 2011: Antioxidative potential of a combined therapy of anti TNFα and Zn acetate in experimental colitis. World Journal of Gastroenterology 17(36): 4099-4103

Ahire, J.Jagannath.; Mokashe, N.Uttamrao.; Patil, H.Jagatrao.; Chaudhari, B.Liladhar. 2013: Antioxidative potential of folate producing probiotic Lactobacillus helveticus CD6. Journal of Food Science and Technology 50(1): 26-34

Ogawa, H.; Xu, F.H.; Uebaba, K.; Origasa, H.; Kondoh, K.; Mikage, M. 2009: Antioxidative potentiality of a Kampo formulation measured by an ex vivo study. Journal of Alternative and Complementary Medicine 15(3): 267-274

Dairi, S.; Madani, K.; Aoun, M.; Him, J.ép.L.K.; Bron, P.; Lauret, C.él.; Cristol, J.-P.; Carbonneau, M.-A. 2014: Antioxidative properties and ability of phenolic compounds of Myrtus communis leaves to counteract in vitro LDL and phospholipid aqueous dispersion oxidation. Journal of Food Science 79(7): C1260-C1270

Oboh, G.; Ademosun, A.O.; Odubanjo, O.V.; Akinbola, I.A. 2013: Antioxidative properties and inhibition of key enzymes relevant to type-2 diabetes and hypertension by essential oils from black pepper. Advances in Pharmacological Sciences 2013: 926047

Fang, Y.; Wang, H.; Zhu, W.; Wang, L.; Liu, H.; Xu, X.; Yin, W.; Sima, Y.; Xu, S. 2014: Antioxidative properties of 4-methylumbelliferone are related to antibacterial activity in the silkworm (Bombyx mori) digestive tract. Journal of Comparative Physiology. B Biochemical Systemic and Environmental Physiology 184(6): 699-708

Nor, F.Mohd.; Suhaila, M.; Aini, I.Nor.; Razali, I. 2009: Antioxidative properties of Murraya koenigii leaf extracts in accelerated oxidation and deep-frying studies. International Journal of Food Sciences and Nutrition 60 Suppl. 2: 1-11

Tai, A.; Fukunaga, K.; Ohno, A.; Ito, H. 2014: Antioxidative properties of ascorbigen in using multiple antioxidant assays. Bioscience Biotechnology and Biochemistry 78(10): 1723-1730

Kuhn, W.; Müller, T.; Büttner, T.; Gerlach, M. 1996: Antioxidative properties of aspirin: dose dependence and clinical implications. European Journal of Neurology 3(3): 275-277

Mu, H.; Zhang, A.; Zhang, W.; Cui, G.; Wang, S.; Duan, J. 2012: Antioxidative properties of crude polysaccharides from Inonotus obliquus. International Journal of Molecular Sciences 13(7): 9194-9206

Kolodziejczyk, J.; Olas, B.; Saluk-Juszczak, J.; Wachowicz, B. 2011: Antioxidative properties of curcumin in the protection of blood platelets against oxidative stress in vitro. Platelets 22(4): 270-276

Khoo, H.E.; Azlan, A.; Ismail, A.; Abas, F. 2012: Antioxidative properties of defatted dabai pulp and peel prepared by solid phase extraction. Molecules 17(8): 9754-9773

Ishimoto, H.; Tai, A.; Yoshimura, M.; Amakura, Y.; Yoshida, T.; Hatano, T.; Ito, H. 2012: Antioxidative properties of functional polyphenols and their metabolites assessed by an ORAC assay. Bioscience Biotechnology and Biochemistry 76(2): 395-399

Egusa Saiga, A.; Nishimura, T. 2013: Antioxidative properties of peptides obtained from porcine myofibrillar proteins by a protease treatment in an Fe (II)-induced aqueous lipid peroxidation system. Bioscience Biotechnology and Biochemistry 77(11): 2201-2204

Tai, A.; Sawano, T.; Ito, H. 2012: Antioxidative properties of vanillic acid esters in multiple antioxidant assays. Bioscience Biotechnology and Biochemistry 76(2): 314-318

Sidorov, A.V.; Maslova, G.T. 2008: Antioxidative protection in the central nervous ganglia of a mollusc Lymnaea stagnalis at modulation of activity of the NO-ergic system. Zhurnal Evoliutsionnoi Biokhimii i Fiziologii 44(5): 453-458

Jakesevic, M.; Aaby, K.; Borge, G.-I.A.; Jeppsson, B.; Ahrné, S.; Molin, G.ör. 2011: Antioxidative protection of dietary bilberry, chokeberry and Lactobacillus plantarum HEAL19 in mice subjected to intestinal oxidative stress by ischemia-reperfusion. Bmc Complementary and Alternative Medicine 11: 8

Huang, Z.-S.; Xiao, H.-J.; Qi, T.; Hu, Z.-M.; Li, H.; Chen, D.-L.; Xu, Y.-L.; Chen, J. 2014: Antioxidative protective effect of icariin on the FeSO4/H 2O 2-damaged human sperm based on confocal raman micro-spectroscopy. Journal of Huazhong University of Science and Technology. Medical Sciences 34(5): 755-760

John, R.; Ahmad, P.; Gadgil, K.; Sharma, S. 2007: Antioxidative response of Lemna polyrrhiza L. to cadmium stress. Journal of Environmental Biology 28(3): 583-589

Zhang, Y-xiu.; Huang, Z-bo.; Zhang, H-mei.; Li, L-feng.; Chai, T-yao. 2009: Antioxidative response of Phytolacca americana and Nicotiana tabacum to manganese stresses. Huan Jing Ke Xue= Huanjing Kexue 30(12): 3676-3683

Huang, W.; Cao, L.; Ye, Z.; Yin, X.; Dou, S. 2010: Antioxidative responses and bioaccumulation in Japanese flounder larvae and juveniles under chronic mercury exposure. Comparative Biochemistry and Physiology. Toxicology and Pharmacology: Cbp 152(1): 99-106

Sgherri, C.; Ranieri, A.; Quartacci, M.F. 2013: Antioxidative responses in Vitis vinifera infected by grapevine fanleaf virus. Journal of Plant Physiology 170(2): 121-128

Meratan, A.A.; Ghaffari, S.M.; Niknam, V.; Salami, M. 2013: Antioxidative responses in calli of two populations of Acanthophyllum laxiusculum with and without B-chromosomes under salt stress. Pakistan Journal of Biological Sciences: Pjbs 16(1): 1-11

Wilczek, G.ży.; Babczyńska, A.; Wilczek, P. 2013: Antioxidative responses in females and males of the spider Xerolycosa nemoralis (Lycosidae) exposed to natural and anthropogenic stressors. Comparative Biochemistry and Physiology. Toxicology and Pharmacology: Cbp 157(2): 119-131

Wang, K.; Zhang, X.; Ervin, E. 2012: Antioxidative responses in roots and shoots of creeping bentgrass under high temperature: effects of nitrogen and cytokinin. Journal of Plant Physiology 169(5): 492-500

Xing, W.; Li, D.; Liu, G. 2010: Antioxidative responses of Elodea nuttallii (Planch.) H. St. John to short-term iron exposure. Plant Physiology and Biochemistry: Ppb 48(10-11): 873-878

Tarchoune, I.; Sgherri, C.; Izzo, R.; Lachaal, M.; Ouerghi, Z.; Navari-Izzo, F. 2010: Antioxidative responses of Ocimum basilicum to sodium chloride or sodium sulphate salinization. Plant Physiology and Biochemistry: Ppb 48(9): 772-777

Mandal, C.; Ghosh, N.; Maiti, S.; Das, K.; Gupta, S.; Dey, N.; Adak, M.K. 2013: Antioxidative responses of Salvinia (Salvinia natans Linn.) to aluminium stress and it's modulation by polyamine. Physiology and Molecular Biology of Plants: An International Journal of Functional Plant Biology 19(1): 91-103

Janknegt, P.J.; de Graaff, C.M.; van de Poll, W.H.; Visser, R.J.W.; Helbling, E.W.; Buma, A.G.J. 2009: Antioxidative responses of two marine microalgae during acclimation to static and fluctuating natural UV radiation. Photochemistry and Photobiology 85(6): 1336-1345

Sun, S-Qin.; He, M.; Cao, T.; Yusuyin, Y.; Han, W.; Li, J-Ling. 2010: Antioxidative responses related to H(2)O(2) depletion in Hypnum plumaeforme under the combined stress induced by Pb and Ni. Environmental Monitoring and Assessment 163(1-4): 303-312

Ling, Q.; Hong, F. 2010: Antioxidative role of cerium against the toxicity of lead in the liver of silver crucian carp. Fish Physiology and Biochemistry 36(3): 367-376

Inoue, K.; Takano, H.; Yanagisawa, R.; Sakurai, M.; Shimada, A.; Satoh, M.; Yoshino, S.; Yamaki, K.; Yoshikawa, T. 2008: Antioxidative role of interleukin-6 in septic lung injury in mice. International Journal of Immunopathology and Pharmacology 21(3): 501-507

Wang, Y.; Lu, Q.; Sheldon, F.S.; Ho, Y.-S.; Phelan, S.A.; Beers, M.F.; Fisher, A.B. 2008: Antioxidative role of peroxiredoxin 6 in acute lung injury. Zhonghua Er Ke Za Zhi 46(10): 739-744

Yu, D.; Zhang, Z.-W.; Yao, H.-D.; Li, S.; Xu, S.-W. 2014: Antioxidative role of selenoprotein W in oxidant-induced chicken splenic lymphocyte death. Biometals: An International Journal on the Role of Metal Ions in Biology Biochemistry and Medicine 27(2): 277-291

Chung, Y.W.; Jeong, D.; Noh, O.J.; Park, Y.H.; Kang, S.I.; Lee, M.G.; Lee, T.-H.; Yim, M.B.; Kim, I.Y. 2009: Antioxidative role of selenoprotein W in oxidant-induced mouse embryonic neuronal cell death. Molecules and Cells 27(5): 609-613

Al-Gubory, K.ïs.H.; Garrel, C. 2012: Antioxidative signalling pathways regulate the level of reactive oxygen species at the endometrial-extraembryonic membranes interface during early pregnancy. International Journal of Biochemistry and Cell Biology 44(9): 1511-1518

Keles, M.; Al, B.; Gumustekin, K.; Demircan, B.; Ozbey, I.; Akyuz, M.; Yilmaz, A.; Demir, E.; Uyanik, A.; Ziypak, T.; Taysi, S. 2010: Antioxidative status and lipid peroxidation in kidney tissue of rats fed with vitamin B(6)-deficient diet. Renal Failure 32(5): 618-622

Zahaĭko, A.L.; Voronina, L.M.; Kaliman, P.A.; Strel'chenko, K.V. 2008: Antioxidative status changes in golden syrian hamsters with experimental metabolic syndrome. Ukrains'kyi Biokhimichnyi Zhurnal 80(3): 103-109

Chen, Y.-L.; Chen, L.-J.; Bair, M.-J.; Yao, M.-L.; Peng, H.-C.; Yang, S.-S.; Yang, S.-C. 2011: Antioxidative status of patients with alcoholic liver disease in southeastern Taiwan. World Journal of Gastroenterology 17(8): 1063-1070

Novaković, N.; Cakić, S.; Todorović, T.; Raicević, B.A.; Dozić, I.; Petrović, V.; Perunović, N.; Gostović, S.S.; Sretenović, J.K.ć; Colak, E. 2013: Antioxidative status of saliva before and after non-surgical periodontal treatment. Srpski Arhiv Za Celokupno Lekarstvo 141(3-4): 163-168

Schneider, A.; Simons, M. 2012: Antioxidative strategies in cognitive impairment: a novel connection between biliverdin-reductase and statins. Journal of Neurochemistry 120(1): 1-3

Mine, Y.; Young, D.; Yang, C. 2015: Antioxidative stress effect of phosphoserine dimers is mediated via activation of the Nrf2 signaling pathway. Molecular Nutrition and Food Research 59(2): 303-314

Márquez-García, B.én.; Córdoba, F. 2009: Antioxidative system and oxidative stress markers in wild populations of Erica australis L. differentially exposed to pyrite mining activities. Environmental Research 109(8): 968-974

Bałajewicz-Nowak, M.; Kazimierz, Pński.; Małgorzata, Mł. 2011: Antioxidative system in pregnant women infected by Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum. Ginekologia Polska 82(10): 732-737

Bajčetić, M.; Otašević, B.; Prekajski, N.Božinović.; Spasić, Sžana.; Spasojević, I. 2014: Antioxidative system in the erythrocytes of preterm neonates with sepsis: the effects of vitamin E supplementation. Annals of Clinical Biochemistry 51(Pt 5): 550-556

Saeaue, L.; Morales, N.Phumala.; Komalamisra, N.; Morales Vargas, R.Enrique. 2011: Antioxidative systems defense against oxidative stress induced by blood meal in Aedes aegypti. Southeast Asian Journal of Tropical Medicine and Public Health 42(3): 542-549

Schnell-Inderst, P.; Kossmann, B.; Fischereder, M.; Klauss, V.; Wasem, Jürgen. 2006: Antioxidative vitamines for prevention of cardiovascular disease for patients after renal transplantation and patients with chronic renal failure. Gms Health Technology Assessment 2: Doc14

Shin, Y.-M.; Jung, H.-J.; Choi, W.-Y.; Lim, C.-J. 2013: Antioxidative, anti-inflammatory, and matrix metalloproteinase inhibitory activities of 20(S)-ginsenoside Rg3 in cultured mammalian cell lines. Molecular Biology Reports 40(1): 269-279

Chang, X.; Wang, J.; Yang, S.; Chen, S.; Song, Y. 2011: Antioxidative, antibrowning and antibacterial activities of sixteen floral honeys. Food and Function 2(9): 541-546

Das Purkayastha, M.; Manhar, A.K.; Das, V.K.; Borah, A.; Mandal, M.; Thakur, A.J.; Mahanta, C.L. 2014: Antioxidative, hemocompatible, fluorescent carbon nanodots from an "end-of-pipe" agricultural waste: exploring its new horizon in the food-packaging domain. Journal of Agricultural and Food Chemistry 62(20): 4509-4520

Lai, H.Y.; Lim, Y.Y.; Tan, S.P. 2009: Antioxidative, tyrosinase inhibiting and antibacterial activities of leaf extracts from medicinal ferns. Bioscience Biotechnology and Biochemistry 73(6): 1362-1366

Mekinić, I.G.ć; Burcul, F.; Blazević, I.; Skroza, D.; Kerum, D.; Katalinić, V. 2013: Antioxidative/acetylcholinesterase inhibitory activity of some Asteraceae plants. Natural Product Communications 8(4): 471-474

Liu, J.; You, L.; Wang, C.; Liu, R. 2012: Antioxidization and antiproliferation of extract from leaves of Toona sinensis. Zhong Nan da Xue Xue Bao. Yi Xue Ban 37(1): 42-47

Bernal-Lopez, M.R.; Garrido-Sanchez, L.; Gomez-Carrillo, V.; Gallego-Perales, J.L.; Llorente-Cortes, V.; Calleja, F.; Gomez-Huelgas, R.; Badimon, L.; Tinahones, F.J. 2013: Antioxidized LDL antibodies are associated with different metabolic pathways in patients with atherosclerotic plaque and type 2 diabetes. Diabetes Care 36(4): 1006-1011

Hadjaz, F.; Besret, S.; Martin-Nizard, F.ço.; Yous, S.ïd.; Dilly, S.éb.; Lebegue, N.; Chavatte, P.; Duriez, P.; Berthelot, P.; Carato, P. 2011: Antioxydant activity of β-carboline derivatives in the LDL oxidation model. European Journal of Medicinal Chemistry 46(6): 2575-2585

Hantz, S.; Alain, S.; Denis, F. 2008: Antipapillomavirus vaccination. Gastroenterologie Clinique et Biologique 32(5 Part 2): S221-S230

Drescher, M.; Veldhuis, G.; van Rooijen, B.D.; Milikisyants, S.; Subramaniam, V.; Huber, M. 2008: Antiparallel arrangement of the helices of vesicle-bound alpha-synuclein. Journal of the American Chemical Society 130(25): 7796-7797

Cerf, E.; Sarroukh, R.; Tamamizu-Kato, S.; Breydo, L.; Derclaye, S.; Dufrêne, Y.F.; Narayanaswami, V.; Goormaghtigh, E.; Ruysschaert, J.-M.; Raussens, V. 2009: Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide. Biochemical Journal 421(3): 415-423

Lu, Q.; Ye, F.; Wei, Z.; Wen, Z.; Zhang, M. 2012: Antiparallel coiled-coil-mediated dimerization of myosin X. Proceedings of the National Academy of Sciences of the United States of America 109(43): 17388-17393

Elliott, J.M.; Ultsch, M.; Lee, J.; Tong, R.; Takeda, K.; Spiess, C.; Eigenbrot, C.; Scheer, J.M. 2014: Antiparallel conformation of knob and hole aglycosylated half-antibody homodimers is mediated by a CH2-CH3 hydrophobic interaction. Journal of Molecular Biology 426(9): 1947-1957

Grintsevich, E.E.; Phillips, M.; Pavlov, D.; Phan, M.; Reisler, E.; Muhlrad, A. 2010: Antiparallel dimer and actin assembly. Biochemistry 49(18): 3919-3927

Lloris-Garcerá, P.; Bianchi, F.; Slusky, J.S.G.; Seppälä, S.; Daley, D.O.; von Heijne, G. 2012: Antiparallel dimers of the small multidrug resistance protein EmrE are more stable than parallel dimers. Journal of Biological Chemistry 287(31): 26052-26059

Gu, L.; Liu, C.; Stroud, J.C.; Ngo, S.; Jiang, L.; Guo, Z. 2014: Antiparallel triple-strand architecture for prefibrillar Aβ42 oligomers. Journal of Biological Chemistry 289(39): 27300-27313

Qiang, W.; Yau, W.-M.; Luo, Y.; Mattson, M.P.; Tycko, R. 2012: Antiparallel β-sheet architecture in Iowa-mutant β-amyloid fibrils. Proceedings of the National Academy of Sciences of the United States of America 109(12): 4443-4448

Krimm, S. 1966: Antiparallelism of chains in polyglycine II. Nature 212(5069): 1482-1483

Gray, B.; Jacobs, A.C.; Mora, A.B.; Zuk, M. 2012: Antiparasite behavior. Current Biology: Cb 22(8): R255-R257

Hanssen, S.A.; Bustnes, J.O.; Schnug, L.; Bourgeon, S.; Johnsen, T.V.; Ballesteros, M.; Sonne, C.; Herzke, D.; Eulaers, I.; Jaspers, V.L.B.; Covaci, A.; Eens, M.; Halley, D.J.; Moum, T.; Ims, R.A.; Erikstad, K.E. 2013: Antiparasite treatments reduce humoral immunity and impact oxidative status in raptor nestlings. Ecology and Evolution 3(16): 5157-5166

Barbosa, M.íl.I.F.; Corrêa, R.S.; de Oliveira, K.M.; Rodrigues, C.; Ellena, J.; Nascimento, O.R.; Rocha, V.íc.P.C.; Nonato, F.R.; Macedo, T.ís.S.; Barbosa-Filho, J.é M.; Soares, M.B.P.; Batista, A.A. 2014: Antiparasitic activities of novel ruthenium/lapachol complexes. Journal of Inorganic Biochemistry 136: 33-39

Arico-Muendel, C.; Centrella, P.A.; Contonio, B.D.; Morgan, B.A.; O'Donovan, G.; Paradise, C.L.; Skinner, S.R.; Sluboski, B.; Svendsen, J.L.; White, K.F.; Debnath, A.; Gut, J.; Wilson, N.; McKerrow, J.H.; DeRisi, J.L.; Rosenthal, P.J.; Chiang, P.K. 2009: Antiparasitic activities of novel, orally available fumagillin analogs. Bioorganic and Medicinal Chemistry Letters 19(17): 5128-5131

Ganfon, H.; Bero, J.; Tchinda, A.T.; Gbaguidi, F.; Gbenou, J.; Moudachirou, M.; Frédérich, M.; Quetin-Leclercq, Jëlle. 2012: Antiparasitic activities of two sesquiterpenic lactones isolated from Acanthospermum hispidum D.C. Journal of Ethnopharmacology 141(1): 411-417

Bou, D.D.; Tempone, A.é G.; Pinto, Ér.G.; Lago, J.ão.H.G.; Sartorelli, P. 2014: Antiparasitic activity and effect of casearins isolated from Casearia sylvestris on Leishmania and Trypanosoma cruzi plasma membrane. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 21(5): 676-681

Salem, M.M.; Capers, J.; Rito, S.; Werbovetz, K.A. 2011: Antiparasitic activity of C-geranyl flavonoids from Mimulus bigelovii. PhytoTherapy Research: Ptr 25(8): 1246-1249

Fernandez, L.S.; Sykes, M.L.; Andrews, K.T.; Avery, V.M. 2010: Antiparasitic activity of alkaloids from plant species of Papua new Guinea and Australia. International Journal of Antimicrobial Agents 36(3): 275-279

Sartorelli, P.íc.; Carvalho, C.S.; Reimão, J.Q.; Ferreira, M.J.é P.; Tempone, A.é G. 2009: Antiparasitic activity of biochanin A, an isolated isoflavone from fruits of Cassia fistula (Leguminosae). Parasitology Research 104(2): 311-314

Hussein, E.M.; Dawoud, H.A.; Salem, A.M.; Atwa, M.M. 2009: Antiparasitic activity of cystine protease inhibitor E-64 against Giardia lamblia excystation in vitro and in vivo. Journal of the Egyptian Society of Parasitology 39(1): 111-119

Dasgupta, S.; Roy, B. 2010: Antiparasitic activity of methanolic extract of Acacia oxyphylla (Leguminosae) against Raillietina echinobothrida. Journal of Parasitic Diseases: Official Organ of the Indian Society for Parasitology 34(1): 14-19

Morais, T.R.; da Costa-Silva, T.A.; Tempone, A.G.; Borborema, S.E.T.; Scotti, M.T.; de Sousa, R.M.F.; Araujo, A.C.C.; de Oliveira, A.; de Morais, S.ér.A.ôn.L.; Sartorelli, P.; Lago, J.ão.H.G. 2014: Antiparasitic activity of natural and semi-synthetic tirucallane triterpenoids from Schinus terebinthifolius (Anacardiaceae): structure/activity relationships. Molecules 19(5): 5761-5776

Sharma, U.; Singh, D.; Kumar, P.; Dobhal, M.P.; Singh, S. 2011: Antiparasitic activity of plumericin and isoplumericin isolated from Plumeria bicolor against Leishmania donovani. Indian Journal of Medical Research 134(5): 709-716

Flores, N.; Jiménez, I.A.; Giménez, A.; Ruiz, G.; Gutiérrez, D.; Bourdy, G.; Bazzocchi, I.L. 2009: Antiparasitic activity of prenylated benzoic acid derivatives from Piper species. Phytochemistry 70(5): 621-627

Ullal, A.J.; Noga, E.J. 2010: Antiparasitic activity of the antimicrobial peptide HbbetaP-1, a member of the beta-haemoglobin peptide family. Journal of Fish Diseases 33(8): 657-664

Machumi, F.; Yenesew, A.; Midiwo, J.O.; Heydenreich, M.; Kleinpeter, E.; Tekwani, B.L.; Khan, S.I.; Walker, L.A.; Muhammad, I. 2012: Antiparasitic and anticancer carvotacetone derivatives of Sphaeranthus bullatus. Natural Product Communications 7(9): 1123-1126

Martínez-Luis, S.; Cherigo, L.; Arnold, E.; Spadafora, C.; Gerwick, W.H.; Cubilla-Rios, L. 2012: Antiparasitic and anticancer constituents of the endophytic fungus Aspergillus sp. strain F1544. Natural Product Communications 7(2): 165-168

Rahman, A.A.; Samoylenko, V.; Jain, S.K.; Tekwani, B.L.; Khan, S.I.; Jacob, M.R.; Midiwo, J.O.; Hester, J.P.; Walker, L.A.; Muhammad, I. 2011: Antiparasitic and antimicrobial isoflavanquinones from Abrus schimperi. Natural Product Communications 6(11): 1645-1650

Fonseca-Papavero, F.C.G.d.; Callegaro, D.; Gama, P.D.d.; Livramento, J.é A.; Vaz, A.J.é; Machado, L.ís.D.R. 2013: Antiparasitic antibodies occur with similar frequency in patients with clinically established multiple sclerosis with or without oligoclonal bands in the cerebrospinal fluid. Arquivos de Neuro-Psiquiatria 71(8): 512-515

Abdel-Mageed, W.M.; Backheet, E.Y.; Khalifa, A.A.; Ibraheim, Z.Z.; Ross, S.A. 2012: Antiparasitic antioxidant phenylpropanoids and iridoid glycosides from Tecoma mollis. Fitoterapia 83(3): 500-507

Galeano, E.; Thomas, O.P.; Robledo, S.; Munoz, D.; Martinez, A. 2011: Antiparasitic bromotyrosine derivatives from the marine sponge Verongula rigida. Marine Drugs 9(10): 1902-1913

Grundmann, F.; Kaiser, M.; Schiell, M.; Batzer, A.; Kurz, M.; Thanwisai, A.; Chantratita, N.; Bode, H.B. 2014: Antiparasitic chaiyaphumines from entomopathogenic Xenorhabdus sp. PB61.4. Journal of Natural Products 77(4): 779-783

Horn, D.; Duraisingh, M.T. 2014: Antiparasitic chemotherapy: from genomes to mechanisms. Annual Review of Pharmacology and Toxicology 54: 71-94

Datta, A.K.; Datta, R.; Sen, B. 2008: Antiparasitic chemotherapy: tinkering with the purine salvage pathway. Advances in Experimental Medicine and Biology 625: 116-132

Graziose, R.; Rojas-Silva, P.; Rathinasabapathy, T.; Dekock, C.; Grace, M.H.; Poulev, A.; Ann Lila, M.; Smith, P.; Raskin, I. 2012: Antiparasitic compounds from Cornus florida L. with activities against Plasmodium falciparum and Leishmania tarentolae. Journal of Ethnopharmacology 142(2): 456-461

Gachet, M.S.é; Kunert, O.; Kaiser, M.; Brun, R.; Zehl, M.; Keller, W.; Muñoz, R.A.; Bauer, R.; Schuehly, W. 2011: Antiparasitic compounds from Cupania cinerea with activities against Plasmodium falciparum and Trypanosoma brucei rhodesiense. Journal of Natural Products 74(4): 559-566

Abdel-Magid, A.F. 2014: Antiparasitic compounds may potentially treat malaria and other parasitic diseases. Acs Medicinal Chemistry Letters 5(8): 842-843

Keiser, J.; Ingram, K.; Utzinger, J.ür. 2011: Antiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control. Parasitology 138(12): 1620-1632

Garcia, H.H. 2008: Antiparasitic drugs in neurocysticercosis: albendazole or praziquantel?. Expert Review of AntI-Infective Therapy 6(3): 295-298

Pérez, J.L.; Carranza, C.; Mateos, F. 2009: Antiparasitic drugs. Review of the useful drugs in the treatment of classic and emergent parasitic diseases. Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 22(2): 93-105

Salas-Sarduy, E.; Cabrera-Muñoz, A.; Cauerhff, A.; González-González, Y.; Trejo, S.án.A.; Chidichimo, A.; Chávez-Planes, M.d.L.A.; Cazzulo, J.J.é 2013: Antiparasitic effect of a fraction enriched in tight-binding protease inhibitors isolated from the Caribbean coral Plexaura homomalla. Experimental Parasitology 135(3): 611-622

Fu, Y.-W.; Zhang, Q.-Z.; Xu, D.-H.; Liang, J.-H.; Wang, B. 2014: Antiparasitic effect of cynatratoside-C from Cynanchum atratum against Ichthyophthirius multifiliis on grass carp. Journal of Agricultural and Food Chemistry 62(29): 7183-7189

Tanweer, A.J.; Chand, N.; Saddique, U.; Bailey, C.A.; Khan, R.U. 2014: Antiparasitic effect of wild rue (Peganum harmala L.) against experimentally induced coccidiosis in broiler chicks. Parasitology Research 113(8): 2951-2960

Sazgarnia, A.; Taheri, A.Reza.; Soudmand, S.; Parizi, A.Jafari.; Rajabi, O.; Darbandi, M.Sadat. 2013: Antiparasitic effects of gold nanoparticles with microwave radiation on promastigots and amastigotes of Leishmania major. International Journal of Hyperthermia: the Official Journal of European Society for Hyperthermic Oncology North American Hyperthermia Group 29(1): 79-86

Meinelt, T.; Staaks, J.; Staaks, G.; Stüber, A.; Bräunig, I. 2007: Antiparasitic effects of peracetic acid (PAA) against infective stages (theronts) of white spot disease, Ichthyophthirius multifiliis in vitro. Deutsche Tierärztliche Wochenschrift 114(10): 384-387

Zheng, W.; Yan, C-Mei.; Zhang, Y-Bin.; Li, Z-Hong.; Li, Z.; Li, X-Ying.; Wang, Z-Wei.; Wang, X.; Chen, W-Qiang.; Yu, X-Hai. 2015: Antiparasitic efficacy of Gracillin and Zingibernsis newsaponin from Costus speciosus (Koen ex. Retz) Sm. against Ichthyophthirius multifiliis. Parasitology 142(3): 473-479

Kaplan, R.M.; Storey, B.E.; Vidyashankar, A.N.; Bissinger, B.W.; Mitchell, S.M.; Howell, S.B.; Mason, M.E.; Lee, M.D.; Pedroso, A.A.; Akashe, A.; Skrypec, D.J. 2014: Antiparasitic efficacy of a novel plant-based functional food using an Ascaris suum model in pigs. Acta Tropica 139: 15-22

Kumar, A.; Raman, R.P.; Kumar, K.; Pandey, P.K.; Kumar, V.; Mohanty, S.; Kumar, S. 2012: Antiparasitic efficacy of piperine against Argulus spp. on Carassius auratus (Linn. 1758): in vitro and in vivo study. Parasitology Research 111(5): 2071-2076

Yıldız, K.; Başalan, M.; Duru, O.; Gökpınar, S. 2011: Antiparasitic efficiency of Artemisia absinthium on Toxocara cati in naturally infected cats. Turkiye Parazitolojii Dergisi 35(1): 10-14

Leverrier, A.él.; Bero, J.; Frédérich, M.; Quetin-Leclercq, J.ël.; Palermo, J. 2013: Antiparasitic hybrids of Cinchona alkaloids and bile acids. European Journal of Medicinal Chemistry 66: 355-363

Reina, M.ía.; Ruiz-Mesia, L.; Ruiz-Mesia, W.; Sosa-Amay, F.E.; Arevalo-Encinas, L.; González-Coloma, A.; Martínez-Díaz, R. 2014: Antiparasitic indole alkaloids from Aspidosperma desmanthum and A. spruceanum from the Peruvian Amazonia. Natural Product Communications 9(8): 1075-1080

Pretzel, J.; Mohring, F.; Rahlfs, S.; Becker, K. 2013: Antiparasitic peptides. Advances in Biochemical Engineering/Biotechnology 135: 157-192

Cerecetto, H.; González, M. 2011: Antiparasitic prodrug nifurtimox: revisiting its activation mechanism. Future Microbiology 6(8): 847-850

Kornele, M.L.; McLean, M.J.; O'Brien, A.E.; Phillippi-Taylor, A.ée.M. 2014: Antiparasitic resistance and grazing livestock in the United States. Journal of the American Veterinary Medical Association 244(9): 1020-1022

Garg, R.K. 2008: Antiparasitic treatment for solitary cysticercus granuloma: to treat or not to treat?. Expert Review of AntI-Infective Therapy 6(1): 15-19

Alvarado-Esquivel, C.; Niewiadomski, A.; Schweickert, B.; Liesenfeld, O. 2011: Antiparasitic treatment suppresses production and avidity of Toxoplasma gondii-specific antibodies in a murine model of acute infection*. European Journal of Microbiology and Immunology 1(3): 249-255

Sloet van Oldruitenborgh-Oosterbaan, M.M.; van Doorn, D.C.K.; Holland, W.; van Herten, J.; Ploeger, H.W.; Fink-Gremmels, J. 2009: Antiparasitic treatments and the prescription obligation for horses. Tijdschrift Voor Diergeneeskunde 134(7): 288-295

Rogier, C.; Moukoko, C.E.E.; Orlandi-Pradines, E.; Briolant, S.éb. 2007: Antiparasitic vaccines: where are we now?. La Revue du Praticien 57(2): 183-188

Wei, Y-Jung.; Palumbo, F.B.; Simoni-Wastila, L.; Shulman, L.M.; Stuart, B.; Beardsley, R.; Brown, C.H. 2014: Antiparkinson drug adherence and its association with health care utilization and economic outcomes in a Medicare Part D population. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research 17(2): 196-204

Wei, Y.-J.; Palumbo, F.B.; Simoni-Wastila, L.; Shulman, L.M.; Stuart, B.; Beardsley, R.; Brown, C. 2013: Antiparkinson drug use and adherence in medicare part D beneficiaries with Parkinson's disease. Clinical Therapeutics 35(10): 1513-1525.E1

Dhanasekaran, M.; Tharakan, B.; Manyam, B.V. 2008: Antiparkinson drug--Mucuna pruriens shows antioxidant and metal chelating activity. PhytoTherapy Research: Ptr 22(1): 6-11

Di Stefano, A.; Sozio, P.; Cerasa, L.Serafina. 2008: Antiparkinson prodrugs. Molecules 13(1): 46-68

Katzenschlager, R.; Jackson, M.J.; Rose, S.; Stockwell, K.; Tayarani-Binazir, K.A.; Zubair, M.; Smith, L.A.; Jenner, P.; Lees, A.J. 2007: Antiparkinsonian activity of L-propyl-L-leucyl-glycinamide or melanocyte-inhibiting factor in MPTP-treated common marmosets. Movement Disorders: Official Journal of the Movement Disorder Society 22(5): 715-719

Ardashov, O.V.; Pavlova, A.V.; Korchagina, D.V.; Volcho, K.P.; Tolstikova, T.'y.G.; Salakhutdinov, N.F. 2013: Antiparkinsonian activity of some 9-N-, O-, S- and C-derivatives of 3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol. Bioorganic and Medicinal Chemistry 21(5): 1082-1087

Micallef, J.ël.; Rey, M.; Eusebio, A.; Audebert, C.; Rouby, F.; Jouve, E.; Tardieu, S.; Blin, O. 2009: Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects. British Journal of Clinical Pharmacology 67(3): 333-340

Kurakhmaeva, K.B.; Voronina, T.A.; Kapica, I.G.; Kreuter, J.; Nerobkova, L.N.; Seredenin, S.B.; Balabanian, V.Yu.; Alyautdin, R.N. 2008: Antiparkinsonian effect of nerve growth factor adsorbed on polybutylcyanoacrylate nanoparticles coated with polysorbate-80. Bulletin of Experimental Biology and Medicine 145(2): 259-262

Sengupta, T.; Vinayagam, J.; Nagashayana, N.; Gowda, B.; Jaisankar, P.; Mohanakumar, K.P. 2011: Antiparkinsonian effects of aqueous methanolic extract of Hyoscyamus niger seeds result from its monoamine oxidase inhibitory and hydroxyl radical scavenging potency. Neurochemical Research 36(1): 177-186

Drabczyńska, A.; Zygmunt, M.łg.; Sapa, J.; Filipek, B.; Müller, C.E.; Kieć-Kononowicz, K. 2011: Antiparkinsonian effects of novel adenosine A(2A) receptor antagonists. Archiv der Pharmazie 344(1): 20-27

Landau, A.M.; Clark, C.; Jivan, S.; Doudet, D.J. 2012: Antiparkinsonian mechanism of electroconvulsive therapy in MPTP-lesioned non-human primates. Neuro-Degenerative Diseases 9(3): 128-138

Lader, M. 2008: Antiparkinsonian medication and pathological gambling. Cns Drugs 22(5): 407-416

Broadstock, M.; Austin, P.J.; Betts, M.J.; Duty, S. 2012: Antiparkinsonian potential of targeting group IIi metabotropic glutamate receptor subtypes in the rodent substantia nigra pars reticulata. British Journal of Pharmacology 165(4b): 1034-1045

Povarnina, P.Y.; Gudasheva, T.A.; Vorontsova, O.N.; Bondarenko, N.A.; Seredenin, S.B. 2011: Antiparkinsonian properties of a nerve growth factor dipeptide mimetic GK-2 in in vivo experiments. Bulletin of Experimental Biology and Medicine 151(6): 690-693

Zibetti, M.; Pesare, M.; Cinquepalmi, A.; Rosso, M.; Bergamasco, B.; Ducati, A.; Lanotte, M.; Lopiano, L. 2008: Antiparkinsonian therapy modifications in PD patients after STN DBS: a retrospective observational analysis. Parkinsonism and Related Disorders 14(8): 608-612

Gonzalez-Aparicio, R.; Flores, J.A.; Fernandez-Espejo, E. 2010: Antiparkinsonian trophic action of glial cell line-derived neurotrophic factor and transforming growth factor β1 is enhanced after co-infusion in rats. Experimental Neurology 226(1): 136-147

Card, N.A. 2010: Antipathetic relationships in child and adolescent development: a meta-analytic review and recommendations for an emerging area of study. Developmental Psychology 46(2): 516-529

Tejero-Sariñena, S.; Barlow, J.; Costabile, A.; Gibson, G.R.; Rowland, I. 2013: Antipathogenic activity of probiotics against Salmonella Typhimurium and Clostridium difficile in anaerobic batch culture systems: is it due to synergies in probiotic mixtures or the specificity of single strains?. Anaerobe 24: 60-65

Annapoorani, A.; Kalpana, B.; Musthafa, K.S.; Pandian, S.K.; Ravi, A.V. 2013: Antipathogenic potential of Rhizophora spp. against the quorum sensing mediated virulence factors production in drug resistant Pseudomonas aeruginosa. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 20(11): 956-963

Lee, K.-M.; Kim, W.-S.; Lim, J.; Nam, S.; Youn, M.; Nam, S.-W.; Kim, Y.; Kim, S.-H.; Park, W.; Park, S. 2009: Antipathogenic properties of green tea polyphenol epigallocatechin gallate at concentrations below the MIC against enterohemorrhagic Escherichia coli O157:H7. Journal of Food Protection 72(2): 325-331

Alexander, C. 1946: Antipathy and social behavior. American Journal of Sociology 51: 288-292

Mynhier, C.R.; Glenn, L.L. 2012: Antipathy towards self-harm patients and nurse education. International Emergency Nursing 20(1): 42

Mutch, N. 1949: Antipeptic and antacid therapy with special reference to adsorbent complexes of calcium and magnesium phosphates. Lancet 1(6560): 859-863

Kim, D.-A.; Jearn, L.-H.; Kim, T.-Y. 2007: Antiperinuclear factor test is more useful than anti-Sa assay when used with anti-cyclic citrullinated peptide test in diagnosis of rheumatoid arthritis. Journal of Rheumatology 34(9): 1944-1945

Hess, A.F. 1910: Antiperistalsis in its Relation to Tubercle Bacilli and other Bacteria in the alimentary Tract. Journal of Medical Research 22(1): 129-144

Pauli, E.M.; Haluck, R.S. 2008: Antiperistaltic (retrograde) intussusception after laparoscopic Roux-en-Y gastric bypass procedure. Surgery for Obesity and Related Diseases: Official Journal of the American Society for Bariatric Surgery 4(4): 567-568

Pomazkin, V.I. 2009: Antiperistaltic cecorectal anastomosis by subtotal colectomy. Khirurgiia 7: 43-46

Hiki, N.; Kaminishi, M.; Yasuda, K.; Uedo, N.; Honjo, H.; Matsuhashi, N.; Hiratsuka, T.; Sekine, C.; Nomura, S.; Yahagi, N.; Tajiri, H.; Suzuki, H. 2011: Antiperistaltic effect and safety of L-menthol sprayed on the gastric mucosa for upper Gi endoscopy: a phase III, multicenter, randomized, double-blind, placebo-controlled study. Gastrointestinal Endoscopy 73(5): 932-941

Constantinoiu, S. 2007: Antiperistaltic esophagoplasty with left colon. Chirurgia 102(6): 709-719

Yang, J.; Duh, E.J.; Caldwell, R.B.; Behzadian, M.A. 2010: Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/beta-catenin signaling pathway and uPAR expression. Investigative Ophthalmology and Visual Science 51(6): 3273-3280

Heinle, R.W. 1949: Antipernicious anemia substances. Postgraduate Medicine 5(3): 197-204

Chen, X.; Lu, J.; He, W.; Chi, H.; Yamashita, K.; Manabe, M.; Kodama, H. 2009: Antiperoxidation activity of triterpenoids from rhizome of Anemone raddeana. Fitoterapia 80(2): 105-111

Türk, G.; Ceribaşi, A.O.; Sakin, F.; Sönmez, M.; Ateşşahin, A. 2010: Antiperoxidative and anti-apoptotic effects of lycopene and ellagic acid on cyclophosphamide-induced testicular lipid peroxidation and apoptosis. Reproduction Fertility and Development 22(4): 587-596

Swathy, S.S.; Panicker, S.; Nithya, R.S.; Anuja, M.M.; Rejitha, S.; Indira, M. 2010: Antiperoxidative and antiinflammatory effect of Sida cordifolia Linn. on quinolinic acid induced neurotoxicity. Neurochemical Research 35(9): 1361-1367

Pragasam, S.J.; Murunikara, V.; Sabina, E.P.; Rasool, M. 2012: Antiperoxidative potential of p-coumaric acid, a common dietary phenol, in adjuvant-induced arthritis in rats. Zhong Xi Yi Jie he Xue Bao 10(8): 932-938

Melo, R.és.B.; Guimarães, S.ér.B.; Silva, P.G.ân.d.B.; Oriá, R.B.; Melo, J.é U.d.S.; Vasconcelos, P.R.L.ão. 2014: Antiperoxidative properties of oil mixes of high ratio Omega-9:Omega-6 and low ratio Omega-6:Omega-3 after molar extraction in rats. Acta Cirurgica Brasileira 29(6): 371-375

Ribeiro, H.V.; Guimarães, R.R.; Teixeira-Souza, R.T.; Mukai, H.; Fernandes, P.R.G.; Lenzi, E.K.; Mendes, R.S. 2013: Antipersistent behavior of defects in a lyotropic liquid crystal during annihilation. Physical Review. e Statistical Nonlinear and Soft Matter Physics 87(5): 054501

Goswami, S.; Chatterjee, A.; Sen, P. 2011: Antipersistent dynamics in kinetic models of wealth exchange. Physical Review. e Statistical Nonlinear and Soft Matter Physics 84(5 Part 1): 051118

Tierno, P.; Sagués, F.; Johansen, T.H.; Sokolov, I.M. 2012: Antipersistent random walk in a two state flashing magnetic potential. Physical Review Letters 109(7): 070601

Chaloner, E. 1996: Antipersonnel landmines. Annals of the Royal College of Surgeons of England 78(6): 562-563

Zirwas, M.J.; Moennich, J. 2008: Antiperspirant and deodorant allergy: diagnosis and management. Journal of Clinical and Aesthetic Dermatology 1(3): 38-43

Hagan, D.B.; Leng, F.J.; Smith, P.M.; Snow, M.; Watson, A. 1997: Antiperspirant compositions based on titanium salts. International Journal of Cosmetic Science 19(6): 271-280

Ceresko, A.R.; Raskin, H.A. 1949: Antipertussis rabbit serum in 95 cases and 15 contacts; preliminary report. Journal-MichiganStateMedicalSociety 48(6): 728

Korobkova, E.I. 1945: Antiphage action of antiplague sera. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 10: 49-53

Dilão, R. 2009: Antiphase and in-phase synchronization of nonlinear oscillators: the Huygens's clocks system. Chaos 19(2): 023118

Lawson, C.A.; Nord, G.L.; Dowty, E.; Hargraves, R.B. 1981: Antiphase domains and reverse thermoremanent magnetism in ilmenite-hematite minerals. Science 213(4514): 1372-1374

Boudec, P.L.; Jaouen, C.; François, P.L.; Bayon, J.F.; Sanchez, F.; Besnard, P.; Stéphan, G. 1993: Antiphase dynamics and chaos in self-pulsing erbium-doped fiber lasers. Optics Letters 18(22): 1890-1892

Bours, R.; van Zanten, M.; Pierik, R.; Bouwmeester, H.; van der Krol, A. 2013: Antiphase light and temperature cycles affect PHYTOCHROME B-controlled ethylene sensitivity and biosynthesis, limiting leaf movement and growth of Arabidopsis. Plant Physiology 163(2): 882-895

Mazzoccoli, G.; Muscarella, L.A.; Fazio, V.M.; Piepoli, A.; Pazienza, V.; Dagostino, M.P.; Giuliani, F.; Polyakova, V.O.; Kvetnoy, I. 2011: Antiphase signalling in the neuroendocrine-immune system in healthy humans. Biomedicine and PharmacoTherapy 65(4): 275-279

Leptos, K.C.; Wan, K.Y.; Polin, M.; Tuval, I.; Pesci, A.I.; Goldstein, R.E. 2013: Antiphase synchronization in a flagellar-dominance mutant of Chlamydomonas. Physical Review Letters 111(15): 158101

Mersch, E.; Vandewalle, N. 2011: Antiphase synchronization of electrically shaken conducting beads. Physical Review. e Statistical Nonlinear and Soft Matter Physics 84(6 Part 1): 061301

Stefanatos, D.; Li, J.-S. 2012: Antiphase synchronization of phase-reduced oscillators using open-loop control. Physical Review. e Statistical Nonlinear and Soft Matter Physics 85(3 Part 2): 037201

Strüber, D.; Rach, S.; Trautmann-Lengsfeld, S.A.; Engel, A.K.; Herrmann, C.S. 2014: Antiphasic 40 Hz oscillatory current stimulation affects bistable motion perception. Brain Topography 27(1): 158-171

Mizushima, Y. 1980: Antiphlogistic activity of detergent and antirheumatic mechanism of phenylbutazone and salicylate. Scandinavian Journal of Rheumatology 9(1): 33-40

Miller, C.T.; Beck, K.; Meade, B.; Wang, X. 2009: Antiphonal call timing in marmosets is behaviorally significant: interactive playback experiments. Journal of Comparative Physiology. a Neuroethology Sensory Neural and Behavioral Physiology 195(8): 783-789

Soliman, A.A.; Csorba, R.; Ullrich, A.; Tsikouras, P.; Rath, W.; von Tempelhoff, G.-F. 2014: Antiphopholipid antibodies and functional activated protein C resistance in patients with breast cancer during anthracycline-based chemotherapy administered through an intravenous port-catheter device. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20(3): 338-340

Ali, H.Y.M.; Abdullah, Z.A. 2007: Antiphosphatidyl serine autoantibodies and premature coronary events. Sultan Qaboos University Medical Journal 7(3): 227-232

Sanmarco, M.; Boffa, M.-C. 2009: Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome. Lupus 18(10): 920-923

Obayashi, S.; Ozaki, Y.; Sugi, T.; Kitaori, T.; Katano, K.; Suzuki, S.; Sugiura-Ogasawara, M. 2010: Antiphosphatidylethanolamine antibodies might not be an independent risk factor for further miscarriage in patients suffering recurrent pregnancy loss. Journal of Reproductive Immunology 85(2): 186-192

Khogeer, H.; Alfattani, A.; Al Kaff, M.; Al Shehri, T.; Khojah, O.; Owaidah, T. 2015: Antiphosphatidylserine antibodies as diagnostic indicators of antiphospholipid syndrome. Lupus 24(2): 186-190

He, J.; Yin, Y.; Luster, T.A.; Watkins, L.; Thorpe, P.E. 2009: Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(22): 6871-6880

Kawakami, T.; Yamazaki, M.; Mizoguchi, M.; Soma, Y. 2009: Antiphosphatidylserine-prothrombin complex antibodies in 3 patients with Behçet disease involving superficial vein thrombophlebitis. Archives of Dermatology 145(2): 171-175

Bertolaccini, M.L.; Sciascia, S.; Sanna, G.; Khamashta, M.A. 2013: Antiphosphatidylserine/prothrombin antibodies in systemic lupus erythematosus. Journal of Rheumatology 40(9): 1620

Ruffatti, A.; Pengo, V. 2009: Antiphosphlipid syndrome classification criteria: comments to the Letter of Jakub Swadzba and Jacek Musial. Journal of thrombosis and haemostasis: JTH 2009

Sirachainan, N.; Pakakasama, S.; Hongeng, S.; Chuansumrit, A.; Tuntiyatorn, L.; Vilaiyuk, S. 2011: Antiphospholid antibody syndrome and Hb E/Beta thalassemia disease post-allogeneic stem cell transplantation. Pediatric Blood and Cancer 57(1): 153-156

Glassock, R.J. 2014: Antiphospholipase A2 receptor autoantibody guided diagnosis and treatment of membranous nephropathy: a new personalized medical approach. Clinical Journal of the American Society of Nephrology: Cjasn 9(8): 1341-1343

Behnert, A.; Schiffer, M.; Müller-Deile, J.; Beck, L.H.; Mahler, M.; Fritzler, M.J. 2014: Antiphospholipase A₂ receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy. Journal of Immunology Research 2014: 143274

Mialdea, M.; Sangle, S.R.; D'Cruz, D.P. 2009: Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis. Journal of Autoimmune Diseases 6: 3

Georgopoulou, S.; Efraimidou, S.; MacLennan, S.J.; Ibrahim, F.; Cox, T. 2015: Antiphospholipid (Hughes) syndrome: description of population and health-related quality of life (HRQoL) using the SF-36. Lupus 24(2): 174-179

Jain, A. 2014: Antiphospholipid Antibody Syndrome Associated with Graves' Disease Presenting as Inferior Vena Cava Thrombosis with Bilateral Lower Limb DVT. Clinical Medicine Insights. Case Reports 7: 37-39

Goodridge, A.; Zhang, T.; Miyata, T.; Lu, S.; Riley, L.W. 2014: Antiphospholipid IgM antibody response in acute and chronic Mycobacterium tuberculosis mouse infection model. Clinical Respiratory Journal 8(2): 137-144

Suhr, J.K.; Jung, H.G. 2018: A Universal Vacant Parking Slot Recognition System Using Sensors Mounted on Off-the-Shelf Vehicles. Sensors 18(4)

Di Prima, F.A.F.; Valenti, O.; Hyseni, E.; Giorgio, E.; Faraci, M.; Renda, E.; De Domenico, R.; Monte, S. 2011: Antiphospholipid Syndrome during pregnancy: the state of the art. Journal of Prenatal Medicine 5(2): 41-53

Serrano, F.át. 2013: Antiphospholipid Syndrome: a complex disease. Journal of Nephropathology 2(1): 73-74

Warkentin, T.E. 2009: Antiphospholipid and anti-PF4 antibodies: an association affecting anti-PF4/heparin assay analysis. Journal of thrombosis and haemostasis: JTH 7(7): 1067-1069

Roye-Green, K.; Frederick, J.; Wharfe, G.; Choo-Kang, E.; DaCosta, V.; Fletcher, H.; Smikle, M. 2011: Antiphospholipid and other autoantibodies in a cohort of habitual aborters and healthy multiparous women in Jamaica. Human Antibodies 20(1-2): 1-5

Lim, W.; Crowther, M.A. 2007: Antiphospholipid antibiodies: a critical review of the literature. Current Opinion in Hematology 14(5): 494-499

Di Simone, N.; Di Nicuolo, F.; D'Ippolito, S.; Castellani, R.; Tersigni, C.; Caruso, A.; Meroni, P.; Marana, R. 2010: Antiphospholipid antibodies affect human endometrial angiogenesis. Biology of Reproduction 83(2): 212-219

Di Simone, N.; D'Ippolito, S.; Marana, R.; Di Nicuolo, F.; Castellani, R.; Pierangeli, S.S.; Chen, P.; Tersigni, C.; Scambia, G.; Meroni, P.L. 2013: Antiphospholipid antibodies affect human endometrial angiogenesis: protective effect of a synthetic peptide (TIFI) mimicking the phospholipid binding site of β(2) glycoprotein i. American Journal of Reproductive Immunology 70(4): 299-308

Fernández-Fresnedo, G.; López-Hoyos, M.; San Segundo, D.; Crespo, J.; Ruiz, J.C.; De Francisco, A.L.M.; Arias, M. 2008: Antiphospholipid antibodies after renal transplantation and cardiovascular disease. Clinical Transplantation 22(5): 567-571

Ching, Y.M.; Arip, M.; Jegasothy, R.; Baskaran, T.P.; Yusof, A.Y.; Bakhtiar, F.; Mustafa, N. 2013: Antiphospholipid antibodies among women experiencing fetal loss. Malaysian Journal of Pathology 35(2): 147-151

García-García, C. 2007: Antiphospholipid antibodies and antiphospholipid syndrome: diagnosis and management. Actas Dermo-Sifiliograficas 98(1): 16-23

Kujovich, J.; Merrill, P.A. 2011: Antiphospholipid antibodies and antithrombin deficiency: double trouble for pregnancy. American Journal of Hematology 86(12): 1028-1031

Holc, I.; Hojs, R.; Cikeš, N.; Ambrožič, A.š; Cučnik, S.ša.; Kveder, T.; Rozman, B.ž; Pahor, A. 2011: Antiphospholipid antibodies and atherosclerosis: insights from rheumatoid arthritis--a five-year follow-up study. Immunobiology 216(12): 1331-1337

Ames, P.R.J.; Margarita, A.; Alves, J.D. 2009: Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome. Clinical Reviews in Allergy and Immunology 37(1): 29-35

Scrobohaci, M.-L. 2008: Antiphospholipid antibodies and cancer. Pathologie-Biologie 56(4): 245-250

Chen, W-Hsi.; Chen, C-Hung.; Chui, C.; Lui, C-Chung.; Chen, C-Jen.; Yin, H-Ling. 2014: Antiphospholipid antibodies and cerebellar ataxia: a clinical analysis and literature review. Neuroimmunomodulation 21(6): 283-290

Spegiorin, L.C.J.F.; Galão, E.A.; De Godoy, J.M.P.; Bagarelli, L.B.; Oliani, A.H. 2007: Antiphospholipid antibodies and growth retardation in intrauterine development. Prague Medical Report 108(2): 185-190

Masliah-Planchon, J.; Darnige, L. 2012: Antiphospholipid antibodies and haemostasis. La Revue de Medecine Interne 33(4): 181-188

Kashef, S.; Karimi, M.; Amirghofran, Z.; Ayatollahi, M.; Pasalar, M.; Ghaedian, M.M.; Kashef, M.A. 2008: Antiphospholipid antibodies and hepatitis C virus infection in Iranian thalassemia major patients. International Journal of Laboratory Hematology 30(1): 11-16

Chighizola, C.B.; de Jesus, G.R. 2014: Antiphospholipid antibodies and infertility. Lupus 23(12): 1232-1238

Wielosz, E.; Dryglewska, M.; Majdan, M. 2009: Antiphospholipid antibodies and kidney involvement in patients with systemic sclerosis. Clinical Rheumatology 28(8): 955-959

Pascut, D.; Princi, T.; Donato, M.; Tamaro, G.; Parco, S. 2009: Antiphospholipid antibodies and lipoprotein(a) in obese children. Acta Paediatrica 98(4): 703-707

Tincani, A.; Taraborelli, M.; Cattaneo, R. 2010: Antiphospholipid antibodies and malignancies. Autoimmunity Reviews 9(4): 200-202

Pham, C.; Shen, Y.-M. 2008: Antiphospholipid antibodies and malignancy. Hematology/Oncology Clinics of North America 22(1): 121-130 Vii

Tănăsescu, R.; Nicolau, A.; Caraiola, S.; Ticmeanu, M.; Cojocaru, I.Mihaela.; Frăsineanu, A.; Ionescu, R.; Hristea, A.; Ene, A.; Anghel, D.; Tănăsescu, R.; Băicuş, C. 2007: Antiphospholipid antibodies and migraine: a retrospective study of 428 patients with inflammatory connective tissue diseases. Romanian Journal of Internal Medicine 45(4): 355-363

Salluh, J.I.F.; Soares, M.ár.; De Meis, E. 2009: Antiphospholipid antibodies and multiple organ failure in critically ill cancer patients. Clinics 64(2): 79-82

Manuck, T.; Branch, D.W.; Lai, Y.; Sibai, B.; Spong, C.Y.; Wendel, G.; Wenstrom, K.; Samuels, P.; Caritis, S.N.; Sorokin, Y.; Miodovnik, M.; O'Sullivan, M.J.; Conway, D.; Wapner, R.J. 2010: Antiphospholipid antibodies and pregnancy outcomes in women heterozygous for factor V Leiden. Journal of Reproductive Immunology 85(2): 180-185

Peluso, G.; Morrone, G. 2007: Antiphospholipid antibodies and recurrent abortions: possible pathogenetic role of annexin A5 investigated by confocal microscopy. Minerva Ginecologica 59(3): 223-229

Lopera-Vallejo, A.és.F.; Alijotas-Reig, J. 2011: Antiphospholipid antibodies and recurrent implantation failure in in-vitro fertilization. the debate goes on. Medicina Clinica 137(15): 697-701

Gigante, A.; Gasperini, M.L.; Cianci, R.; Barbano, B.; Giannakakis, K.; Di Donato, D.; Fuiano, G.; Amoroso, A. 2009: Antiphospholipid antibodies and renal involvement. American Journal of Nephrology 30(5): 405-412

Tsuruta, Y.; Uchida, K.; Itabashi, M.; Yumura, W.; Nitta, K. 2009: Antiphospholipid antibodies and renal outcomes in patients with lupus nephritis. Internal Medicine 48(21): 1875-1880

Urbanus, R.T.; Siegerink, B.; Roest, M.; Rosendaal, F.R.; de Groot, P.G.; Algra, A. 2009: Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. LANCET. Neurology 8(11): 998-1005

Majka, D.S.; Liu, K.; Pope, R.M.; Karlson, E.W.; Vu, T.-H.T.; Teodorescu, M.; Chang, R.W. 2013: Antiphospholipid antibodies and sub-clinical atherosclerosis in the Coronary Artery Risk Development in Young Adults (CARDIA) cohort. Inflammation Research: Official Journal of the European Histamine Research Society . 62(10): 919-927

Mubarak, M.; Nasri, H. 2013: Antiphospholipid antibodies and systemic scleroderma. Turkish Journal of Haematology: Official Journal of Turkish Society of Haematology 30(4): 429-430

Mérelle, S.Y.M.; Sorbi, M.J.; van Doornen, L.J.P.; Passchier, J. 2008: Lay trainers with migraine for a home-based behavioral training: a 6-month follow-up study. Headache 48(9): 1311-1325

Strobl, F.; Anderl, A.; Stelzer, E.H. 2018: A universal vector concept for a direct genotyping of transgenic organisms and a systematic creation of homozygous lines. Elife 7

Brey, R.L.; Muscal, E.; Chapman, J. 2011: Antiphospholipid antibodies and the brain: a consensus report. Lupus 20(2): 153-157

Goldsmith, D.P. 1998: Antiphospholipid antibodies and the pediatric patient. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 4(2): 47-49

Tong, M.; Viall, C.A.; Chamley, L.W. 2015: Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment. Human Reproduction Update 21(1): 97-118

Urbanus, R.T.; de Laat, B. 2010: Antiphospholipid antibodies and the protein C pathway. Lupus 19(4): 394-399

Moulis, G.; Delavigne, K.; Huguet, F.; Fortenfant, F.; Beyne-Rauzy, O.; Adoue, D. 2011: Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome. La Revue de Medecine Interne 32(12): 724-729

Musiał, J. 2012: Antiphospholipid antibodies and thrombosis. Thrombosis Research 129(3): 345-347

Artenjak, A.; Lakota, K.; Frank, M.; Čučnik, Sša.; Rozman, Bž.; Božič, B.; Shoenfeld, Y.; Sodin-Semrl, S. 2012: Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review. Autoimmunity Reviews 11(12): 873-882

Ulrich, V.; Konaniah, E.S.; Lee, W.-R.; Khadka, S.; Shen, Y.-M.; Herz, J.; Salmon, J.E.; Hui, D.Y.; Shaul, P.W.; Mineo, C. 2014: Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice. Journal of the American Heart Association 3(5): E001369

Kolarz, B.; Majdan, M.; Darmochwal-Kolarz, D.A.; Dryglewska, M. 2014: Antiphospholipid antibodies during 6-month treatment with infliximab: a preliminary report. Medical science monitor: international medical journal of experimental and clinical research 20: 1227-1231

Atta, A.M.; Estevam, P.; Paraná, R.; Pereira, C.M.; Leite, B.C.O.; Sousa-Atta, M.L.B. 2008: Antiphospholipid antibodies in Brazilian hepatitis C virus carriers. Brazilian Journal of Medical and Biological Research 41(6): 489-492

Tavil, B.; Ozyurek, E.; Gumruk, F.; Cetin, M.; Gurgey, A. 2007: Antiphospholipid antibodies in Turkish children with thrombosis. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 18(4): 347-352

Martinaud, C.; Gisserot, O.; Graffin, B.; Gaillard, T.; Brisou, P.; Cynober, T.ér.ès.; de Jaureguiberry, J.P.; Delaunay, J.; Aguilon, P. 2008: Antiphospholipid antibodies in a family with dehydrated hereditary stomatocytosis. Thrombosis Research 122(4): 572-575

Becker, A.C.; Libhaber, E.; Sliwa, K.; Singh, S.; Stewart, S.; Tikly, M.; Essop, M.R. 2011: Antiphospholipid antibodies in black south africans with hiv and acute coronary syndromes: prevalence and clinical correlates. Bmc Research Notes 4: 379

George, M.; Ahluwalia, J.; Gupta, A.; Masih, J.; Bose, S.K.; Singh, S. 2014: Antiphospholipid antibodies in children with Kawasaki disease: a preliminary study from north India. Rheumatology International 34(6): 849-850

Dentali, F.; Crowther, M. 2010: Antiphospholipid antibodies in critical illness. Critical Care Medicine 38(2 Suppl): S51-S56

Vassalo, J.; Spector, N.; Meis, E.d.; Soares, M.ár.; Salluh, J.I.F. 2014: Antiphospholipid antibodies in critically ill patients. Revista Brasileira de Terapia Intensiva 26(2): 176-182

Vassalo, J.; Spector, N.; de Meis, E.; Rabello, L.íg.S.C.F.; Rosolem, M.ír.M.; do Brasil, P.E.A.A.; Salluh, J.I.F.; Soares, M.ár. 2014: Antiphospholipid antibodies in critically ill patients with cancer: a prospective cohort study. Journal of Critical Care 29(4): 533-538

Shetty, S.; Vora, S.; Kulkarni, B.; Mota, L.; Ghosh, K. 2009: Antiphospholipid antibodies in haemophilia patients with severe bleeding tendency: cause, consequence or a consequential cause?. Haemophilia: the Official Journal of the World Federation of Hemophilia 15(5): 1104-1108

Al Samarrai, A.A.; Hilmi, F.A.; Al-Allawi, N.A.; Murad, A.F. 2012: Antiphospholipid antibodies in iraqi women with recurrent mid-trimester abortions. Journal of Laboratory Physicians 4(2): 78-82

Lis-Święty, A.; Brzezińska-Wcisło, L.; Arasiewicz, H.; Bergler-Czop, B. 2014: Antiphospholipid antibodies in localized scleroderma: the potential role of screening tests for the detection of antiphospholipid syndrome. Postepy Dermatologii i Alergologii 31(2): 65-70

Mahaum, N.; Prete, P.E. 2011: Antiphospholipid antibodies in malignancy: are these pathogenic or epiphenomena?. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 17(8): 429-431

Berkun, Y.; Simchen, M.J.; Strauss, T.; Menashcu, S.; Padeh, S.; Kenet, G. 2014: Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome?. Lupus 23(10): 986-993

Echigo, T.; Hasegawa, M.; Inaoki, M.; Yamazaki, M.; Sato, S.; Takehara, K. 2007: Antiphospholipid antibodies in patients with autoimmune blistering disease. Journal of the American Academy of Dermatology 57(3): 397-400

Greco, T.P.; Conti-Kelly, A.M.; Matsuura, E.; Greco, T.; Dier, K.J.; Svanas, G.; Doyle, R.; Lopez, L.R. 2007: Antiphospholipid antibodies in patients with coronary artery disease: new cardiac risk factors?. Annals of the new York Academy of Sciences 1108: 466-474

Telejko, B.; Bachórzewska-Gajewska, H.; Zonenberg, A.; Kraśnicki, P.ł; Nikołajuk, A.; Abdelrazek, S.; Dobrzycki, S.ła.; Górska, M. 2006: Antiphospholipid antibodies in patients with coronary heart disease and the disturbances of glucose tolerance. Polskie Archiwum Medycyny Wewnetrznej 116(3): 845-852

Darnige, L.; Peffault de Latour, R.ég.; Zemori, L.; Socié, G.ér.; Fischer, A.-M.; Helley, D. 2011: Antiphospholipid antibodies in patients with paroxysmal nocturnal haemoglobinuria receiving eculizumab. British Journal of Haematology 153(6): 789-791

Stricker, R.B.; Johnson, L. 2012: Antiphospholipid antibodies in patients with persistent Lyme disease symptoms. Lupus 21(3): 346-347

Greco, T.P.; Conti-Kelly, A.M.; Greco, T.P. 2011: Antiphospholipid antibodies in patients with purported 'chronic Lyme disease'. Lupus 20(13): 1372-1377

Miyara, M.; Diemert, M.-C.; Amoura, Z.; Musset, L. 2012: Antiphospholipid antibodies in practice. La Revue de Medecine Interne 33(4): 176-180

Kovács, M.ón.; Hartwig, M.; Aleksza, M.; Tihanyi, M.; Nagy, T.án.; Vajda, G.; Daru, J.óz.; Gasztonyi, B.át. 2012: Antiphospholipid antibodies in relation to sterility/infertility. Human Immunology 73(7): 726-731

Furmańczyk-Zawiska, A.; Bączkowska, T.; Sadowska, A.; Szmidt, J.; Chmura, A.; Durlik, M. 2013: Antiphospholipid antibodies in renal allograft recipients. Transplantation Proceedings 45(4): 1655-1660

Avcin, T.; Toplak, N. 2007: Antiphospholipid antibodies in response to infection. Current Rheumatology Reports 9(3): 212-218

Gladd, D.A.; Olech, E. 2009: Antiphospholipid antibodies in rheumatoid arthritis: identifying the dominoes. Current Rheumatology Reports 11(1): 43-51

Peaceman, A.M. 2014: Antiphospholipid antibodies in stillbirth. Obstetrics and Gynecology 123(1): 184

Sharma, V. 2010: Antiphospholipid antibodies in stroke. Journal of Postgraduate Medicine 56(1): 49; Author Reply 49-50

Ames, P.R.J. 2009: Antiphospholipid antibodies in systemic sclerosis: a double oxidative hit?. Clinical Rheumatology 28(8): 881-882

Paulmyer-Lacroix, O.; Despierres, L.; Courbiere, B.; Bardin, N. 2014: Antiphospholipid antibodies in women undergoing in vitro fertilization treatment: clinical value of IgA anti-β2glycoprotein i antibodies determination. Biomed Research International 2014: 314704

Mishra, M.N.; Rohatgi, S. 2009: Antiphospholipid antibodies in young Indian patients with stroke. Journal of Postgraduate Medicine 55(3): 161-164

Mishra, M.N.; Kalra, R.; Gupta, M.K. 2007: Antiphospholipid antibodies in young myocardial infarction patients. Indian Journal of Biochemistry and Biophysics 44(6): 481-484

Yamada, H.; Atsumi, T.; Kobashi, G.; Ota, C.; Kato, E.H.; Tsuruga, N.; Ohta, K.; Yasuda, S.; Koike, T.; Minakami, H. 2009: Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. Journal of Reproductive Immunology 79(2): 188-195

Mulla, M.J.; Brosens, J.J.; Chamley, L.W.; Giles, I.; Pericleous, C.; Rahman, A.; Joyce, S.K.; Panda, B.; Paidas, M.J.; Abrahams, V.M. 2009: Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway. American Journal of Reproductive Immunology 62(2): 96-111

Viall, C.A.; Chen, Q.; Liu, B.; Hickey, A.; Snowise, S.; Salmon, J.E.; Stone, P.R.; Chamley, L.W. 2013: Antiphospholipid antibodies internalised by human syncytiotrophoblast cause aberrant cell death and the release of necrotic trophoblast debris. Journal of Autoimmunity 47: 45-57

Mulla, M.J.; Myrtolli, K.; Brosens, J.J.; Chamley, L.W.; Kwak-Kim, J.Y.; Paidas, M.J.; Abrahams, V.M. 2010: Antiphospholipid antibodies limit trophoblast migration by reducing IL-6 production and STAT3 activity. American Journal of Reproductive Immunology 63(5): 339-348

Lázaro, I.; Carmona, F.; Reverter, J.Carlos.; Cervera, R.; Tassies, D.; Balasch, J. 2009: Antiphospholipid antibodies may impair factor XIIa-dependent activation of fibrinolysis in pregnancy: in vitro evidence with human endothelial cells in culture and monoclonal anticardiolipin antibodies. American Journal of Obstetrics and Gynecology 201(1): 87.E1-87.E6

Andreoli, L.; Fredi, M.; Nalli, C.; Franceschini, F.; Meroni, P.L.; Tincani, A. 2013: Antiphospholipid antibodies mediate autoimmunity against dying cells. Autoimmunity 46(5): 302-306

Neville, C.; Rauch, J.; Kassis, J.; Solymoss, S.; Joseph, L.; Belisle, P.; Levine, J.S.; Fortin, P.R. 2009: Antiphospholipid antibodies predict imminent vascular events independently from other risk factors in a prospective cohort. Thrombosis and Haemostasis 101(1): 100-107

Duftner, C.; Seiler, R.üd.; Dejaco, C.; Chemelli-Steingruber, I.; Schennach, H.; Klotz, W.; Rieger, M.; Herold, M.; Falkensammer, J.ür.; Fraedrich, G.; Schirmer, M. 2014: Antiphospholipid antibodies predict progression of abdominal aortic aneurysms. Plos one 9(6): E99302

Ramesh, S.; Morrell, C.N.; Tarango, C.; Thomas, G.D.; Yuhanna, I.S.; Girardi, G.; Herz, J.; Urbanus, R.T.; de Groot, P.G.; Thorpe, P.E.; Salmon, J.E.; Shaul, P.W.; Mineo, C. 2011: Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPi and apoER2. Journal of Clinical Investigation 121(1): 120-131

Diallo, M.; Niang, S.O.; Kane, A.; Dieng, M.T.; Ndiaye, B. 2007: Antiphospholipid antibodies syndrome in dermatology in Dakar: 11 case report. Dakar Medical 52(1): 41-45

Sène, D.; Piette, J.-C.; Cacoub, P. 2008: Antiphospholipid antibodies, antiphospholipid syndrome and infections. Autoimmunity Reviews 7(4): 272-277

Alijotas-Reig, J. 2008: Antiphospholipid antibodies, antiphospholipid syndrome and suprarenal haematoma. Medicina Clinica 131(19): 759

Sène, D.; Piette, J.-C.; Cacoub, P. 2009: Antiphospholipid antibodies, antiphospholipid syndrome and viral infections. La Revue de Medecine Interne 30(2): 135-141

Arvanitakis, Z.; Brey, R.L.; Rand, J.H.; Schneider, J.A.; Leurgans, S.E.; Yu, L.; Buchman, A.S.; Arfanakis, K.; Fleischman, D.A.; Boyle, P.A.; Bennett, D.A.; Levine, S.R. 2013: Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study. Neuroepidemiology 40(2): 73-84

Englander, M.; Davie, J.M. 1997: Antiphospholipid antibodies, cocaine use, and stroke in a young woman. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 3(4): 224-226

Zawilska, K. 2007: Antiphospholipid antibodies--risk factors for venous thromboembolism and arterial thrombosis. Polskie Archiwum Medycyny Wewnetrznej 117 Suppl: 41-45

Urbanus, R.T.; de Groot, P.G. 2011: Antiphospholipid antibodies--we are not quite there yet. Blood Reviews 25(2): 97-106

Koudriavtseva, T.; Plantone, D.; Renna, R. 2014: Antiphospholipid antibodies: a possible biomarker of disease activity in multiple sclerosis and neuromyelitis optica spectrum disorders. Journal of Neurology 261(10): 2028-2029

Cervera, R.; Font, J.; Asherson, R.A. 1997: Antiphospholipid antibodies: guidelines for determination. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 3(6): 368-374

Vlachoyiannopoulos, P.G.; Samarkos, M.; Sikara, M.; Tsiligros, P. 2007: Antiphospholipid antibodies: laboratory and pathogenetic aspects. Critical Reviews in Clinical Laboratory Sciences 44(3): 271-338

Horstman, L.L.; Jy, W.; Bidot, C.J.; Ahn, Y.S.; Kelley, R.E.; Zivadinov, R.; Maghzi, A.H.; Etemadifar, M.; Mousavi, S.A.; Minagar, A. 2009: Antiphospholipid antibodies: paradigm in transition. Journal of Neuroinflammation 6: 3

Kirchoff-Torres, K.; Levine, S.R. 2009: Antiphospholipid antibodies: pinning risk on a moving target. LANCET. Neurology 8(11): 971-973

Ingen-Housz-Oro, S.; Leroy-Matheron, C.; Hüe, S. 2012: Antiphospholipid antibodies: what dermatologists must know. Annales de Dermatologie et de Venereologie 139(5): 417-420

Wolberg, A.S. 2007: Antiphospholipid antibody effects on monocytes. Current Rheumatology Reports 9(3): 198-204

Tincani, A.; Andreoli, L.; Casu, C.; Cattaneo, R.; Meroni, P. 2010: Antiphospholipid antibody profile: implications for the evaluation and management of patients. Lupus 19(4): 432-435

Zheng, H.; Chen, Y.; Ao, W.; Shen, Y.; Chen, X.-w.; Dai, M.; Wang, X.-d.; Yan, Y.-c.; Yang, C.-d. 2009: Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases. Arthritis Research and Therapy 11(3): R93

Anonymous 1920: A University Appeal. Hospital 68(1768): 78

Lim, W. 2009: Antiphospholipid antibody syndrome. Hematology. American Society of Hematology. Education Program 2009: 233-239

Sangle, N.A.; Smock, K.J. 2011: Antiphospholipid antibody syndrome. Archives of Pathology and Laboratory Medicine 135(9): 1092-1096

Yang, P.; Kruh, J.N.; Foster, C.Stephen. 2012: Antiphospholipid antibody syndrome. Current Opinion in Ophthalmology 23(6): 528-532

Kutteh, W.H.; Hinote, C.D. 2014: Antiphospholipid antibody syndrome. Obstetrics and Gynecology Clinics of North America 41(1): 113-132

Prahalad, S.; Ostrov, B.E. 1998: Antiphospholipid antibody syndrome and adrenal insufficiency in a 15-year-old girl. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 4(2): 87-91

Ostrowski, R.A.; Robinson, J.A. 2008: Antiphospholipid antibody syndrome and autoimmune diseases. Hematology/Oncology Clinics of North America 22(1): 53-65 Vi

Kutteh, W.H. 2014: Antiphospholipid antibody syndrome and reproduction. Current Opinion in Obstetrics and Gynecology 26(4): 260-265

Gündoğdu, F.; Unlü, Y.; Bariş, N.; Arslan, S. 2008: Antiphospholipid antibody syndrome leading to massive pulmonary embolism and sudden death. Turk Kardiyoloji Dernegi Arsivi: Turk Kardiyoloji Derneginin Yayin Organidir 36(7): 467-469

Tang, J.; Fillmore, G.; Nussenblatt, R.B. 2009: Antiphospholipid antibody syndrome mimicking serpiginous choroidopathy. Ocular Immunology and Inflammation 17(4): 278-281

Choudhary, S.; Herschthal, J.; Chimento, S.M.; Green, J.B.; Milikowski, C.; Andrews, D.; Cohen, J.; Kerdel, F. 2013: Antiphospholipid antibody syndrome presenting with purpura fulminans. International Journal of Dermatology 52(8): 1026-1027

Silverberg, J.I.; Votava, H.J.; Smith, B.L. 2012: Antiphospholipid antibody syndrome secondary to trimethoprim/sulfamethoxazole. Journal of Drugs in Dermatology: Jdd 11(9): 1117-1118

Acikel, S.; Akdemir, R.; Dogan, M.; Kilic, H.; Yesilay, A.B. 2010: Antiphospholipid antibody syndrome: coexistence of left ventricular apical thrombus and deep vein thrombosis causing pulmonary thromboembolism in a patient with systemic lupus erythematosus. Echocardiography 27(2): 198-201

Hambly, N.; Sekhon, S.; McIvor, R.Andrew. 2014: Antiphospholipid antibody syndrome: diffuse alveolar hemorrhage and Libman-Sacks endocarditis in the absence of prior thrombotic events. Ulster Medical Journal 83(1): 47-49

Hughes, G.R.V.; Shoenfeld, Y. 2012: Antiphospholipid antibody testing - slow progress?. International Journal of Clinical Practice 66(6): 533-535

Devreese, K.M.J. 2014: Antiphospholipid antibody testing and standardization. International Journal of Laboratory Hematology 36(3): 352-363

Favaloro, E.J.; Wong, R.C.W. 2014: Antiphospholipid antibody testing for the antiphospholipid syndrome: a comprehensive practical review including a synopsis of challenges and recent guidelines. Pathology 46(6): 481-495

Chen, W.-H.; Chen, C.-J. 2009: Antiphospholipid antibody, head-shaking and ataxia: an evidence of non-vascular neurotoxicity and successful treatment by plasmapheresis. Rheumatology International 29(7): 827-829

Orzechowski, N.M.; Wolanskyj, A.P.; Ahlskog, J.E.; Kumar, N.; Moder, K.G. 2008: Antiphospholipid antibody-associated chorea. Journal of Rheumatology 35(11): 2165-2170

Contractor, T.; Bell, A.; Khasnis, A.; Silverberg, B.J.; Martinez, M.W. 2013: Antiphospholipid antibody-associated non-infective mitral valve endocarditis successfully treated with medical therapy. Journal of Heart Valve Disease 22(1): 36-38

Blank, M.; Shoenfeld, Y. 2010: Antiphospholipid antibody-mediated reproductive failure in antiphospholipid syndrome. Clinical Reviews in Allergy and Immunology 38(2-3): 141-147

Singh, U.; Rastogi, H.; Patne, S.C. 2012: Antiphospholipid antibody-related Bell's palsy in young women. Singapore Medical Journal 53(3): e55-e56

Tincani, A.; Casu, C.; Cartella, S.; Ziglioli, T.; Cattaneo, R. 2010: Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations. Reumatismo 62(1): 65-75

Oku, K.; Amengual, O.; Atsumi, T. 2014: Antiphospholipid scoring: significance in diagnosis and prognosis. Lupus 23(12): 1269-1272

Elezović, I.; Matijević-Aleksić, N.; Rolović, Z. 1994: Antiphospholipid sydrome--recurrent thrombosis and foetal loss due to antiphospholipid antibodies. Srpski Arhiv Za Celokupno Lekarstvo 122(5-6): 179-181

George, D.; Erkan, D. 2009: Antiphospholipid syndrome. Progress in Cardiovascular Diseases 52(2): 115-125

Ruiz-Irastorza, G.; Crowther, M.; Branch, W.; Khamashta, M.A. 2010: Antiphospholipid syndrome. Lancet 376(9751): 1498-1509

Nelson, G.N. 2010: Antiphospholipid syndrome. Journal of Hand Surgery 35(11): 1890-2; Quiz 1892

Lim, W. 2013: Antiphospholipid syndrome. Hematology. American Society of Hematology. Education Program 2013: 675-680

Tektonidou, M.G.; Sotsiou, F.; Moutsopoulos, H.M. 2008: Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS. Journal of Rheumatology 35(10): 1983-1988

Sherer, Y.; Blank, M.; Shoenfeld, Y. 2007: Antiphospholipid syndrome (APS): where does it come from?. Best Practice and Research. Clinical Rheumatology 21(6): 1071-1078

Hughes, G.R.V. 2010: Antiphospholipid syndrome (Hughes syndrome): 10 clinical topics. Lupus 19(4): 343-346

Szturmowicz, M. 2009: Antiphospholipid syndrome - an update on diagnosis and treatment. Pneumonologia i Alergologia Polska 77(5): 460-468

Mata, R.; Llamas, P.; Román, A.; Prieto, E.; López, J.L.; Tomás, J.F.; Subirá, D. 2008: Antiphospholipid syndrome after non-myeloablative hematopoietic cell transplantation. Thrombosis Research 122(2): 283-284

Diaz, J.S.; Octavio, J.G.; Fernandez-Guerrero, M.L. 2010: Antiphospholipid syndrome and acute HIV infection. Emerging Infectious Diseases 16(2): 360-361

Martí, V.; Seixo, F.; Santaló, M.; Serra, A. 2014: Antiphospholipid syndrome and acute myocardial infarction: treatment with thrombectomy and abciximab. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 33(7-8): 465.E1

De Carvalho, J.él.F.; Levy, R.A.; Shoenfeld, Y. 2014: Antiphospholipid syndrome and antibodies. Journal of Immunology Research 2014: 942869

Nalli, C.; Piantoni, S.; Andreoli, L.; Motta, M.; Tincani, A. 2012: Antiphospholipid syndrome and antiphospholipid antibodies in children: the two sides of the coin. Israel Medical Association Journal: Imaj 14(5): 310-312

Beckhauser, A.Paula.; Arana, Lís.Augusto.; Skare, T.Larocca. 2008: Antiphospholipid syndrome and bilateral retinal artery and vein occlusion: case report. Arquivos Brasileiros de Oftalmologia 71(2): 282-285

Reinstein, E.; Shoenfeld, Y. 2007: Antiphospholipid syndrome and cancer. Clinical Reviews in Allergy and Immunology 32(2): 184-187

Mayer, M.; Cerovec, M.; Rados, M.; Cikes, N. 2010: Antiphospholipid syndrome and central nervous system. Clinical Neurology and Neurosurgery 112(7): 602-608

Liberato, B.; Levy, R.A. 2007: Antiphospholipid syndrome and cognition. Clinical Reviews in Allergy and Immunology 32(2): 188-191

Souza, F.Henrique.Carlos.de.; Levy-Neto, Mício.; Shinjo, S.Katsuyuki. 2012: Antiphospholipid syndrome and dermatomyositis/polymyositis: a rare association. Revista Brasileira de Reumatologia 52(4): 642-644

Morissette, N.; Gorman, T. 2010: Antiphospholipid syndrome and homozygous factor V Leiden mutation in a young patient with Libman-Sacks endocarditis and stroke. American Journal of Medicine 123(9): E3-E4

Galindo García, C.G.; Bernárdez Zapata, F.J.; Hernández Marín, I.; Ayala, A.R. 2007: Antiphospholipid syndrome and human reproduction. Ginecologia y Obstetricia de Mexico 75(5): 277-285

Roccatello, D.; Rossi, D.; Giachino, O.; Bazzan, M.; Mazzucco, G. 2007: Antiphospholipid syndrome and kidney. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 24(2): 111-120

Fraga, G.; Ballarín, J.; Jiménez, I.; Díaz, M.; Arce, Y.; Rodríguez, J.I.; Cubells, J. 2007: Antiphospholipid syndrome and lupus nephritis treated with rituximab. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 27(5): 560-564

Revaux, A.él.; Mekinian, A.èn.; Nicaise, P.; Bucourt, M.; Cornelis, F.ço.; Lachassinne, E.; Chollet-Martin, S.; Fain, O.; Carbillon, L. 2015: Antiphospholipid syndrome and other autoimmune diseases associated with chronic intervillositis. Archives of Gynecology and Obstetrics 291(6): 1229-1236

Plowman, E.K.; Okun, M.S. 2011: Antiphospholipid syndrome and other lupus-related movement disorders. Handbook of Clinical Neurology 100: 237-245

Caldas, C.A.M.; de Carvalho, J.él.F. 2013: Antiphospholipid syndrome and polyarteritis nodosa: a diagnostic and therapeutic challenge. Rheumatology International 33(10): 2697-2698

Romano, G.; Gremese, E. 2007: Antiphospholipid syndrome and preeclampsia. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 24(3): 195-201

Zatti, S.; Rebaioli, C.B.; Lojacono, A.; Rovetto, B.; Barbolini, E.; Taglietti, M.; Nuzzo, M.; Tincani, A. 2006: Antiphospholipid syndrome and pregnancy. Women's Health 2(6): 873-880

Gadó, K.ár.; Domján, G. 2012: Antiphospholipid syndrome and pregnancy. Orvosi Hetilap 153(31): 1207-1218

Delesalle, C.; de Vienne, C.; Le Hello, C.; Verspyck, E.; Dreyfus, M. 2015: Antiphospholipid syndrome and pregnancy: Obstetrical prognosis according to the type of APS. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 44(5): 463-470

Henriques, C.C.; Lourenço, F.; Lopéz, B.ña.; Panarra, A.ón.; Riso, N. 2012: Antiphospholipid syndrome and recurrent thrombosis--limitations of current treatment strategies. BMJ Case Reports

Sciascia, S.; Bazzan, M.; Baldovino, S.; Vaccarino, A.; Rossi, D.; Russo, A.; Roccatello, D. 2011: Antiphospholipid syndrome and relapsing polychondritis: an unusual association. Lupus 20(12): 1336-1337

Rehak, M.; Müller, M.; Scholz, M.; Wiercinska, J.; Niederwieser, D.; Wiedemann, P. 2009: Antiphospholipid syndrome and retinal vein occlusion. Meta-analysis of Published Studies. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 106(5): 427-434

Bandettini di Poggio, M.; Murdaca, G.; Puppo, F.; Primavera, A. 2010: Antiphospholipid syndrome and reversible posterior leukoencephalopathy syndrome. Seminars in Arthritis and Rheumatism 40(3): E9-10

Shoenfeld, Y.; Meroni, P.Luigi.; Toubi, E. 2009: Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?. Current Opinion in Rheumatology 21(5): 495-500

Shroff, A.; Chung, H-Oh.; Khalidi, N.A.; Spyropoulos, A. 2011: Antiphospholipid syndrome and the aorta: a rare presentation. Journal of Rheumatology 38(8): 1808-1809

Muscal, E.; Brey, R.L. 2010: Antiphospholipid syndrome and the brain in pediatric and adult patients. Lupus 19(4): 406-411

Majdan, M. 2010: Antiphospholipid syndrome and the kidney diseases. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 28(167): 341-344

Tebo, A.E. 2014: Antiphospholipid syndrome and the relevance of antibodies to negatively charged phospholipids in diagnostic evaluation. Lupus 23(12): 1313-1316

Fikri Benbrahim, O.; Levy, F.; Santos Barajas, J.; Carrasco Prado, M. 2009: Antiphospholipid syndrome and thrombotic microangiopathy. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 29(3): 276-277

Atanassova, P.A. 2007: Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview. Yonsei Medical Journal 48(6): 901-926

Snipelisky, D.; Stancampiano, F.; Shapiro, B. 2013: Antiphospholipid syndrome as a cause for recurrent myocardial infarction. Acute Cardiac Care 15(3): 80-82

Khan, S. 2011: Antiphospholipid syndrome as cause of cognitive decline or dementia in the elderly. Journal of the Royal College of Physicians of Edinburgh 41(2): 187-8; author reply 188-9

Toyoshima, M.; Maegaki, Y.; Yotsumata, K.; Takei, S.; Kawano, Y. 2007: Antiphospholipid syndrome associated with human herpesvirus-6 infection. Pediatric Neurology 37(6): 449-451

Fedorchenko, S.V.; Klimenko, Z.B.; Martynovich, T.L. 2009: Antiphospholipid syndrome at the onset of clinical manifestations of chronic autoimmune hepatitis of type i. Terapevticheskii Arkhiv 81(11): 14-16

Mitamura, Y.; Takahara, M.; Ito, T.; Nakano, M.; Moroi, Y.; Furue, M. 2013: Antiphospholipid syndrome complicated by unilateral pleural effusion. Case Reports in Dermatology 5(2): 198-202

Yu, J.; Han, J-li.; Wang, G-song. 2011: Antiphospholipid syndrome complicated with acute myocardial infarction: a case report. Zhonghua Xin Xue Guan Bing Za Zhi 39(1): 84

Akhmed-zadeh, V.A. 2008: Antiphospholipid syndrome correction in pregnant and parturient women by the combined methods therapy. Georgian Medical News 2008(164): 27-33

Faillace, C.és.; de Carvalho, J.él.F. 2012: Antiphospholipid syndrome development after rituximab treatment. Joint Bone Spine 79(2): 200-201

Visseaux, B.; Masliah-Planchon, J.; Fischer, A-Marie.; Darnige, L. 2011: Antiphospholipid syndrome diagnosis: an update. Annales de Biologie Clinique 69(4): 411-418

Shoenfeld, Y.; Meroni, P.L.; Cervera, R. 2008: Antiphospholipid syndrome dilemmas still to be solved: 2008 status. Annals of the Rheumatic Diseases 67(4): 438-442

Balderramo, D.C.; García, O.; Colmenero, J.; Espinosa, G.; Forns, X.; Ginès, P. 2009: Antiphospholipid syndrome during pegylated interferon alpha-2a therapy for chronic hepatitis C. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 41(7): E4-E7

Meyer, A.; Rotman-Pikielny, P.; Natour, A.; Levy, Y. 2010: Antiphospholipid syndrome following a diphtheria-tetanus vaccination: coincidence vs. causality. Israel Medical Association Journal: Imaj 12(10): 638-639

Tavakoli, M.; Roghaee, S.; Soheilian, R.; Soheilian, M. 2011: Antiphospholipid syndrome following toxoplasma retinochoroiditis. Ocular Immunology and Inflammation 19(5): 311-313

Meroni, P.L.; Chighizola, C.B.; Rovelli, F.; Gerosa, M. 2014: Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers. Arthritis Research and Therapy 16(2): 209

Zamora-Ustaran, A.; Escarcega-Alarcón, R.O.; Garcia-Carrasco, M.; Faugier, E.; Mendieta-Zeron, S.; Mendoza-Pinto, C.; Montiel-Jarquin, A.; Muñoz-Guarneros, M.; Lopez-Colombo, A.; Cervera, R. 2012: Antiphospholipid syndrome in Mexican children. Israel Medical Association Journal: Imaj 14(5): 286-289

Teh, C.L.; Leong, T.S. 2015: Antiphospholipid syndrome in Sarawak: real world experience in a developing country. Clinical Rheumatology 34(1): 175-178

Mount, G.R.; Roebuck, J.D. 2009: Antiphospholipid syndrome in a 21-year-old with Klinefelter syndrome. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 15(1): 27-28

Bhat, M.A.; Kawoosa, M.S.; Bhat, J.I.; Ali, S.W. 2011: Antiphospholipid syndrome in a neonate. Pediatric Dermatology 28(3): 342-345

Anakwue, R.Chinedu.; Chijioke, C.; Mbah, A.; Onuh, A.; Okwara, C. 2013: Antiphospholipid syndrome in a young Nigerian girl presenting with gangrenous toes. Cardiovascular Journal of Africa 24(9-10): E8

Paudyal, B. 2010: Antiphospholipid syndrome in childhood systemic lupus erythematosus. Journal of Nepal Health Research Council 8(1): 51-54

Rai, R.; Sekar, C.Shanmuga.; Kumaresan, M. 2010: Antiphospholipid syndrome in dermatology: an update. Indian Journal of Dermatology Venereology and Leprology 76(2): 116-124

Dekeyser, M.; Zuily, S.ép.; Champigneulle, J.; Eschwège, V.ér.; Frimat, L.; Perret-Guillaume, C.; Wahl, D. 2014: Antiphospholipid syndrome in nephrology. Kidney damage and practical aspects of the management. Nephrologie and Therapeutique 10(1): 1-9

Pavlović, D.M.; Pavlović, A.M. 2010: Antiphospholipid syndrome in neurology. Srpski Arhiv Za Celokupno Lekarstvo 138(9-10): 651-657

Khamashta, M. 2012: Antiphospholipid syndrome in obstetrics. La Revue de Medecine Interne 33(Suppl 2): A7

Ravelli, A.; Martini, A. 2007: Antiphospholipid syndrome in pediatrics. Rheumatic Diseases Clinics of North America 33(3): 499-523

Ruiz-Irastorza, G.; Khamashta, M.A. 2007: Antiphospholipid syndrome in pregnancy. Rheumatic Diseases Clinics of North America 33(2): 287-297 Vi

Bick, R.L. 2008: Antiphospholipid syndrome in pregnancy. Hematology/Oncology Clinics of North America 22(1): 107-120 Vii

Matusiak-Kita, M.; Murawski, M.; Gryboś, M. 2008: Antiphospholipid syndrome in pregnancy--actual therapeutic methods. Wiadomosci Lekarskie 61(10-12): 273-276

Matusiak-Kita, M.; Murawski, M.; Gryboś, M. 2009: Antiphospholipid syndrome in pregnancy--contemporary opinions concerning pathogenesis and diagnostic criteria. Wiadomosci Lekarskie 62(1): 21-25

Barbour, T.D.; Crosthwaite, A.; Chow, K.; Finlay, M.J.; Better, N.; Hughes, P.D.; Cohney, S.J. 2014: Antiphospholipid syndrome in renal transplantation. Nephrology 19(4): 177-185

Buliková, A.; Zavrelová, J.; Penka, M. 2009: Antiphospholipid syndrome in the year 2009. Vnitrni Lekarstvi 55(3): 253-262

Katzav, A.; Faust-Socher, A.; Kvapil, F.; Michaelson, D.M.; Blank, M.; Pick, C.G.; Shoenfeld, Y.; Korczyn, A.D.; Chapman, J. 2011: Antiphospholipid syndrome induction exacerbates a transgenic Alzheimer disease model on a female background. Neurobiology of Aging 32(2): 272-279

Morchi, G.S.; Wolfe, R.R.; Kay, J.D. 2009: Antiphospholipid syndrome leading to myocardial infarction in a Fontan patient 17 years after Norwood palliation. Congenital Heart Disease 4(1): 54-58

Nakao, S.; Akimoto, K.; Inamori, M.; Suzuki, A.; Suzuki, K.; Iida, H.; Endo, H.; Akiyama, T.; Fujita, K.; Yoneda, M.; Takahashi, H.; Abe, Y.; Kobayashi, N.; Kubota, K.; Yamanaka, S.; Nakajima, A. 2008: Antiphospholipid syndrome manifested by gastrointestinal bleeding: can we overlook endoscopically revealed small lesions?. Digestion 77(3-4): 139-140

Ghazavi, M.; Bamford, M.W.; Mensah, P.; Harman, K.E. 2012: Antiphospholipid syndrome masquerading as necrotising fasciitis. Journal of Plastic Reconstructive and Aesthetic Surgery: Jpras 65(11): E322-E323

Erre, G.Luca.; Bosincu, L.; Faedda, R.; Fenu, P.; Masala, A.; Sanna, M.; Taras, L.; Longu, M.Giovanna.; Piras, M.; Soro, G.; Satta, A.Ercole.; Passiu, G. 2014: Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study. Rheumatology International 34(4): 535-541

Asherson, R.A.; Klumb, E.M. 2008: Antiphospholipid syndrome nephropathy in different scenarios. Journal of Rheumatology 35(10): 1909-1911

Singh, A.; Blank, M.; Shoenfeld, Y.; Illges, H. 2008: Antiphospholipid syndrome patients display reduced titers of soluble CD21 in their sera irrespective of circulating anti-beta2-glycoprotein-I autoantibodies. Rheumatology International 28(7): 661-665

Barcellona, D.; Fenu, L.; Vannini, M.L.; Piras, M.; Marongiu, F. 2012: Antiphospholipid syndrome patients: the performance of Coagucheck XS in the monitoring of Vitamin K-Antagonists. Thrombosis Research 129(4): E168-E170

Camargo, E.W.; Freire, P.V.; Silva, C.A.; dos Santos, N.R.; da Mota, L.M.H.; Pereira, R.M.R.; de Carvalho, J.él.F. 2012: Antiphospholipid syndrome plus rheumatic fever: a higher risk factor for stroke?. Rheumatology International 32(6): 1721-1725

Starke, R.; Amoako, P.; Cytryn, L.; Mahesh, S. 2007: Antiphospholipid syndrome presenting as adrenal haemorrhage. New Zealand Medical Journal 120(1256): U2589

Li, C-Hsun.; Chou, M-Chuan.; Liu, C-Kuan.; Lai, C-Lian. 2013: Antiphospholipid syndrome presenting as progressive neuropsychiatric disorders: two case reports. Neuropsychiatric Disease and Treatment 9: 739-742

Phatak, S.; Redkar, N.; Patil, M.A.; Karnik, N.D. 2012: Antiphospholipid syndrome presenting as pulmonary thrombosis and pancreatitis in a young man. BMJ Case Reports

Boltin, D.; Boguslavski, V.; Sagi, L.; Goor, Y.; Elkayam, O. 2009: Antiphospholipid syndrome presenting as unilateral renal artery occlusion: case report and literature review. Rheumatology International 29(7): 831-835

Crome, C.R.; Rajagopalan, S.; Kuhan, G.; Fluck, N. 2012: Antiphospholipid syndrome presenting with acute digital ischaemia, avascular necrosis of the femoral head and superior mesenteric artery thrombus. BMJ Case Reports

Hegazi, M.O.; Mourou, M.; Hassanien, O.A. 2009: Antiphospholipid syndrome presenting with superior vena cava thrombosis. Iranian Journal of Immunology: Iji 6(2): 103-106

Pierangeli, S.S.; Erkan, D. 2010: Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?. Lupus 19(4): 475-485

Amigo-Castañeda, M.C. 2005: Antiphospholipid syndrome treatment, to whom, when and how long?. Reumatologia Clinica 1(Suppl 2): S52-S58

Karasawa, N.; Taniguchi, Y.; Hidaka, T.; Katayose, K.; Kameda, T.; Side, K.; Shimoda, H.; Nagata, K.; Kubuki, Y.; Matsunaga, T.; Shimoda, K. 2010: Antiphospholipid syndrome with autoimmune hemolytic anemia which mimics thrombotic thrombocytopenic purpura. Japanese Journal of Clinical Hematology 51(4): 275-280

Saji, M.; Nakajima, A.; Sendo, W.; Tanaka, M.; Koseki, Y.; Ichikawa, N.; Harigai, M.; Akama, H.; Taniguchi, A.; Terai, C.; Hara, M.; Kamatani, N. 2001: Antiphospholipid syndrome with complete abdominal aorta occlusion and chondritis. Modern Rheumatology 11(2): 159-161

Wan, P.-J.; Zhao, X.-Q.; Au-Yeung, K.; Zheng, J. 2011: Antiphospholipid syndrome with cutaneous necrotic lesion of the lower limbs. Journal of Rheumatology 38(4): 786-787

Lee, C.E.; Zain, A.A.; Pang, Y.K. 2010: Antiphospholipid syndrome with pulmonary artery embolism and multiple venous thromboses. Medical Journal of Malaysia 65(3): 221-223

Sharma, V.K.; Chaturvedi, R.; Manoj Luthra, V. 2011: Antiphospholipid syndrome, cardiac surgery and cardiopulmonary bypass. Annals of Cardiac Anaesthesia 14(2): 146-149

Musallam, K.M.; Uthman, I.; Taher, A.T. 2009: Antiphospholipid syndrome, microalbuminuria, and risk of venous thromboembolism. JAMA 302(9): 945; Author Reply 945-6

Hughes, G.R.V. 2010: Antiphospholipid syndrome, migraine and stroke. Lupus 19(5): 555-556

Cohen, C.; Mekinian, A.èn.; Rouvier, P.; Pham, I.; Fain, O. 2012: Antiphospholipid syndrome, systemic lupus erythematosus: endocarditis and glomerulopathy. La Revue du Praticien 62(3): 316

Musiał, J. 2007: Antiphospholipid syndrome--a magnifying glass of medicine. Polskie Archiwum Medycyny Wewnetrznej 117(1-2): 41-43

Uppal, R.S.; Stillaert, F.B.; Hamdi, M. 2008: Antiphospholipid syndrome--a rare cause of free flap thrombosis in perforator flap breast reconstruction. Journal of Plastic Reconstructive and Aesthetic Surgery: Jpras 61(3): 347-348

Nasri, H. 2013: Antiphospholipid syndrome-associated nephropathy: Current concepts. Journal of Renal Injury Prevention 2(1): 1-2

Thomas, J. 1998: Antiphospholipid syndrome-current status. Indian Journal of Dermatology Venereology and Leprology 64(1): 6-11

Van Os, G.M.A.; Urbanus, R.T.; Agar, C.; Meijers, J.C.M.; de Groot, P.G. 2010: Antiphospholipid syndrome. Current insights into laboratory diagnosis and pathophysiology. Hamostaseologie 30(3): 139-143

Pechlaner, C. 2010: Antiphospholipid syndrome. what benefit has the label?. Bmj 340: C2983

Ardalan, M.; Vahedi, A. 2013: Antiphospholipid syndrome: a disease of protean face. Journal of Nephropathology 2(1): 81-84

Donadini, M.P.; Crowther, M. 2010: Antiphospholipid syndrome: a challenging hypercoagulable state with systemic manifestations. Hematology/Oncology Clinics of North America 24(4): 669-676 Vii

Dusse, L.M.S.; Silva, F.D.e.; Freitas, L.íc.G.ça.; Rios, D.R.A.; Armond, S.C.; Marcolino, M.S. 2014: Antiphospholipid syndrome: a clinical and laboratorial challenge. Revista da Associacao Medica Brasileira 60(2): 181-186

Palomo, I.; Segovia, F.; Ortega, C.; Pierangeli, S. 2009: Antiphospholipid syndrome: a comprehensive review of a complex and multisystemic disease. Clinical and Experimental Rheumatology 27(4): 668-677

Monteiro, A.é V.; Branco, L.ís.M.; de Sousa, L.íd.; Ferreira, R.C. 2015: Antiphospholipid syndrome: a recurrent cardiac thromboembolic insult in spite of optimal anticoagulation. Reumatologia Clinica 11(3): 177-178

García de Lucas, M.ía.D.; Olalla, J.án.; Martín-Salido, E.; Espinosa, G. 2013: Antiphospholipid syndrome: analysis of 27 patients. Medicina Clinica 141(4): 182-183

Gray, J.M.; Khamashta, M.A. 2011: Antiphospholipid syndrome: coming of age. Reumatologia Clinica 7(3): 151-153

Pengo, V.; Banzato, A.; Bison, E.; Denas, G.; Padayattil Jose, S.; Ruffatti, A. 2010: Antiphospholipid syndrome: critical analysis of the diagnostic path. Lupus 19(4): 428-431

D'Cruz, D.P. 2012: Antiphospholipid syndrome: diagnosis. La Revue de Medecine Interne 33(Suppl 2): A5-A6

Martinović, D.; Radić, M.; Fabijanić, D.; Fabijanić, A. 2007: Antiphospholipid syndrome: from diagnosis to treatment. Lijecnicki Vjesnik 129(8-9): 281-285

Pengo, V. 2011: Antiphospholipid syndrome: interpretation of laboratory data. Journal of Thrombosis and Haemostasis: Jth 9(2): 402-403

Weiss, S.; Nyzio, J.B.; Cines, D.; Detre, J.; Milas, B.L.; Narula, N.; Floyd, T.F. 2008: Antiphospholipid syndrome: intraoperative and postoperative anticoagulation in cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia 22(5): 735-739

Tripodi, A.; de Groot, P.G.; Pengo, V. 2011: Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment. Journal of Internal Medicine 270(2): 110-122

Cervera, R.; Espinosa, G. 2010: Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies. Expert Opinion on Therapeutic Targets 14(12): 1279-1282

Gris, J.-C.; Bouvier, S. 2013: Antiphospholipid syndrome: looking for a refocusing. Thrombosis Research 131(Suppl 1): S28-S31

Bokarev, I.N.; Arshinov, A.V.; Mel'nikov, A.L. 2007: Antiphospholipid syndrome: modern problems. Klinicheskaia Meditsina 85(11): 4-8

De Moerloose, P.; Tirefort-Dimitrova, Y.; Noger, F.; Spycher-Elbes, R.; Boehlen, F.ço. 2010: Antiphospholipid syndrome: much new data. Revue Medicale Suisse 6(235): 298-301

Forastiero, R. 2007: Antiphospholipid syndrome: new light comes from in vivo studies. Journal of Thrombosis and Haemostasis: Jth 5(9): 1825-1827

Mehdi, A.A.; Uthman, I.; Khamashta, M. 2010: Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future. European Journal of Clinical Investigation 40(5): 451-464

Ksouri, H.; Mellouli, F.; Béjaoui, M. 2008: Antiphospholipid syndrome: pathophysiology and clinicobiological aspects. Archives de l'Institut Pasteur de Tunis 85(1-4): 91-105

Dafer, R.M.; Biller, J.é 2008: Antiphospholipid syndrome: role of antiphospholipid antibodies in neurology. Hematology/Oncology Clinics of North America 22(1): 95

Greaves, M. 2011: Antiphospholipid syndrome: unusual clinical presentations. Thrombosis Research 127 Suppl. 3: S47-S50

Koniari, I.; Siminelakis, S.N.; Baikoussis, N.G.; Papadopoulos, G.; Goudevenos, J.; Apostolakis, E. 2010: Antiphospholipid syndrome; its implication in cardiovascular diseases: a review. Journal of Cardiothoracic Surgery 5: 101

Bick, R.L.; Baker, W.F. 2008: Antiphospholipid syndromes. Hematology/Oncology Clinics of North America 22(1): Xiii-Xxiv

Amin, N.M. 2008: Antiphospholipid syndromes in infectious diseases. Hematology/Oncology Clinics of North America 22(1): 131-143 VII-VIII

Hunt, R.D.; Robinson, M.; Patel, R.; Franks, A.G. 2012: Antiphospholipid-antibody-associated panniculitis. Dermatology Online Journal 18(12): 18

Comellas-Kirkerup, L.ía.; Hernández-Molina, G.; Cabral, A.R. 2010: Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study. Blood 116(16): 3058-3063

Peluso, S.; Antenora, A.; De Rosa, A.; Roca, A.; Maddaluno, G.; Brescia Morra, V.; De Michele, G. 2012: Antiphospholipid-related chorea. Frontiers in Neurology 3: 150

Lockshin, M.D. 2012: Antiphospholipid: to test, or not to test, that is the question. International Journal of Clinical Practice 66(7): 620-621

Nseir, B.; Panicker, J. 2008: Antiphospholipids antibodies in a 12-month-old presenting with idiopathic thrombocytopenic purpura. Pediatric Hematology and Oncology 25(3): 233-235

Siegel, J.N. 2001: Antiphosphotyrosine blotting. Current Protocols in Immunology Chapter 11: Unit 11.3

Kuz Tekşut, T.; Özcan, H.; Işık, M.; Karslı, F. 2013: Antiphospolipid syndrome related chorea gravidarum case with psychotic symptoms misdiagnosed as conversion disorder: case report. Turk Psikiyatri Dergisi 24(4): 280-283

Madrid Villegas, A.; Díaz Peralta, K.; González Tapia, César.; Catalán Marín, K.; Espinoza Catalán, L. 2015: Antiphytopathogenic activity of Psoralea glandulosa (Fabaceae) against Botrytis cinerea and Phytophthora cinnamomi. Natural Product Research 29(6): 586-588

Dunkić, V.; Bezić, N.; Vuko, E. 2011: Antiphytoviral activity of essential oil from endemic species Teucrium arduini. Natural Product Communications 6(9): 1385-1388

Bezić, N.; Vuko, E.; Dunkić, V.; Ruščić, M.; Blažević, I.; Burčul, F. 2011: Antiphytoviral activity of sesquiterpene-rich essential oils from four croatian teucrium species. Molecules 16(9): 8119-8129

Tanriverdi, F.; De Bellis, A.; Bizzarro, A.; Sinisi, A.A.; Bellastella, G.; Pane, E.; Bellastella, A.; Unluhizarci, K.; Selcuklu, A.; Casanueva, F.F.; Kelestimur, F. 2008: Antipituitary antibodies after traumatic brain injury: is head trauma-induced pituitary dysfunction associated with autoimmunity?. European Journal of Endocrinology 159(1): 7-13

De Graaff, L.C.G.; De Bellis, A.; Bellastella, A.; Hokken-Koelega, A.C.S. 2009: Antipituitary antibodies in dutch patients with idiopathic hypopituitarism. Hormone Research 71(1): 22-27

De Bellis, A.; Colao, A.; Pivonello, R.; Savoia, A.; Battaglia, M.; Ruocco, G.; Tirelli, G.; Lombardi, G.; Bellastella, A.; Bizzarro, A. 2007: Antipituitary antibodies in idiopathic hyperprolactinemic patients. Annals of the new York Academy of Sciences 1107: 129-135

Moya Chimenti, E.; Alvarez Doforno, R.; Villaroel Bajo, A.; Frutos, R.; Pallardo Sánchez, L.F.; Alvarez Escolá, C. 2010: Antipituitary antibodies in patients with suspected autoimmune hypophysitis. Endocrinologia y Nutricion: Organo de la Sociedad Espanola de Endocrinologia y Nutricion 57(4): 160-164

Rodrigues, I.S.C.; Tavares, V.íc.N.; Pereira, S.ér.L.ís.d.S.; Costa, F.áv.N.d. 2009: Antiplaque and antigingivitis effect of Lippia Sidoides: a double-blind clinical study in humans. Journal of Applied Oral Science: Revista Fob 17(5): 404-407

Salgado, A.D.Y.; Maia, J.L.; Pereira, S.ér.L.ís.d.S.; de Lemos, T.L.G.; Mota, O.ív.M.d.L. 2006: Antiplaque and antigingivitis effects of a gel containing Punica granatum Linn extract: a double-blind clinical study in humans. Journal of Applied Oral Science: Revista Fob 14(3): 162-166

Shim, J.-Y.; Yim, S.-B.; Chung, J.-H.; Hong, K.S. 2012: Antiplaque and antigingivitis effects of a mouthrinse containing cetylpyridinium chloride, triclosan and dipotassium glycyrrhizinate. Journal of Periodontal and Implant Science 42(2): 33-38

Charles, C.A.; Amini, P.; Gallob, J.; Shang, H.; McGuire, J.A.; Costa, R. 2012: Antiplaque and antigingivitis efficacy of an alcohol-free essential-oil containing mouthrinse: a 2-week clinical trial. American Journal of Dentistry 25(4): 195-198

Chainani, S.H.; Siddana, S.; Reddy, C.; Manjunathappa, T.H.; Manjunath, M.; Rudraswamy, S. 2014: Antiplaque and antigingivitis efficacy of triphala and chlorhexidine mouthrinse among schoolchildren - a cross-over, double-blind, randomised controlled trial. Oral Health and Preventive Dentistry 12(3): 209-217

Sanz, M.; Serrano, J.; Iniesta, M.; Santa Cruz, I.; Herrera, D. 2013: Antiplaque and antigingivitis toothpastes. Monographs in Oral Science 23: 27-44

Lee, S.S.; Aprecio, R.M.; Zhang, W.; Arambula, M.; Wilkins, K.B.; Stephens, J.A.; Kim, J.S.; Li, Y. 2008: Antiplaque/antigingivitis efficacy and safety of a cetylpyridinium chloride/zinc gluconate mucoadhesive gel. Results of a 6-month clinical trial. Compendium of Continuing Education in Dentistry 29(5): 302-304; 306 308 Passim

Latha, C.; Shriram, V.D.; Jahagirdar, S.S.; Dhakephalkar, P.K.; Rojatkar, S.R. 2009: Antiplasmid activity of 1'-acetoxychavicol acetate from Alpinia galanga against multi-drug resistant bacteria. Journal of Ethnopharmacology 123(3): 522-525

Nieuwenhuizen, L.; Roosendaal, G.; Mastbergen, S.C.; Coeleveld, K.; Biesma, D.H.; Lafeber, F.P.J.G.; Schutgens, R.E.G. 2014: Antiplasmin, but not amiloride, prevents synovitis and cartilage damage following hemarthrosis in hemophilic mice. Journal of Thrombosis and Haemostasis: Jth 12(2): 237-245

Ahmed, E.-H.M.; Nour, B.Y.M.; Mohammed, Y.G.; Khalid, H.S. 2010: Antiplasmodial Activity of Some Medicinal Plants Used in Sudanese Folk-medicine. Environmental Health Insights 4: 1-6

Gboeloh, L.B.; Okon, O.E.; Udoh, S.E. 2014: Antiplasmodial Effect of Anthocleista vogelii on Albino Mice Experimentally Infected with Plasmodium berghei berghei (NK 65). Journal of Parasitology Research 2014: 731906

Builders, M.I.; Uguru, M.O.; Aguiyi, C. 2012: Antiplasmodial Potential of the African Mistletoe: Agelanthus dodoneifolius Polh and Wiens. Indian Journal of Pharmaceutical Sciences 74(3): 223-229

Melariri, P.; Campbell, W.; Etusim, P.; Smith, P. 2011: Antiplasmodial Properties and Bioassay-Guided Fractionation of Ethyl Acetate Extracts from Carica papaya Leaves. Journal of Parasitology Research 2011: 104954

King, H.; Tonkin, I.M. 1946: Antiplasmodial action and chemical constitution; guanidines and diguanides. Journal of the Chemical Society 1946: 1063-1069

Vaiana, N.; Marzahn, M.; Parapini, S.; Liu, P.; Dell'Agli, M.; Pancotti, A.; Sangiovanni, E.; Basilico, N.; Bosisio, E.; Dunn, B.M.; Taramelli, D.; Romeo, S. 2012: Antiplasmodial activities of 4-aminoquinoline-statine compounds. Bioorganic and Medicinal Chemistry Letters 22(18): 5915-5918

Wansi, J.D.; Hussain, H.; Tcho, A.T.; Kouam, S.F.; Specht, S.; Sarite, S.R.; Hoerauf, A.; Krohn, K. 2010: Antiplasmodial activities of furoquinoline alkaloids from Teclea afzelii. PhytoTherapy Research: Ptr 24(5): 775-777

Lebouvier, N.; Jullian, V.ér.; Desvignes, I.; Maurel, S.év.; Parenty, A.; Dorin-Semblat, D.; Doerig, C.; Sauvain, M.; Laurent, D. 2009: Antiplasmodial activities of homogentisic acid derivative protein kinase inhibitors isolated from a Vanuatu marine sponge Pseudoceratina sp. Marine Drugs 7(4): 640-653

Chung, I-Min.; Moon, H-In. 2009: Antiplasmodial activities of sesquiterpene lactone from Carpesium cernum. Journal of Enzyme Inhibition and Medicinal Chemistry 24(1): 131-135

Zimmerman, T.; Moneriz, C.; Diez, A.; Bautista, J.é M.; Gómez Del Pulgar, T.; Cebrián, A.; Lacal, J.C. 2013: Antiplasmodial activity and mechanism of action of RSM-932A, a promising synergistic inhibitor of Plasmodium falciparum choline kinase. Antimicrobial Agents and ChemoTherapy 57(12): 5878-5888

Dhooghe, L.; Maregesi, S.; Mincheva, I.; Ferreira, D.; Marais, J.P.J.; Lemière, F.; Matheeussen, A.; Cos, P.; Maes, L.; Vlietinck, A.; Apers, S.; Pieters, L. 2010: Antiplasmodial activity of (I-3,II-3)-biflavonoids and other constituents from Ormocarpum kirkii. Phytochemistry 71(7): 785-791

Chandel, S.; Bagai, U. 2010: Antiplasmodial activity of Ajuga bracteosa against Plasmodium berghei infected BALB/c mice. Indian Journal of Medical Research 131: 440-444

Hnawia, E.; Hassani, L.; Deharo, E.; Maurel, S.év.; Waikedre, J.; Cabalion, P.; Bourdy, G.èv.; Valentin, A.; Jullian, V.ér.; Fogliani, B. 2011: Antiplasmodial activity of new Caledonia and Vanuatu traditional medicines. Pharmaceutical Biology 49(4): 369-376

Dell'Agli, M.; Galli, G.V.; Corbett, Y.; Taramelli, D.; Lucantoni, L.; Habluetzel, A.; Maschi, O.; Caruso, D.; Giavarini, F.; Romeo, S.; Bhattacharya, D.; Bosisio, E. 2009: Antiplasmodial activity of Punica granatum L. fruit rind. Journal of Ethnopharmacology 125(2): 279-285

Graziose, R.; Rathinasabapathy, T.; Lategan, C.; Poulev, A.; Smith, P.J.; Grace, M.; Lila, M.Ann.; Raskin, I. 2011: Antiplasmodial activity of aporphine alkaloids and sesquiterpene lactones from Liriodendron tulipifera L. Journal of Ethnopharmacology 133(1): 26-30

Wangchuk, P.; Bremner, J.B.; Samten; Skelton, B.W.; White, A.H.; Rattanajak, R.; Kamchonwongpaisan, S. 2010: Antiplasmodial activity of atisinium chloride from the Bhutanese medicinal plant, Aconitum orochryseum. Journal of Ethnopharmacology 130(3): 559-562

Boya, C.A.; Herrera, L.; Guzman, H.M.; Gutierrez, M. 2012: Antiplasmodial activity of bacilosarcin a isolated from the octocoral-associated bacterium Bacillus sp. collected in Panama. Journal of Pharmacy and Bioallied Sciences 4(1): 66-69

Bagavan, A.; Rahuman, A.A.; Kamaraj, C.; Kaushik, N.K.; Mohanakrishnan, D.; Sahal, D. 2011: Antiplasmodial activity of botanical extracts against Plasmodium falciparum. Parasitology Research 108(5): 1099-1109

Rajendran, C.; Begam, M.; Kumar, D.; Baruah, I.; Gogoi, H.K.; Srivastava, R.B.; Veer, V. 2014: Antiplasmodial activity of certain medicinal plants against chloroquine resistant Plasmodium berghei infected white albino BALB/c mice. Journal of Parasitic Diseases: Official Organ of the Indian Society for Parasitology 38(2): 148-152

Kerubo, L.O.; Midiwo, J.O.; Derese, S.; Langat, M.K.; Akala, H.M.; Waters, N.C.; Peter, M.; Heydenreich, M. 2013: Antiplasmodial activity of compounds from the surface exudates of Senecio roseiflorus. Natural Product Communications 8(2): 175-176

Graziose, R.; Grace, M.H.; Rathinasabapathy, T.; Rojas-Silva, P.; Dekock, C.; Poulev, A.; Lila, M.A.; Smith, P.; Raskin, I. 2013: Antiplasmodial activity of cucurbitacin glycosides from Datisca glomerata (C. Presl) Baill. Phytochemistry 87: 78-85

Sangian, H.; Faramarzi, H.; Yazdinezhad, A.; Mousavi, S.J.; Zamani, Z.; Noubarani, M.; Ramazani, A. 2013: Antiplasmodial activity of ethanolic extracts of some selected medicinal plants from the northwest of Iran. Parasitology Research 112(11): 3697-3701

Boyom, F.Fekam.; Kemgne, Eénie.Madiesse.; Tepongning, R.; Ngouana, V.; Mbacham, W.Fon.; Tsamo, E.; Zollo, P.Henri.Amvam.; Gut, J.; Rosenthal, P.J. 2009: Antiplasmodial activity of extracts from seven medicinal plants used in malaria treatment in Cameroon. Journal of Ethnopharmacology 123(3): 483-488

Veerabadhran, M.; Manivel, N.; Mohanakrishnan, D.; Sahal, D.; Muthuraman, S. 2014: Antiplasmodial activity of extracts of 25 cyanobacterial species from coastal regions of Tamil Nadu. Pharmaceutical Biology 52(10): 1291-1301

Appiah-Opong, R.; Nyarko, A.K.; Dodoo, D.; Gyang, F.N.; Koram, K.A.; Ayisi, N.K. 2011: Antiplasmodial activity of extracts of Tridax procumbens and Phyllanthus amarus in in vitro Plasmodium falciparum culture systems. Ghana Medical Journal 45(4): 143-150

Chung, I.-M.; Seo, S.-H.; Kang, E.-Y.; Park, W.-H.; Park, S.-D.; Moon, H.-I. 2010: Antiplasmodial activity of isolated compounds from Carpesium divaricatum. PhytoTherapy Research: Ptr 24(3): 451-453

Sinha, M.; Dola, V.R.; Agarwal, P.; Srivastava, K.; Haq, W.; Puri, S.K.; Katti, S.B. 2014: Antiplasmodial activity of new 4-aminoquinoline derivatives against chloroquine resistant strain. Bioorganic and Medicinal Chemistry 22(14): 3573-3586

Sashidhara, K.V.; Kumar, M.; Modukuri, R.K.; Srivastava, R.K.; Soni, A.; Srivastava, K.; Singh, S.V.; Saxena, J.K.; Gauniyal, H.M.; Puri, S.K. 2012: Antiplasmodial activity of novel keto-enamine chalcone-chloroquine based hybrid pharmacophores. Bioorganic and Medicinal Chemistry 20(9): 2971-2981

Okokon, J.E.; Nwafor, P.A. 2009: Antiplasmodial activity of root extract and fractions of Croton zambesicus. Journal of Ethnopharmacology 121(1): 74-78

Sisodia, B.S.; Negi, A.S.; Darokar, M.P.; Dwivedi, U.N.; Khanuja, S.P.S. 2012: Antiplasmodial activity of steroidal chalcones: evaluation of their effect on hemozoin synthesis and the new permeation pathway of Plasmodium falciparum-infected erythrocyte membrane. Chemical Biology and Drug Design 79(4): 610-615

Montoia, A.; Rocha E Silva, L.F.; Torres, Z.E.; Costa, D.S.; Henrique, M.C.; Lima, E.S.; Vasconcellos, M.C.; Souza, R.C.Z.; Costa, M.R.F.; Grafov, A.; Grafova, I.; Eberlin, M.N.; Tadei, W.P.; Amorim, R.C.N.; Pohlit, A.M. 2014: Antiplasmodial activity of synthetic ellipticine derivatives and an isolated analog. Bioorganic and Medicinal Chemistry Letters 24(12): 2631-2634

Miranda Júnior, R.Nonato.Cardoso.; Dolabela, M.Fâni.; da Silva, M.Nascimento.; Póvoa, M.Marins.; Maia, Jé.Guilherme.S. 2012: Antiplasmodial activity of the andiroba (Carapa guianensis Aubl., Meliaceae) oil and its limonoid-rich fraction. Journal of Ethnopharmacology 142(3): 679-683

Grace, M.H.; Lategan, C.; Graziose, R.; Smith, P.J.; Raskin, I.; Lila, M.A. 2012: Antiplasmodial activity of the ethnobotanical plant Cassia fistula. Natural Product Communications 7(10): 1263-1266

Chea, A.; Bun, S-Siya.; Azas, N.; Gasquet, M.; Bory, S.; Ollivier, E.; Elias, R. 2010: Antiplasmodial activity of three bisbenzylisoquinoline alkaloids from the tuber of Stephania rotunda. Natural Product Research 24(18): 1766-1770

Ravikumar, S.; Ramanathan, G.; Inbaneson, S.J.; Ramu, A. 2011: Antiplasmodial activity of two marine polyherbal preparations from Chaetomorpha antennina and Aegiceras corniculatum against Plasmodium falciparum. Parasitology Research 108(1): 107-113

Silva, A.F.; Bastos, E.L.; Torres, M.D.T.; Costa-da-Silva, A.é L.; Ioshino, R.S.; Capurro, M.L.; Alves, F.áv.L.; Miranda, A.; Vieira, R.d.F.F.; Oliveira, V.X. 2014: Antiplasmodial activity study of angiotensin Ii via Ala scan analogs. Journal of Peptide Science: An Official Publication of the European Peptide Society 20(8): 640-648

Ezenyi, I.C.; Salawu, O.A.; Kulkarni, R.; Emeje, M. 2014: Antiplasmodial activity-aided isolation and identification of quercetin-4'-methyl ether in Chromolaena odorata leaf fraction with high activity against chloroquine-resistant Plasmodium falciparum. Parasitology Research 113(12): 4415-4422

Wangchuk, P.; Bremner, J.B.; Rattanajak, R.; Kamchonwongpaisan, S. 2010: Antiplasmodial agents from the Bhutanese medicinal plant Corydalis calliantha. PhytoTherapy Research: Ptr 24(4): 481-485

Nasrullah, A.A.; Zahari, A.; Mohamad, J.; Awang, K. 2013: Antiplasmodial alkaloids from the bark of Cryptocarya nigra (Lauraceae). Molecules 18(7): 8009-8017

Okokon, J.E.; Etebong, E.O.; Udobang, J.A.; Essien, G.E. 2012: Antiplasmodial and analgesic activities of Clausena anisata. Asian Pacific Journal of Tropical Medicine 5(3): 214-219

Okokon, J.E.; Umoh, E.E.; Etim, E.I.; Jackson, C.L. 2009: Antiplasmodial and antidiabetic activities of ethanolic leaf extract of Heinsia crinata. Journal of Medicinal Food 12(1): 131-136

Kückelhaus, S.A.S.; Leite, J.é R.S.A.; Muniz-Junqueira, M.I.; Sampaio, R.N.; Bloch, C.; Tosta, C.E. 2009: Antiplasmodial and antileishmanial activities of phylloseptin-1, an antimicrobial peptide from the skin secretion of Phyllomedusa azurea (Amphibia). Experimental Parasitology 123(1): 11-16

Panseeta, P.; Lomchoey, K.; Prabpai, S.; Kongsaeree, P.; Suksamrarn, A.; Ruchirawat, S.; Suksamrarn, S. 2011: Antiplasmodial and antimycobacterial cyclopeptide alkaloids from the root of Ziziphus mauritiana. Phytochemistry 72(9): 909-915

Pan, E.; Gorka, A.P.; Alumasa, J.N.; Slebodnick, C.; Harinantenaina, L.; Brodie, P.J.; Roepe, P.D.; Randrianaivo, R.; Birkinshaw, C.; Kingston, D.G.I. 2011: Antiplasmodial and antiproliferative pseudoguaianolides of Athroisma proteiforme from the Madagascar Dry Forest. Journal of Natural Products 74(10): 2174-2180

Schlapper, C.; Seebacher, W.; Faist, J.; Kaiser, M.; Brun, R.; Saf, R.; Weis, R. 2009: Antiplasmodial and antitrypanosomal activities of aminobicyclo[2.2.2]octyl omega-aminoalkanoates. European Journal of Medicinal Chemistry 44(2): 736-744

Faist, J.; Seebacher, W.; Schlapper, C.; Kaiser, M.; Brun, R.; Saf, R.; Weis, R. 2009: Antiplasmodial and antitrypanosomal activity of bicyclic amides and esters of dialkylamino acids. Bioorganic and Medicinal Chemistry 17(10): 3595-3603

Abdel-Sattar, E.; Harraz, F.M.; Al-Ansari, S.M.A.; El-Mekkawy, S.; Ichino, C.; Kiyohara, H.; Otoguro, K.; Omura, S.; Yamada, H. 2009: Antiplasmodial and antitrypanosomal activity of plants from the Kingdom of Saudi Arabia. Journal of Natural Medicines 63(2): 232-239

Hata, Y.; Zimmermann, S.; Quitschau, M.; Kaiser, M.; Hamburger, M.; Adams, M. 2011: Antiplasmodial and antitrypanosomal activity of pyrethrins and pyrethroids. Journal of Agricultural and Food Chemistry 59(17): 9172-9176

Feng, T.-S.; Guantai, E.M.; Nell, M.J.; van Rensburg, C.E.J.; Hoppe, H.C.; Chibale, K. 2011: Antiplasmodial and antitumor activity of dihydroartemisinin analogs derived via the aza-Michael addition reaction. Bioorganic and Medicinal Chemistry Letters 21(10): 2882-2886

Okokon, J.E.; Etebong, E.O.; Udobang, J.A.; Obot, J. 2012: Antiplasmodial and antiulcer activities of Melanthera scadens. Asian Pacific Journal of Tropical Biomedicine 2(1): 16-20

Muganga, R.; Angenot, L.; Tits, M.; Frédérich, M. 2010: Antiplasmodial and cytotoxic activities of Rwandan medicinal plants used in the treatment of malaria. Journal of Ethnopharmacology 128(1): 52-57

Grace, M.H.; Lategan, C.; Mbeunkui, F.; Graziose, R.; Smith, P.J.; Raskin, I.; Lila, M.A. 2010: Antiplasmodial and cytotoxic activities of drimane sesquiterpenes from Canella winterana. Natural Product Communications 5(12): 1869-1872

Lacroix, D.; Prado, S.; Kamoga, D.; Kasenene, J.; Namukobe, J.; Krief, S.; Dumontet, V.; Mouray, E.; Bodo, B.; Brunois, F. 2011: Antiplasmodial and cytotoxic activities of medicinal plants traditionally used in the village of Kiohima, Uganda. Journal of Ethnopharmacology 133(2): 850-855

Moon, H.-I.; Lee, J.-H.; Lee, Y.-C.; Kim, K.-S. 2011: Antiplasmodial and cytotoxic activity of coumarin derivatives from dried roots of Angelica gigas Nakai in vitro. Immunopharmacology and Immunotoxicology 33(4): 663-666

Chung, I.-M.; Ghimire, B.K.; Kang, E.-Y.; Moon, H.-I. 2010: Antiplasmodial and cytotoxic activity of khellactone derivatives from Angelica purpuraefolia Chung. PhytoTherapy Research: Ptr 24(3): 469-471

Moon, H.-I. 2010: Antiplasmodial and cytotoxic activity of phloroglucinol derivatives from Hypericum erectum Thunb. PhytoTherapy Research: Ptr 24(6): 941-944

Talontsi, F.M.; Lamshöft, M.; Douanla-Meli, C.; Kouam, S.F.; Spiteller, M. 2014: Antiplasmodial and cytotoxic dibenzofurans from Preussia sp. harboured in Enantia chlorantha Oliv. Fitoterapia 93: 233-238

Moosophon, P.; Kanokmedhakul, S.; Kanokmedhakul, K.; Buayairaksa, M.; Noichan, J.; Poopasit, K. 2013: Antiplasmodial and cytotoxic flavans and diarylpropanes from the stems of Combretum griffithii. Journal of Natural Products 76(7): 1298-1302

Singh, P.; Sachdeva, S.; Raj, R.; Kumar, V.; Mahajan, M.P.; Nasser, S.; Vivas, L.; Gut, J.; Rosenthal, P.J.; Feng, T.-S.; Chibale, K. 2011: Antiplasmodial and cytotoxicity evaluation of 3-functionalized 2-azetidinone derivatives. Bioorganic and Medicinal Chemistry Letters 21(15): 4561-4563

Barea, C.; Pabón, A.; Galiano, S.; Pérez-Silanes, S.; Gonzalez, G.; Deyssard, C.; Monge, A.; Deharo, E.; Aldana, I. 2012: Antiplasmodial and leishmanicidal activities of 2-cyano-3-(4-phenylpiperazine-1-carboxamido) quinoxaline 1,4-dioxide derivatives. Molecules 17(8): 9451-9461

Elfita, E.; Muharni, M.; Latief, M.; Darwati, D.; Widiyantoro, A.; Supriyatna, S.; Bahti, H.H.; Dachriyanus, D.; Cos, P.; Maes, L.; Foubert, K.; Apers, S.; Pieters, L. 2009: Antiplasmodial and other constituents from four Indonesian Garcinia spp. Phytochemistry 70(7): 907-912

Marti, G.; Eparvier, V.ér.; Moretti, C.; Prado, S.; Grellier, P.; Hue, N.; Thoison, O.; Delpech, B.; Guéritte, F.ço.; Litaudon, M. 2010: Antiplasmodial benzophenone derivatives from the root barks of Symphonia globulifera (Clusiaceae). Phytochemistry 71(8-9): 964-974

Marti, G.; Eparvier, V.ér.; Moretti, C.; Susplugas, S.; Prado, S.; Grellier, P.; Retailleau, P.; Guéritte, F.ço.; Litaudon, M. 2009: Antiplasmodial benzophenones from the trunk latex of Moronobea coccinea (Clusiaceae). Phytochemistry 70(1): 75-85

Amorim Madeira, P.J.; Sitoe, A.R.F.; Gonçalves, D.; Rodrigues, T.; Guedes, R.C.; Lopes, F.; Moreira, R.; Bronze, M.R.ár. 2014: Antiplasmodial drugs in the gas phase: a CID and DFT study of quinolon-4(1H)-imine derivatives. Journal of the American Society for Mass Spectrometry 25(9): 1650-1661

Quintana, J.C.; Chacón, A.M.; Vargas, L.; Segura, C.; Gutiérrez, J.M.; Alarcón, J.C. 2012: Antiplasmodial effect of the venom of Crotalus durissus cumanensis, crotoxin complex and Crotoxin B. Acta Tropica 124(2): 126-132

Dapper, D.V.; Aziagba, B.N.; Ebong, O.O. 2007: Antiplasmodial effects of the aqueous extract of Phyllantus amarus Schumach and Thonn against Plasmodium berghei in Swiss albino mice. Nigerian Journal of Physiological Sciences: Official Publication of the Physiological Society of Nigeria 22(1-2): 19-25

Afolayan, A.F.; Mann, M.G.A.; Lategan, C.A.; Smith, P.J.; Bolton, J.J.; Beukes, D.R. 2009: Antiplasmodial halogenated monoterpenes from the marine red alga Plocamium cornutum. Phytochemistry 70(5): 597-600

Zhang, G.-P.; Xiao, Z.-Y.; Rafique, J.; Arfan, M.; Smith, P.J.; Lategan, C.A.; Hu, L.-H. 2009: Antiplasmodial isoflavanones from the roots of Sophora mollis. Journal of Natural Products 72(7): 1265-1268

Adams, M.; Christen, M.; Plitzko, I.; Zimmermann, S.; Brun, R.; Kaiser, M.; Hamburger, M. 2010: Antiplasmodial lanostanes from the Ganoderma lucidum mushroom. Journal of Natural Products 73(5): 897-900

Upadhyay, H.C.; Sisodia, B.S.; Verma, R.K.; Darokar, M.P.; Srivastava, S.K. 2013: Antiplasmodial potential of extracts from two species of genus Blumea. Pharmaceutical Biology 51(10): 1326-1330

Bagai, U.; Walter, N.S. 2014: Antiplasmodial potential of homeopathic drugs Chelidonium and nosode against Plasmodium berghei infection. Journal of Complementary and Integrative Medicine 11(3): 195-201

Kamaraj, C.; Kaushik, N.K.; Mohanakrishnan, D.; Elango, G.; Bagavan, A.; Zahir, A.A.; Rahuman, A.A.; Sahal, D. 2012: Antiplasmodial potential of medicinal plant extracts from Malaiyur and Javadhu hills of South India. Parasitology Research 111(2): 703-715

Kaushik, N.K.; Bagavan, A.; Rahuman, A.A.; Mohanakrishnan, D.; Kamaraj, C.; Elango, G.; Zahir, A.A.; Sahal, D. 2013: Antiplasmodial potential of selected medicinal plants from eastern Ghats of South India. Experimental Parasitology 134(1): 26-32

Park, Y.-J.; Chung, I.-M.; Moon, H.-I. 2010: Antiplasmodial procyanidins derivatives from Chinese Hawthorn. Immunopharmacology and Immunotoxicology 32(4): 607-610

Barliana, M.I.; Suradji, E.W.; Abdulah, R.; Diantini, A.; Hatabu, T.; Nakajima-Shimada, J.; Subarnas, A.; Koyama, H. 2014: Antiplasmodial properties of kaempferol-3-O-rhamnoside isolated from the leaves of Schima wallichii against chloroquine-resistant Plasmodium falciparum. Biomedical Reports 2(4): 579-583

Induli, M.; Gebru, M.; Abdissa, N.; Akala, H.; Wekesa, I.; Byamukama, R.; Heydenreich, M.; Murunga, S.; Dagne, E.; Yenesew, A. 2013: Antiplasmodial quinones from the rhizomes of Kniphofia foliosa. Natural Product Communications 8(9): 1261-1264

Lhinhatrakool, T.; Prabpai, S.; Kongsaeree, P.; Sutthivaiyakit, S. 2011: Antiplasmodial sesquiterpene alkaloids from the roots of Maytenus mekongensis. Journal of Natural Products 74(6): 1386-1391

Mba'ning, B.M.; Lenta, B.N.; Noungoué, D.T.; Antheaume, C.; Fongang, Y.F.; Ngouela, S.èr.A.; Boyom, F.F.; Rosenthal, P.J.; Tsamo, E.; Sewald, N.; Laatsch, H. 2013: Antiplasmodial sesquiterpenes from the seeds of Salacia longipes var. camerunensis. Phytochemistry 96: 347-352

Schoof, S.; Pradel, G.; Aminake, M.N.; Ellinger, B.; Baumann, S.; Potowski, M.; Najajreh, Y.; Kirschner, M.; Arndt, H.-D. 2010: Antiplasmodial thiostrepton derivatives: proteasome inhibitors with a dual mode of action. Angewandte Chemie 49(19): 3317-3321

Chianese, G.; Yerbanga, S.R.; Lucantoni, L.; Habluetzel, A.; Basilico, N.; Taramelli, D.; Fattorusso, E.; Taglialatela-Scafati, O. 2010: Antiplasmodial triterpenoids from the fruits of neem, Azadirachta indica. Journal of Natural Products 73(8): 1448-1452

Boyom, F.F.; Ngouana, V.; Kemgne, E.A.ée.M.; Zollo, P.H.A.; Menut, C.; Bessiere, J.M.; Gut, J.; Rosenthal, P.J. 2011: Antiplasmodial volatile extracts from Cleistopholis patens Engler and Diels and Uvariastrum pierreanum Engl. (Engl. and Diels) (Annonaceae) growing in Cameroon. Parasitology Research 108(5): 1211-1217

Jonville, M.C.; Kodja, H.; Strasberg, D.; Pichette, A.; Ollivier, E.; Frédérich, M.; Angenot, L.; Legault, J. 2011: Antiplasmodial, anti-inflammatory and cytotoxic activities of various plant extracts from the Mascarene Archipelago. Journal of Ethnopharmacology 136(3): 525-531

Malebo, H.M.; Tanja, W.; Cal, M.; Swaleh, S.A.M.; Omolo, M.O.; Hassanali, A.; Séquin, U.; Hamburger, M.; Brun, R.; Ndiege, I.O. 2009: Antiplasmodial, anti-trypanosomal, anti-leishmanial and cytotoxicity activity of selected Tanzanian medicinal plants. Tanzania Journal of Health Research 11(4): 226-234

Ruphin, F.P.; Baholy, R.; Emmanue, A.; Amelie, R.; Martin, M.-T.; Koto-te-Nyiwa, N. 2013: Antiplasmodial, cytotoxic activities and characterization of a new naturally occurring quinone methide pentacyclic triterpenoid derivative isolated from Salacia leptoclada Tul. (Celastraceae) originated from Madagascar. Asian Pacific Journal of Tropical Biomedicine 3(10): 780-784

Riggleman, R.A.; de Pablo, J.J. 2008: Antiplasticization and local elastic constants in trehalose and glycerol mixtures. Journal of Chemical Physics 128(22): 224504

Serebruany, V.L.; Eisert, C.; Atar, D.; Ferguson, J.J. 2009: Antiplatelet 'resistance' and 'non-responders': what do these terms really mean?. Fundamental and Clinical Pharmacology 23(1): 11-18

Kim, D-Seon.; Ji, H.Dong.; Rhee, M.Hee.; Sung, Y-Young.; Yang, W-Kyung.; Kim, S.Hyung.; Kim, H-Kyoung. 2014: Antiplatelet Activity of Morus alba Leaves Extract, Mediated via Inhibiting Granule Secretion and Blocking the Phosphorylation of Extracellular-Signal-Regulated Kinase and Akt. Evidence-Based Complementary and Alternative Medicine: Ecam 2014: 639548

Mannucci, P.M. 1993: Antiplatelet Agents in Acute Myocardial Infarction and in the Post-infarction Period. Platelets 4(S1): 24-25

Saraf, S.; Bensalha, I.; Gorog, D.A. 2009: Antiplatelet Resistance-Does it Exist and how to Measure it?. Clinical Medicine. Cardiology 3: 77-91

Ali, F.Y.; Armstrong, P.C.J.; Dhanji, A-Rehan.A.; Tucker, A.T.; Paul-Clark, M.J.; Mitchell, J.A.; Warner, T.D. 2009: Antiplatelet actions of statins and fibrates are mediated by PPARs. Arteriosclerosis Thrombosis and Vascular Biology 29(5): 706-711

Davis, S.M.; Donnan, G.A. 2009: Antiplatelet activity. Stroke 40(6): 2275

Geraldo, R.B.; Bello, M.L.; Dias, L.R.S.; Vera, M.A.F.; Nagashima, T.; Abreu, P.A.; Santos, M.B.; Albuquerque, M.G.; Cabral, L.M.; Freitas, A.C.C.; Kalil, M.V.; Rodrigues, C.R.; Castro, H.C. 2010: Antiplatelet activity and structure-activity relationship study of Pyrazolopyridine Derivatives as potential series for treating thrombotic diseases. Journal of Atherosclerosis and Thrombosis 17(7): 730-739

Hiyasat, B.; Sabha, D.; Grotzinger, K.; Kempfert, J.; Rauwald, J.-W.; Mohr, F.-W.; Dhein, S. 2009: Antiplatelet activity of Allium ursinum and Allium sativum. Pharmacology 83(4): 197-204

Oh, C.-H.; Shin, J.-I.; Mo, S.J.; Yun, S.-J.; Kim, S.-H.; Rhee, Y.-H. 2013: Antiplatelet activity of L-sulforaphane by regulation of platelet activation factors, glycoprotein IIb/IIIa and thromboxane A2. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 24(5): 498-504

Kamruzzaman, S.M.; Endale, M.; Oh, W.-J.; Park, S.-C.; Kim, T.-H.; Lee, I.-K.; Cho, J.Y.; Park, H.-J.; Kim, S.K.; Yun, B.-S.; Rhee, M.H. 2011: Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase. PhytoTherapy Research: Ptr 25(11): 1596-1603

Lai, Y.-S.; Shih, C.-Y.; Huang, Y.-F.; Chou, T.-C. 2010: Antiplatelet activity of alpha-lipoic acid. Journal of Agricultural and Food Chemistry 58(15): 8596-8603

Im, J.-H.; Jin, Y.-R.; Lee, J.-J.; Yu, J.-Y.; Han, X.-H.; Im, S.-H.; Hong, J.T.; Yoo, H.-S.; Pyo, M.-Y.; Yun, Y.-P. 2009: Antiplatelet activity of beta-carboline alkaloids from Perganum harmala: a possible mechanism through inhibiting PLCgamma2 phosphorylation. Vascular Pharmacology 50(5-6): 147-152

Jin, Y.-R.; Im, J.-H.; Park, E.-S.; Cho, M.-R.; Han, X.-H.; Lee, J.-J.; Lim, Y.; Kim, T.-J.; Yun, Y.-P. 2008: Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity. Journal of Cardiovascular Pharmacology 51(1): 45-54

Shih, C-Yu.; Lin, I-Hsin.; Ding, J-Cheng.; Chen, F-Chi.; Chou, T-Chong. 2014: Antiplatelet activity of nifedipine is mediated by inhibition of NF-κB activation caused by enhancement of PPAR-β/-γ activity. British journal of pharmacology 171(6): 1490-1500

Park, E.-S.; Lim, Y.; Lee, S.-H.; Kwon, B.-M.; Yoo, H.-S.; Hong, J.-T.; Yun, Y.-P. 2011: Antiplatelet activity of obovatol, a biphenolic component of Magnolia Obovata, in rat arterial thrombosis and rabbit platelet aggregation. Journal of Atherosclerosis and Thrombosis 18(8): 659-669

Davidson, D.C.; Hirschman, M.P.; Spinelli, S.L.; Morrell, C.N.; Schifitto, G.; Phipps, R.P.; Maggirwar, S.B. 2011: Antiplatelet activity of valproic acid contributes to decreased soluble CD40 ligand production in HIV type 1-infected individuals. Journal of Immunology 186(1): 584-591

Minuz, P.; Calabria, S.; Fava, C. 2014: Antiplatelet activity of β-blockers: new light on existing data. British Journal of Clinical Pharmacology 78(5): 937-939

Bath, P.M.W. 2009: Antiplatelet activity should be measured routinely: no. Stroke 40(6): 2273-2274

Chang, H.; Yanachkov, I.B.; Dix, E.J.; Yanachkova, M.; Li, Y.; Barnard, M.R.; Wright, G.E.; Michelson, A.D.; Frelinger, A.L. 2014: Antiplatelet activity, P2Y₁ and P2Y₁₂ inhibition, and metabolism in plasma of stereoisomers of diadenosine 5',5'″-P¹ ,P⁴-dithio-P²,P³-chloromethylenetetraphosphate. Plos one 9(4): E94780

Varon, D.; Spectre, G. 2009: Antiplatelet agents. Hematology. American Society of Hematology. Education Program 2009: 267-272

Steg, G. 2013: Antiplatelet agents. Bulletin de l'Academie Nationale de Medecine 197(2): 375-387; Discussion: 387-388

Lip, G.Y.; Felmeden, D.C.; Dwivedi, G. 2011: Antiplatelet agents and anticoagulants for hypertension. Cochrane Database of Systematic Reviews 12: Cd003186

Llau, J.V.; Ferrandis, R.; López Forte, C. 2009: Antiplatelet agents and anticoagulants: management of the anticoagulated surgical patient. Cirugia Espanola 85(Suppl 1): 7-14

Billett, H.H. 2008: Antiplatelet agents and arterial thrombosis. Cardiology Clinics 26(2): 189-201 Vi

Yagnik, V.D. 2011: Antiplatelet agents and bleeding time after endoscopic biopsy of the gastric antrum in Japanese patients. Digestive Endoscopy: Official Journal of the Japan Gastroenterological Endoscopy Society 23(3): 268

Drouet, L.; Bal dit Sollier, C.; Henry, P. 2010: Antiplatelet agents and diabetes mellitus. Annales de Cardiologie et d'Angeiologie 59(Suppl 2): S56-S64

Ranucci, M. 2014: Antiplatelet agents and heart surgery: new drugs, new challenges?. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 46(2): 205-206

Reny, J.-L.; Roffi, M.; Fontana, P. 2013: Antiplatelet agents and older patients: which drugs and what evidence?. Revue Medicale Suisse 9(405): 2034-2038

Lin, E.; Padmanabhan, R.; Moonis, M. 2010: Antiplatelet agents and proton pump inhibitors - personalizing treatment. Pharmacogenomics and Personalized Medicine 3: 101-109

Casado-Arroyo, R.én.; Muñoz-Villalenguas, M.ía.; Lanas Arbeloa, A. 2011: Antiplatelet agents and proton pump inhibitors. how can the risk-benefit balance be optimized in patients at risk for cardiovascular disease and gastrointestinal bleeding?. Gastroenterologia y Hepatologia 34(7): 478-491

Payne, D.A.; Twigg, M.W.; Hayes, P.D.; Naylor, A.R. 2010: Antiplatelet agents and risk factors for bleeding postcarotid endarterectomy. Annals of Vascular Surgery 24(7): 900-907

Matsukawa, H.; Shinoda, M.; Yamamoto, D.; Fujii, M.; Murakata, A.; Ishikawa, R.; Omata, F. 2011: Antiplatelet agents are risk factors for cerebellar hemorrhage in patients with primary intracerebral hemorrhage. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 20(4): 346-351

Tarandovskiy, I.D.; Artemenko, E.O.; Panteleev, M.A.; Sinauridze, E.I.; Ataullakhanov, F.I. 2013: Antiplatelet agents can promote two-peaked thrombin generation in platelet rich plasma: mechanism and possible applications. Plos one 8(2): E55688

John, B.K.; Arramraju, S.; Shalomov, A.; Sison, C.; Rubin, M. 2011: Antiplatelet agents do not impact the hospital course in patients with gastrointestinal bleeding. Journal of Clinical Gastroenterology 45(7): 583-589

Palmer, S.C.; Di Micco, L.; Razavian, M.; Craig, J.C.; Perkovic, V.; Pellegrini, F.; Jardine, M.J.; Webster, A.C.; Zoungas, S.; Strippoli, G.F.M. 2013: Antiplatelet agents for chronic kidney disease. Cochrane Database of Systematic Reviews 2: Cd008834

Wong, P.F.; Chong, L.Y.; Mikhailidis, D.P.; Robless, P.; Stansby, G. 2011: Antiplatelet agents for intermittent claudication. Cochrane Database of Systematic Reviews 11: Cd001272

Duley, L.; Henderson-Smart, D.J.; Meher, S.; King, J.F. 2007: Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews 2007(2): Cd004659

Brown, J.; Lethaby, A.; Maxwell, H.; Wawrzyniak, A.J.; Prins, M.H. 2008: Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database of Systematic Reviews 2008(4): Cd000535

Chandiramani, M.; Seed, P.; Poston, L.; Shennan, A.H. 2007: Antiplatelet agents for prevention of pre-eclampsia. Lancet 370(9600): 1685; Author Reply 1685-6

Hegge, K.A. 2009: Antiplatelet agents for prevention of recurrent ischemic stroke. South Dakota Medicine: the Journal of the South Dakota State Medical Association 62(1): 15-17

Bernstein, R.A. 2008: Antiplatelet agents for secondary prevention of stroke. Current Treatment Options in Cardiovascular Medicine 10(3): 223-228

Yip, S.; Benavente, O. 2011: Antiplatelet agents for stroke prevention. Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics 8(3): 475-487

Coleman, C.I.; Tuttle, L.A.; Teevan, C.; Baker, W.L.; White, C.M.; Reinhart, K.M. 2010: Antiplatelet agents for the prevention of arteriovenous fistula and graft thrombosis: a meta analysis. International Journal of Clinical Practice 64(9): 1239-1244

Sakhuja, R.; Yeh, R.W.; Bhatt, D.L. 2010: Antiplatelet agents in acute coronary syndromes. Current Problems in Cardiology 35(3): 123-170

Lorgis, L.; Richard, C.; Zeller, M.; Gudjoncik, A.; Buffet, P.; L'Huillier, I.; Cottin, Y. 2010: Antiplatelet agents in acute coronary syndromes. Data from the main clinical trials. Annales de Cardiologie et d'Angeiologie 59(Suppl 2): S47-S55

Lopes, R.D. 2011: Antiplatelet agents in cardiovascular disease. Journal of Thrombosis and Thrombolysis 31(3): 306-309

Gresele, P. 2013: Antiplatelet agents in clinical practice and their haemorrhagic risk. Blood Transfusion 11(3): 349-356

May, C.H.; Lincoff, A.M. 2012: Antiplatelet agents in ischemic heart disease. Handbook of Experimental Pharmacology 210: 495-518

Weber, R.; Weimar, C.; Diener, H-C. 2009: Antiplatelet agents in stroke prevention: acute and long-term treatment strategies. Hamostaseologie 29(4): 326-333

O'Riordan, J.M.; Margey, R.J.; Blake, G.; O'Connell, P.R. 2009: Antiplatelet agents in the perioperative period. Archives of Surgery 144(1): 69-76; Discussion 76

Amara, W.; Ben Youssef, I.; Monsel, F.; Sergent, J. 2011: Antiplatelet agents increase hemorrhagic risk in patients undergoing a cardiac pacemaker or ICD implantation. Annales de Cardiologie et d'Angeiologie 60(5): 267-271

Wiviott, S.D.; de Lemos, J.A. 2007: Antiplatelet agents make a comeback in ST-elevation myocardial infarction. American Heart Journal 154(4): 603-606

Barta, J.; Sanganalmath, S.K.; Kumamoto, H.; Takeda, N.; Edes, I.án.; Dhalla, N.S. 2008: Antiplatelet agents sarpogrelate and cilostazol affect experimentally-induced ventricular arrhythmias and mortality. Cardiovascular Toxicology 8(3): 127-135

Aranki, S.F.; Body, S.C. 2009: Antiplatelet agents used for early intervention in acute coronary syndrome: myocardial salvage versus bleeding complications. Journal of Thoracic and Cardiovascular Surgery 138(4): 807-810

Siracuse, J.J.; Robich, M.P.; Gautam, S.; Kasper, E.M.; Moorman, D.W.; Hauser, C.J. 2010: Antiplatelet agents, warfarin, and epidemic intracranial hemorrhage. Surgery 148(4): 724-729; Discussion: 729-730

Reny, J.-L.; Zufferey, A.; Berdagué, P.; Fontana, P. 2010: Antiplatelet agents: which one, when and for whom?. La Revue de Medecine Interne 31(Suppl 3): S339-S341

Ma, L.; Lu, N.; Wu, G. 2015: Antiplatelet aggregation and endothelial protection of I4, a new synthetic anti-diabetes sulfonylurea compound. Platelets 26(4): 342-348

Moharam, B.A.; Jantan, I.; Ahmad, F.b.; Jalil, J. 2010: Antiplatelet aggregation and platelet activating factor (PAF) receptor antagonistic activities of the essential oils of five Goniothalamus species. Molecules 15(8): 5124-5138

Lee, C.-L.; Yen, M.-H.; Chang, F.-R.; Wu, C.-C.; Wu, Y.-C. 2014: Antiplatelet aggregation effects of phenanthrenes from Calanthe arisanensis. Natural Product Communications 9(1): 83-84

Gurbel, P.A.; Tantry, U.S. 2014: Antiplatelet and anticoagulant agents in heart failure: current status and future perspectives. JACC. Heart Failure 2(1): 1-14

Devlin, H.L.; Hosman, A.E.; Shovlin, C.L. 2013: Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia. New England Journal of Medicine 368(9): 876-878

Jennings, L.K.; Saucedo, J.F. 2008: Antiplatelet and anticoagulant agents: key differences in mechanisms of action, clinical application, and therapeutic benefit in patients with non-ST-segment-elevation acute coronary syndromes. Current Opinion in Cardiology 23(4): 302-308

Andrews, L. 2013: Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion after peripheral endovascular treatment. Clinical Nurse Specialist Cns 27(3): 121-122

Robertson, L.; Ghouri, M.A.; Kovacs, F. 2012: Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment. Cochrane Database of Systematic Reviews 2012(8): Cd002071

Lau, A-Jiang.; Toh, D-Fung.; Chua, T-Kian.; Pang, Y-Keng.; Woo, S-On.; Koh, H-Ling. 2009: Antiplatelet and anticoagulant effects of Panax notoginseng: comparison of raw and steamed Panax notoginseng with Panax ginseng and Panax quinquefolium. Journal of Ethnopharmacology 125(3): 380-386

De Andrade Moura, L.; Marqui de Almeida, A.C.; Domingos, T.F.S.; Ortiz-Ramirez, F.; Cavalcanti, D.N.ão.; Teixeira, V.ér.L.; Fuly, A.é L. 2014: Antiplatelet and anticoagulant effects of diterpenes isolated from the marine alga, Dictyota menstrualis. Marine Drugs 12(5): 2471-2484

Lumley, M.; Perera, D. 2013: Antiplatelet and anticoagulant strategies in acute coronary syndrome: where we are in 2013. Future Cardiology 9(3): 371-385

Hanna, E.B.; Glancy, D.L.; Saucedo, J.F. 2010: Antiplatelet and anticoagulant therapies in acute coronary syndromes. Cardiovascular Drugs and Therapy 24(1): 61-70

Fitzgerald, D.J.; Fitzgerald, G.A. 1991: Antiplatelet and anticoagulant therapy during coronary thrombolysis. Trends in Cardiovascular Medicine 1(1): 29-35

Gersh, B.J.; Freedman, J.E.; Granger, C.B. 2011: Antiplatelet and anticoagulant therapy for stroke prevention in patients with non-valvular atrial fibrillation: evidence based strategies and new developments. Revista Espanola de Cardiologia 64(4): 260-268

Capodanno, D.; Angiolillo, D.J.; Tamburino, C. 2011: Antiplatelet and anticoagulant therapy in elderly patients. Giornale Italiano di Cardiologia 12(3): 186-197

Almadi, M.A.; Barkun, A.; Brophy, J. 2011: Antiplatelet and anticoagulant therapy in patients with gastrointestinal bleeding: an 86-year-old woman with peptic ulcer disease. JAMA 306(21): 2367-2374

Lorenzen, N.D.; Eldrup, N.; Laustsen, J. 2007: Antiplatelet and anticoagulant treatment after percutaneous transluminal angioplasty for peripheral arteriosclerosis. Survey of a Cochrane review. Ugeskrift for Laeger 169(39): 3279-3282

Sato, H.; Kasai, K.; Tanaka, T.; Kita, T.; Tanaka, N. 2008: Role of tumor necrosis factor-alpha and interleukin-1beta on lung dysfunction following hemorrhagic shock in rats. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 14(5): Br79-Br87

Massel, D.R.; Little, S.H. 2013: Antiplatelet and anticoagulation for patients with prosthetic heart valves. Cochrane Database of Systematic Reviews 7: Cd003464

Yorkgitis, B.K.; Ruggia-Check, C.; Dujon, J.E. 2014: Antiplatelet and anticoagulation medications and the surgical patient. American Journal of Surgery 207(1): 95-101

Ott, M.M.; Eriksson, E.; Vanderkolk, W.; Christianson, D.; Davis, A.; Scholten, D. 2010: Antiplatelet and anticoagulation therapies do not increase mortality in the absence of traumatic brain injury. Journal of Trauma 68(3): 560-563

Bhatt, D.L.; Hulot, J.-S.éb.; Moliterno, D.J.; Harrington, R.A. 2014: Antiplatelet and anticoagulation therapy for acute coronary syndromes. Circulation Research 114(12): 1929-1943

Itoh, Y. 2013: Antiplatelet and anticoagulation therapy in acute cerebral infarction. Rinsho Shinkeigaku 53(11): 1172-1174

Francis, D.O.; Dang, J.H.; Fritz, M.A.; Garrett, C.G. 2014: Antiplatelet and anticoagulation therapy in microlaryngeal surgery. Laryngoscope 124(4): 928-934

Oh, J.; Smiddy, W.E.; Kim, S.S. 2011: Antiplatelet and anticoagulation therapy in vitreoretinal surgery. American Journal of Ophthalmology 151(6): 934-939.E3

Schnabel, M.J.; Gierth, M.; Bründl, J.; Chaussy, C.G.; Burger, M.; Fritsche, H.-M. 2014: Antiplatelet and anticoagulative medication during shockwave lithotripsy. Journal of Endourology 28(9): 1034-1039

Chelucci, R.C.; Dutra, L.A.ôn.; Lopes Pires, M.E.; de Melo, T.R.F.; Bosquesi, P.L.; Chung, M.C.; Dos Santos, J.L. 2014: Antiplatelet and antithrombotic activities of non-steroidal anti-inflammatory drugs containing an N-acyl hydrazone subunit. Molecules 19(2): 2089-2099

Ku, S.-K.; Bae, J.-S. 2014: Antiplatelet and antithrombotic activities of purpurogallin in vitro and in vivo. Bmb Reports 47(7): 376-381

Fan, H.-Y.; Fu, F.-H.; Yang, M.-Y.; Xu, H.; Zhang, A.-H.; Liu, K. 2010: Antiplatelet and antithrombotic activities of salvianolic acid a. Thrombosis Research 126(1): E17-E22

Lu, W.-Q.; Qiu, Y.; Li, T.-J.; Tao, X.; Sun, L.-N.; Chen, W.-S. 2011: Antiplatelet and antithrombotic activities of timosaponin B-II, an extract of Anemarrhena asphodeloides. Clinical and Experimental Pharmacology and Physiology 38(7): 430-434

Dumas, M.; Nadal-Wollbold, F.; Gaussem, P.; Perez, M.; Mirault, T.; Létienne, R.; Bourbon, T.; Grelac, F.; Le Grand, B.; Bachelot-Loza, C. 2012: Antiplatelet and antithrombotic effect of F 16618, a new thrombin proteinase-activated receptor-1 (PAR1) antagonist. British Journal of Pharmacology 165(6): 1827-1835

Valgimigli, M.; Minarelli, M. 2010: Antiplatelet and antithrombotic treatment after primary percutaneous coronary intervention: balancing safety and efficacy. American Heart Journal 160(6 Suppl): S36-S41

Poliacikova, P.; Cockburn, J.; de Belder, A.; Trivedi, U.; Hildick-Smith, D. 2013: Antiplatelet and antithrombotic treatment after transcatheter aortic valve implantation - comparison of regimes. Journal of Invasive Cardiology 25(10): 544-548

Poredos, P.; Jezovnik, M.K. 2010: Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease. International Angiology: a Journal of the International Union of Angiology 29(1): 20-26

Chen, L.; Liu, M.; Bai, H.; Chen, P.; Xia, F.; Han, D.; Jiang, L. 2009: Antiplatelet and thermally responsive poly(N-isopropylacrylamide) surface with nanoscale topography. Journal of the American Chemical Society 131(30): 10467-10472

Aref, S.; Sleem, T.; El Menshawy, N.; Ebrahiem, L.; Abdella, D.; Fouda, M.; Samara, N.Abou.; Menessy, A.; Abdel-Ghaffar, H.; Bassam, A.; Abdel Wahaab, M. 2009: Antiplatelet antibodies contribute to thrombocytopenia associated with chronic hepatitis C virus infection. Hematology 14(5): 277-281

Marathe, B.M.; Prislovsky, A.; Astrakhan, A.; Rawlings, D.J.; Wan, J.Y.; Strom, T.S. 2009: Antiplatelet antibodies in WASP(-) mice correlate with evidence of increased in vivo platelet consumption. Experimental Hematology 37(11): 1353-1363

Ghosh, K.; Kulkarni, B.; Shetty, S.; Nair, S. 2009: Antiplatelet antibodies in cases of Glanzmann's thrombasthenia with and without a history of multiple platelet transfusion. Indian Journal of Human Genetics 15(1): 23-27

McMillan, R. 2009: Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production. Hematology/Oncology Clinics of North America 23(6): 1163-1175

Mittal, K.; McNamara, M.J.; Curtis, B.R.; McCrae, K.R. 2014: Antiplatelet antibodies in oxaliplatin-induced immune thrombocytopenia. Jrsm Open 5(6): 2054270414531126

Torii, Y.; Shimizu, T.; Yokoi, T.; Sugimoto, H.; Katashiba, Y.; Ozasa, R.; Fujita, S.; Adachi, Y.; Maki, M.; Nomura, S. 2011: Antiplatelet antibody may cause delayed transfusion-related acute lung injury. International Journal of General Medicine 4: 677-680

Sun, D.-S.; King, C.-C.; Huang, H.-S.; Shih, Y.-L.; Lee, C.-C.; Tsai, W.-J.; Yu, C.-C.; Chang, H.-H. 2007: Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice. Journal of Thrombosis and Haemostasis: Jth 5(11): 2291-2299

Shinohara, Y.; Gotoh, F.; Tohgi, H.; Hirai, S.; Terashi, A.; Fukuuchi, Y.; Otomo, E.; Itoh, E.; Matsuda, T.; Sawada, T.; Yamaguchi, T.; Nishimaru, K.; Ohashi, Y. 2008: Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study. Cerebrovascular Diseases 26(1): 63-70

Teramoto, S.; Yamamoto, H.; Yamaguchi, Y.; Ishii, M.; Hibi, S.; Kume, H.; Ouchi, Y. 2008: Antiplatelet cilostazol, an inhibitor of type IIi phosphodiesterase, improves swallowing function in patients with a history of stroke. Journal of the American Geriatrics Society 56(6): 1153-1154

Bollati, M.; Gaita, F.; Anselmino, M. 2011: Antiplatelet combinations for prevention of atherothrombotic events. Vascular Health and Risk Management 7: 23-30

Mackenzie, I.S.; Coughtrie, M.W.H.; MacDonald, T.M.; Wei, L. 2010: Antiplatelet drug interactions. Journal of Internal Medicine 268(6): 516-529

Scott, S.A.; Owusu Obeng, A.; Hulot, J.-S.éb. 2014: Antiplatelet drug interactions with proton pump inhibitors. Expert Opinion on Drug Metabolism and Toxicology 10(2): 175-189

Gladding, P.; Webster, M.; Ormiston, J.; Olsen, S.; White, H. 2008: Antiplatelet drug nonresponsiveness. American Heart Journal 155(4): 591-599

Guha, S.; Mookerjee, S.; Guha, P.; Sardar, P.; Deb, S.; Roy, P.D.; Karmakar, R.; Mani, S.; Hema, M.B.; Pyne, S.; Chakraborti, P.; Deb, P.K.; Lahiri, P.; Chaudhuri, U. 2009: Antiplatelet drug resistance in patients with recurrent acute coronary syndrome undergoing conservative management. Indian Heart Journal 61(4): 348-352

Reny, J-Luc.; Berdagué, P.; Poncet, A.; Barazer, I.; Nolli, Séverine.; Fabbro-Peray, P.; Schved, J-François.; Bounameaux, H.; Mach, Fçois.; de Moerloose, P.; Fontana, P.; Arquizan, C.; Böge, G.; Boissier, E.; Bonvini, R.; Boukriche, Y.; Cazaban, S.; Dumas, C.; Gueddi, S.; Joan, N.; Marty-Ané, C.; Nangou, P.; Oziol, E.; Perrier, A.; Quéré, I.; Reber, G.; Robert-Ebadi, H.; Righini, M.; Sedighian, S.; Simorre, B.; Sztajzel, R. 2012: Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study. Circulation 125(25): 3201-3210

Angiolillo, D.J.; Suryadevara, S.; Capranzano, P.; Zenni, M.Z.; Guzman, L.A.; Bass, T.A. 2009: Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 73(1): 1-14

Tello-Montoliu, A.; Ueno, M.; Angiolillo, D.J. 2011: Antiplatelet drug therapy: role of pharmacodynamic and genetic testing. Future Cardiology 7(3): 381-402

Aronow, W.S. 2013: Antiplatelet drug use in patients with non-ST-segment elevation acute coronary syndromes. Postgraduate Medicine 125(1): 51-58

De Meyer, S.F.; Vanhoorelbeke, K.; Broos, K.; Salles, I.I.; Deckmyn, H. 2008: Antiplatelet drugs. British Journal of Haematology 142(4): 515-528

Anonymous 2011: Antiplatelet drugs and gastrointestinal disorders: when and how effective are inhibitors of proton pump?. Terapevticheskii arkhiv 83(10): 68-71

Winning, J.; Neumann, J.; Kohl, M.; Claus, R.A.; Reinhart, K.; Bauer, M.; Lösche, W. 2010: Antiplatelet drugs and outcome in mixed admissions to an intensive care unit. Critical Care Medicine 38(1): 32-37

Schmidt, M.; Johansen, M.B.; Lash, T.L.; Christiansen, C.F.; Christensen, S.; Sørensen, H.T. 2010: Antiplatelet drugs and risk of subarachnoid hemorrhage: a population-based case-control study. Journal of Thrombosis and Haemostasis: Jth 8(7): 1468-1474

Lacut, K.; van der Maaten, J.; Le Gal, G.ég.; Cornily, G.ér.; Mottier, D.; Oger, E. 2008: Antiplatelet drugs and risk of venous thromboembolism: results from the EDITH case-control study. Haematologica 93(7): 1117-1118

Vasudeva, P.; Goel, A.; Sengottayan, V.K.; Sankhwar, S.; Dalela, D. 2009: Antiplatelet drugs and the perioperative period: what every urologist needs to know. Indian Journal of Urology: Iju: Journal of the Urological Society of India 25(3): 296-301

Sugimoto, M.; Uotani, T.; Nishino, M.; Yamade, M.; Sahara, S.; Yamada, T.; Osawa, S.; Sugimoto, K.; Umemura, K.; Watanabe, H.; Miyajima, H.; Furuta, T. 2013: Antiplatelet drugs are a risk factor for esophageal mucosal injury. Digestion 87(4): 281-289

Leys, D.; Balucani, C.; Cordonnier, C. 2009: Antiplatelet drugs for ischemic stroke prevention. Cerebrovascular Diseases 27 Suppl. 1: 120-125

Anonymous 2009: Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice. Prescrire international 18(104): 272-273

Squizzato, A.; Romualdi, E.; Passamonti, F.; Middeldorp, S. 2013: Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia. Cochrane Database of Systematic Reviews 4: Cd006503

Krötz, F.; Sohn, H.-Y.; Klauss, V. 2008: Antiplatelet drugs in cardiological practice: established strategies and new developments. Vascular Health and Risk Management 4(3): 637-645

Cadiou, G.én.ël.; Adam, M.; Caussin, M.; Landrin, I.; Mariette, N.; Capet, C.; Mouton-Schleifer, D.; Remy, E.; Kadri, N.; Doucet, J. 2012: Antiplatelet drugs in the elderly: prescriptions often inappropriate and reduced tolerance by associated diseases and drugs. Fundamental and Clinical Pharmacology 26(2): 307-313

Vogt, A. 1999: Antiplatelet drugs plus thrombolysis in myocardial infarction: where are we now?. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 11(6): 377-383

Coimbra, L.S.; Steffens, J.P.; Muscará, M.N.; Rossa, C.; Spolidorio, L.C. 2014: Antiplatelet drugs reduce the immunoinflammatory response in a rat model of periodontal disease. Journal of Periodontal Research 49(6): 729-735

Coccheri, S. 2010: Antiplatelet drugs--do we need new options? with a reappraisal of direct thromboxane inhibitors. Drugs 70(7): 887-908

Patrono, C.; Baigent, C.; Hirsh, J.; Roth, G. 2008: Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl): 199S-233S

Eikelboom, J.W.; Hirsh, J.; Spencer, F.A.; Baglin, T.P.; Weitz, J.I. 2012: Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl): e89S

Hall, R.; Mazer, C.D. 2011: Antiplatelet drugs: a review of their pharmacology and management in the perioperative period. Anesthesia and Analgesia 112(2): 292-318

Gan, K.-H.; Teng, C.-H.; Lin, H.-C.; Chen, K.-T.; Chen, Y.-C.; Hsu, M.-F.; Wang, J.-P.; Teng, C.-M.; Lin, C.-N. 2008: Antiplatelet effect and selective binding to cyclooxygenase by molecular docking analysis of 3-alkylaminopropoxy-9,10-anthraquinone derivatives. Biological and Pharmaceutical Bulletin 31(8): 1547-1551

Chang, M.-C.; Wang, T.-M.; Yeung, S.-Y.; Jeng, P.-Y.; Liao, C.-H.; Lin, T.-Y.; Lin, C.-C.; Lin, B.-R.; Jeng, J.-H. 2011: Antiplatelet effect by p-cresol, a uremic and environmental toxicant, is related to inhibition of reactive oxygen species, ERK/p38 signaling and thromboxane A2 production. Atherosclerosis 219(2): 559-565

Fukushima, K.; Kobayashi, Y.; Kitahara, H.; Iwata, Y.; Kuroda, N.; Ooyama, M.; Kuwabara, Y.; Nomura, F.; Komuro, I. 2010: Antiplatelet effect of 50-mg maintenance dose of clopidogrel compared to 200 mg ticlopidine: a preliminary study. Heart and Vessels 25(1): 41-44

Mangiacapra, F.; Patti, G.; Barbato, E.; Orlic, D.; Peace, A.J.; D'Ambrosio, A.; Ostojic, M.; Wijns, W.; Di Sciascio, G. 2012: Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 Mi (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study. International Journal of Cardiology 160(3): 213-214

Papp, J.; Sandor, B.; Vamos, Z.; Botor, D.; Toth, A.; Rabai, M.; Kenyeres, P.; Cseplo, P.; Juricskay, I.; Mezosi, E.; Koller, A.; Toth, K. 2014: Antiplatelet effect of acetylsalicylic acid, metamizole and their combination - in vitro and in vivo comparisons. Clinical Hemorheology and Microcirculation 56(1): 1-12

Grove, E.L. 2012: Antiplatelet effect of aspirin in patients with coronary artery disease. Danish Medical Journal 59(9): B4506

Chang, M.-C.; Chang, H.-H.; Wang, T.-M.; Chan, C.-P.; Lin, B.-R.; Yeung, S.-Y.; Yeh, C.-Y.; Cheng, R.-H.; Jeng, J.-H. 2014: Antiplatelet effect of catechol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production. Plos one 9(8): E104310

Seo, K.-D.; Kim, Y.D.; Yoon, Y.-W.; Kim, J.-Y.; Lee, K.-Y. 2014: Antiplatelet effect of clopidogrel can be reduced by calcium-channel blockers. Yonsei Medical Journal 55(3): 683-688

Lepäntalo, A.; Virtanen, K.S.; Reséndiz, J.C.; Mikkelsson, J.; Viiri, L.E.; Karhunen, P.J.; Lassila, R. 2009: Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor. Thrombosis Research 124(2): 193-198

Bjelland, T.W.; Hjertner, Øy.; Klepstad, P.ål.; Kaisen, K.; Dale, O.; Haugen, B.ør.O. 2010: Antiplatelet effect of clopidogrel is reduced in patients treated with therapeutic hypothermia after cardiac arrest. Resuscitation 81(12): 1627-1631

Yamada, K.; Hirayama, T.; Hasegawa, Y. 2007: Antiplatelet effect of losartan and telmisartan in patients with ischemic stroke. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 16(5): 225-231

Addad, F.; Chakroun, T.; Elalamy, I.; Abderazek, F.; Chouchene, S.; Dridi, Z.; Gerotziafas, G.T.; Hatmi, M.; Hassine, M.; Gamra, H. 2010: Antiplatelet effect of once- or twice-daily aspirin dosage in stable coronary artery disease patients with diabetes. International Journal of Hematology 92(2): 296-301

Kocić, I.; Racek-Król, B.; Wapniarska, I.; Rusiecka, I.; Wasilewski, R.; Bitel, M. 2010: Antiplatelet effect of statins is augmented in diabetic rabbits. Pharmacological Reports: Pr 62(2): 410-413

Beigel, R.; Fefer, P.; Rosenberg, N.; Novikov, I.; Elian, D.; Fink, N.; Segev, A.; Guetta, V.; Hod, H.; Matetzky, S. 2013: Antiplatelet effect of thienopyridine (clopidogrel or prasugrel) pretreatment in patients undergoing primary percutaneous intervention for ST elevation myocardial infarction. American Journal of Cardiology 112(10): 1551-1556

Seo, E.Ji.; Lee, D-Ung.; Kwak, J.Hwan.; Lee, S-Mee.; Kim, Y.Shik.; Jung, Y-Sook. 2011: Antiplatelet effects of Cyperus rotundus and its component (+)-nootkatone. Journal of Ethnopharmacology 135(1): 48-54

Lee, J.-H.; Kim, M.; Chang, K.-H.; Hong, C.Y.; Na, C.-S.; Dong, M.-S.; Lee, D.; Lee, M.-Y. 2015: Antiplatelet effects of Rhus verniciflua stokes heartwood and its active constituents--fisetin, butein, and sulfuretin--in rats. Journal of Medicinal Food 18(1): 21-30

Lee, B-Joon.; Jo, I-Young.; Bu, Y.; Park, J-Woo.; Maeng, S.; Kang, H.; Jang, W.; Hwang, D-Sang.; Lee, W.; Min, K.; Kim, J-In.; Yoo, H.Hyun.; Lew, J-Hwan. 2011: Antiplatelet effects of Spatholobus suberectus via inhibition of the glycoprotein IIb/IIIa receptor. Journal of Ethnopharmacology 134(2): 460-467

Kimura, Y.; Shimizu, M.; Kohara, S.; Yoshii, F.; Sato, H.; Shinohara, Y. 2006: Antiplatelet effects of a Kampo medicine, Orengedokuto. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 15(6): 277-282

Flöck, A.; Zobel, A.; Bauriedel, G.; Tuleta, I.; Hammerstingl, C.; Höfels, S.; Schuhmacher, A.; Maier, W.; Nickenig, G.; Skowasch, D. 2010: Antiplatelet effects of antidepressant treatment: a randomized comparison between escitalopram and nortriptyline. Thrombosis Research 126(2): E83-E87

Kirkby, N.S.; Leadbeater, P.D.M.; Chan, M.V.; Nylander, S.; Mitchell, J.A.; Warner, T.D. 2011: Antiplatelet effects of aspirin vary with level of P2Y₁₂ receptor blockade supplied by either ticagrelor or prasugrel. Journal of Thrombosis and Haemostasis: Jth 9(10): 2103-2105

Antonino, M.J.; Coppolecchia, R.; Mahla, E.; Bliden, K.P.; Tantry, U.S.; Gurbel, P.A. 2010: Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone. Thrombosis Research 126(5): 384-385

Lee, D.-H.; Kim, H.-H.; Cho, H.-J.; Bae, J.-S.; Yu, Y.-B.; Park, H.-J. 2014: Antiplatelet effects of caffeic acid due to Ca(2＋) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation. Journal of Atherosclerosis and Thrombosis 21(1): 23-37

Sibbing, D.; Schulz, S.; Braun, S.; Morath, T.; Stegherr, J.; Mehilli, J.; Schömig, A.; von Beckerath, N.; Kastrati, A. 2010: Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement. Journal of Thrombosis and Haemostasis: Jth 8(2): 250-256

González, A.; Moniche, F.; Cayuela, A.; Gonzalez-Marcos, J.R.ón.; Mayol, A.; Montaner, J. 2014: Antiplatelet effects of clopidogrel dose adjustment (75 mg/d vs 150 mg/d) after carotid stenting. Journal of Vascular Surgery 60(2): 428-435

Velmurugan, S.; Kapil, V.; Ghosh, S.M.; Davies, S.; McKnight, A.; Aboud, Z.; Khambata, R.S.; Webb, A.J.; Poole, A.; Ahluwalia, A. 2013: Antiplatelet effects of dietary nitrate in healthy volunteers: involvement of cGMP and influence of sex. Free Radical Biology and Medicine 65: 1521-1532

Hobson, A.R.; Dawkins, K.D.; Curzen, N.P. 2008: Antiplatelet effects of licking an aspirin tablet can be detected by thrombelastography. Acute Cardiac Care 10(1): 62-63

Undas, A.; Celińiska-Löwenhoff, M. 2007: Antiplatelet effects of micronized fenofibrate in subjects with dyslipidemia. Polskie Archiwum Medycyny Wewnetrznej 117(5-6): 235-240

Tuleta, I.; Bauriedel, G.; Hasenbank, I.; Andrié, R.é; Pabst, S.; Nickenig, G.; Skowasch, D. 2009: Antiplatelet effects of n-3 polyunsaturated fatty acids compared with aspirin: a pilot study with whole-blood aggregometry. Thrombosis Research 124(6): 724-726

Fontenele, J.B.; Leal, L.K.A.M.; Silveira, E.R.; Felix, F.H.; Bezerra Felipe, C.íc.F.; Viana, G.S.B. 2009: Antiplatelet effects of piplartine, an alkamide isolated from Piper tuberculatum: possible involvement of cyclooxygenase blockade and antioxidant activity. Journal of Pharmacy and Pharmacology 61(4): 511-515

Alexopoulos, D.; Panagiotou, A.; Xanthopoulou, I.; Komninakis, D.; Kassimis, G.; Davlouros, P.; Fourtounas, C.; Goumenos, D. 2011: Antiplatelet effects of prasugrel vs. double clopidogrel in patients on hemodialysis and with high on-treatment platelet reactivity. Journal of Thrombosis and Haemostasis: Jth 9(12): 2379-2385

Bernlochner, I.; Mayer, K.; Morath, T.; Orban, M.; Schulz, S.; Schömig, A.; Braun, S.; Kastrati, A.; Sibbing, D. 2013: Antiplatelet efficacy of prasugrel in patients with high on-clopidogrel treatment platelet reactivity and a history of coronary stenting. Thrombosis and Haemostasis 109(3): 517-524

Arora, R.R.; Rai, F. 2009: Antiplatelet intervention in acute coronary syndrome. American Journal of Therapeutics 16(5): E29-E40

Meyer, D.M.; Compton, P.; Eastwood, J.-A.; Gylys, K.; Zivin, J.A. 2013: Antiplatelet loading improves behavioral outcome in a rabbit model of stroke. Stroke 44(11): 3246-3248

Lisman, T.; Porte, R.J. 2007: Antiplatelet medication after liver transplantation: does it affect outcome?. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 13(5): 644-646

Nickman, N.A.; Biskupiak, J.; Creekmore, F.; Shah, H.; Brixner, D.I. 2007: Antiplatelet medication management in patients hospitalized with ischemic stroke. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(21): 2250-2256

Hiremath, S.; Holden, R.M.; Fergusson, D.; Zimmerman, D.L. 2009: Antiplatelet medications in hemodialysis patients: a systematic review of bleeding rates. Clinical Journal of the American Society of Nephrology: Cjasn 4(8): 1347-1355

Stone, W.M.; Naidu, S.G.; Chapital, A.; Money, S.R. 2010: Antiplatelet medications: old and emerging therapies. Annals of Vascular Surgery 24(1): 140-148

Silvain, J.; Cayla, G.; O'Connor, S.A.; Collet, J-Philippe.; Montalescot, G. 2011: Antiplatelet options for secondary prevention in acute coronary syndromes. Expert Review of Cardiovascular Therapy 9(11): 1403-1415

Lee, J.; Park, Y.S.; Lee, C.-H.; Lee, S.-M.; Yoo, C.-G.; Kim, Y.W.; Han, S.K.; Yim, J.-J. 2013: Antiplatelet or anticoagulant therapy might not increase the risk of haemoptysis in patients with bronchiectasis. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 17(7): 989-991

Abdel-Latif, A.; Moliterno, D.J. 2009: Antiplatelet polypharmacy in primary percutaneous coronary intervention: trying to understand when more is better. Circulation 119(25): 3168-3170

Vilahur, G.; Badimon, L. 2013: Antiplatelet properties of natural products. Vascular Pharmacology 59(3-4): 67-75

Oxley, T.J.; Dowling, R.J.; Mitchell, P.J.; Davis, S.; Yan, B. 2011: Antiplatelet resistance and thromboembolic complications in neurointerventional procedures. Frontiers in Neurology 2: 83

Walter, P.N.; Tsakiris, D.A.; Romanens, M.; Arnet, I.; Hersberger, K.E. 2014: Antiplatelet resistance in outpatients with monitored adherence. Platelets 25(7): 532-538

Topçuoglu, M.A.; Arsava, E.M.; Ay, H. 2011: Antiplatelet resistance in stroke. Expert Review of Neurotherapeutics 11(2): 251-263

Gurbel, P.A.; Tantry, U.S. 2009: Antiplatelet resistance--fact or myth?. American Heart Hospital Journal 7(1): 50-57

Nakajima, T. 2018: A University Approach to Promoting the Proper Formulation and Use of Hospital Preparations. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 138(6): 763-766

Ishida, K.; Messé, S.R. 2014: Antiplatelet strategies for secondary prevention of stroke and TIA. Current Atherosclerosis Reports 16(11): 449

Braunwald, E.; Angiolillo, D.; Bates, E.; Berger, P.B.; Bhatt, D.; Cannon, C.P.; Furman, M.I.; Gurbel, P.; Michelson, A.D.; Peterson, E.; Wiviott, S. 2008: Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes. Clinical Cardiology 31(3 Suppl 1: I2-I9

Cassese, S.; Galasso, G.; Sciahbasi, A.; Scacciatella, P.; Muçaj, A.; Piccolo, R.; D'Anna, C.; Pangrazi, A.; Lioy, E.; Marra, S.; Piscione, F. 2013: Antiplatelet the Rapy after Genous EPC-capturing coro Nary stenT implantatiOn: the ARGENTO study: a prospective, multicenter registry. International Journal of Cardiology 167(3): 757-761

Dupont, A.G.; Gabriel, D.A.; Cohen, M.G. 2009: Antiplatelet therapies and the role of antiplatelet resistance in acute coronary syndrome. Thrombosis Research 124(1): 6-13

Bunimov, N.; Laneuville, O. 2013: Antiplatelet therapies: aspirin at the heart of new directions. Cardiovascular and Hematological Disorders Drug Targets 13(3): 173-184

Mousa, S.A. 2010: Antiplatelet therapies: drug interactions in the management of vascular disorders. Methods in Molecular Biology 663: 203-219

Giannitsis, E.; Katus, H.A. 2012: Antiplatelet therapy - ticagrelor. Hamostaseologie 32(3): 177-185

Olivier, C.B.; Diehl, P.; Bode, C.; Moser, M. 2014: Antiplatelet therapy after acute coronary syndrome. Therapeutic strategies and treatment duration. Herz 39(7): 808-813

Nowell, J.; Jahangiri, M. 2007: Antiplatelet therapy after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 32(6): 945

Goto, S.; Toda, E. 2009: Antiplatelet therapy after coronary intervention in Asia and Japan: the Asian perspective of antiplatelet intervention. Hamostaseologie 29(4): 321-325